Processing 00000000.tx.1: A Caenorhabditis elegans Parkin mutant with altered solubility couples -synuclein aggregation to proteotoxic stress Wolfdieter Springer1, Thorsten Hoppe1,, Enrico Schmidt2 and Ralf Baumeister1,2,* 1ABI/Molecular Neurogenetics, University of Munich, Germany and 2Bio3/Bioinformatics and Molecular Genetics, University of Freiburg, Germany * To whom correspondence should be addressed at: Bio3/Bioinformatics and Molecular Genetics, University of Freiburg, Schaenzlestr. 

Phrase: "A Caenorhabditis elegans Parkin mutant with altered solubility couples -synuclein aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "to proteotoxic stress Wolfdieter Springer1,"

Phrase: "Thorsten Hoppe1,"

Phrase: ", Enrico Schmidt2"

Phrase: "and"

Phrase: "Ralf Baumeister1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* 1ABI/Molecular Neurogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597047:Neurogenetics [Biomedical Occupation or Discipline]

Phrase: "University of Munich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "2Bio3/Bioinformatics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "University of Freiburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Bio3/Bioinformatics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "University of Freiburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Schaenzlestr."
Processing 00000000.tx.2: 1, 79104 Freiburg, Germany. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "79104 Freiburg,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.3: Tel: +49 7612032799; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+49 7612032799"

Phrase: ";"
Processing 00000000.tx.4: Fax: +49 7612038351; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+49 7612038351"

Phrase: ";"
Processing 00000000.tx.5: Email: baumeister{at}celegans.de Received June 7, 2005; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "baumeister{at}celegans.de Received June 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0011198:DE [Geographic Area]
   795   C0017480:DE [Geographic Area]
   795   C1514756:Received [Qualitative Concept]
   795   C3541240:DE [Idea or Concept]

Phrase: "2005"

Phrase: ";"
Processing 00000000.tx.6: Revised September 21, 2005; 

Phrase: "Revised September 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2005"

Phrase: ";"
Processing 00000000.tx.7: Accepted September 28, 2005  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mutations in the human parkin gene encoding an E3 ubiquitin ligase have been associated with early-onset recessive forms of Parkinson's disease (PD). 

Phrase: "Accepted September 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2005  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in the human parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "an E3 ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "been"

Phrase: "associated with early-onset recessive forms of Parkinson's disease"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   781   C0814120:early disease onset [Disease or Syndrome]
   764   C0030567:Parkinson Disease [Disease or Syndrome]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1521736:Parkinson's Disease [Functional Concept]
   764   C1833334:Early-onset [Finding]
   764   C2681933:PARKINSON DISEASE [Gene or Genome]
   762   C0243083:associated disease [Pathologic Function]
   762   C0277793:disease onset [Temporal Concept]
   762   C0679245:early disease [Temporal Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0332162:Onset [Qualitative Concept]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C1279919:Early [Temporal Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1522492:Form [Functional Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(PD"

Phrase: ")."
Processing 00000000.tx.8: However, the molecular mechanisms by which mutations in the parkin gene cause PD are still under debate. 

Phrase: "However,"

Phrase: "the molecular mechanisms by which mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the parkin gene cause PD"

Phrase: "are"

Phrase: "still under debate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0870392:debate [Activity]
Processing 00000000.tx.9: Here, we identified and characterized the Caenorhabditis elegans parkin homolog, pdr-1. 

Phrase: "Here,"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the Caenorhabditis elegans parkin homolog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1334043:Homolog [Gene or Genome]
   712 E C2697616:Homology [Qualitative Concept]

Phrase: "pdr-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]
Processing 00000000.tx.10: PDR-1 protein physically associates and cooperates with a conserved degradation machinery to mediate ubiquitin conjugation. 

Phrase: "PDR-1 protein physically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C2263837:PDR protein [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "cooperates with a conserved degradation machinery to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243125:degradation [Functional Concept]
   748   C0337076:machinery [Manufactured Object]
   748   C0699900:Degradation [Organism Function]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "ubiquitin conjugation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1160466:conjugation [Cell Function]
   789 E C0522529:Conjugated [Spatial Concept]
Processing 00000000.tx.11: Strikingly, in contrast to pdr-1 loss-of-function mutants, an in-frame deletion variant with altered solubility and intracellular localization properties is hypersensitive toward different proteotoxic stress conditions. 

Phrase: "Strikingly,"

Phrase: "in contrast to pdr-1 loss-of-function mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "an in-frame deletion variant with altered solubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "intracellular localization properties"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]
   734   C1660749:intracellular localization [Cell Function]

Phrase: "is"

Phrase: "hypersensitive toward different proteotoxic stress conditions."
Processing 00000000.tx.12: Both endoplasmic reticulum-derived folding stress and cytosolic stress conferred by expression of mutant human -synuclein resulted in severe developmental defects and lethality in pdr-1(lg103) mutant background. 

Phrase: "Both endoplasmic reticulum-derived folding stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   911   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   804   C0038435:Stress [Finding]
   733 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "cytosolic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "conferred by expression of mutant human -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086418:Human [Human]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "resulted in severe developmental defects"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0000768:Developmental defect [Congenital Abnormality]
   760   C0205082:Severe [Qualitative Concept]
   760   C0243067:defects [Functional Concept]
   760   C0458003:Developmental [Qualitative Concept]
   760   C0678723:Developmental [Organism Function]
   726   C1274040:Result [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "lethality in pdr-1"

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.13: Furthermore, we show that the corresponding truncated protein PDR-1(aa24247) aggregates in cell culture, but still interacts with its ubiquitylation co-enzymes. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the corresponding truncated protein PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0154830:PDR [Disease or Syndrome]
   804   C1418444:PDR [Gene or Genome]
   804   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in cell culture,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "but"

Phrase: "still"

Phrase: "interacts with its ubiquitylation co-enzymes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C1519751:Ubiquitylation [Molecular Function]
Processing 00000000.tx.14: Thus, it might block the cellular degradation/detoxification machinery and therefore renders worms highly vulnerable to protein folding stress. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "might"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the cellular degradation/detoxification machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0337076:machinery [Manufactured Object]

Phrase: "and"

Phrase: "therefore"

Phrase: "renders"

Phrase: "worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "highly vulnerable to protein folding stress."
Processing 00000000.tx.15: In contrast to other complete gene knockouts or RNAi models of Parkin function, this C. elegans model recapitulates Parkin insolubility and aggregation similar to several autosomal recessive juvenile parkinsonism (AR-JP)-linked Parkin mutations. 

Phrase: "In contrast to other complete gene knockouts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0599772:Knockouts, Gene [Molecular Biology Research Technique]

Phrase: "or"

Phrase: "RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136031:RNAi [Genetic Function]

Phrase: "models of Parkin function,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1418270:PARKIN [Gene or Genome]
   770   C1705273:Function [Intellectual Product]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3161035:Model [Intellectual Product]

Phrase: "this C. elegans model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C0162610:C ELEGANS [Eukaryote]

Phrase: "recapitulates"

Phrase: "Parkin insolubility"

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "similar to several autosomal recessive juvenile parkinsonism (AR-JP)-linked Parkin mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.16: We suggest that such Parkin variants that either confer a neomorphic function or a partial loss-of-function may help to further elucidate the biological function of Parkin in vivo and the pathogenic mechanisms resulting in AR-JP. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such Parkin variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "that either"

Phrase: "confer"

Phrase: "a neomorphic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "or"

Phrase: "a partial loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "elucidate"

Phrase: "the biological function of Parkin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0031845:Biological function, NOS [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0031843:function [Physiologic Function]
   760   C0205460:biological [Qualitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "the pathogenic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "resulting in AR-JP."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   820   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   790   C0332294:Resulting in [Functional Concept]
   790   C0441748:Autosomal recessive [Intellectual Product]
   790   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0596142:autosomal [Cell Component]
   753   C0678226:resulting [Functional Concept]
   753   C3146221:Juvenile [Age Group]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]
Processing 00000000.tx.17: Due to high-throughput capacity of C. elegans, this model is particularly well suited to identify genetic and chemical modifiers of toxicity.  

Phrase: "Due to high-throughput capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "of C. elegans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "particularly well suited to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205170:Well [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: "identify"

Phrase: "genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "chemical modifiers of toxicity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C1516451:Chemical Modifier [Chemical Viewed Functionally]
           Modifier
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.18: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting about 12% of the population over the age of 65. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "the second most common neurodegenerative disorder affecting about 12% of the population"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   755   C0525045:Disorder of affect [Mental or Behavioral Dysfunction]
           disorder affect
   736   C0392760:Affecting [Functional Concept]
   736   C1314939:Affecting [Functional Concept]
   703 E C0001721:Affect [Mental Process]

Phrase: "over the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.19: PD is mainly characterized by motor dysfunctions, resulting from selective loss of dopaminergic neurons in the substantia nigra (1). 

Phrase: "PD"

Phrase: "is"

Phrase: "mainly"

Phrase: "characterized by motor dysfunctions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0234131:dysfunctions motor [Sign or Symptom]
   770   C1513492:Motor [Functional Concept]
   770   C1705994:Motor [Manufactured Object]
   770   C1880022:Characterized [Activity]
   737   C0031847:dysfunction [Functional Concept]
   737   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "resulting from selective loss of dopaminergic neurons"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   853   C3550005:Loss of dopaminergic neurons [Finding]
   804   C0598940:Loss of neurons [Finding]
           neuron loss
   778   C1512035:Dopaminergic Neurons [Cell]
   748   C0027882:Neurons [Cell]
   748   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0678226:resulting [Functional Concept]
   748   C1517945:Loss [Quantitative Concept]
   732 E C1850496:Neuronal loss [Finding]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: A neuropathological hallmark of idiopathic PD is the formation of cytoplasmic protein inclusions called Lewy bodies. 

Phrase: "A neuropathological hallmark of idiopathic PD"

Phrase: "is"

Phrase: "the formation of cytoplasmic protein inclusions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597295:protein formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.21: A major component of these aggregates is the presynaptic protein -synuclein, implicated in many biological processes (2). 

Phrase: "A major component of these aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "the presynaptic protein -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "implicated in many biological processes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0031845:Biological Processes [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: Moreover, rare dominant mutations of -synuclein (35) and genomic multiplications (68) have been identified to be causative for the disease. 

Phrase: "Moreover,"

Phrase: "rare dominant mutations of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(35"

Phrase: ")"

Phrase: "and"

Phrase: "genomic multiplications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2911648:Multiplication [Quantitative Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "causative for the disease."
Processing 00000000.tx.23: A number of transgenic animal models have been generated that overexpress -synuclein in mice, flies (reviewed in 9) and in Caenorhabditis elegans (10). 

Phrase: "A number of transgenic animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C3274659:Model Number [Intellectual Product]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "that"

Phrase: "overexpress -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "synuclein in mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]

Phrase: "("

Phrase: "reviewed in 9"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: "and in Caenorhabditis elegans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0162610:Caenorhabditis elegans [Eukaryote]
   770   C0006638:Caenorhabditis [Eukaryote]
   770   C1515981:And [Idea or Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.24: In contrast to the rare dominant -synuclein mutations, mutations in the parkin gene cause autosomal recessive juvenile parkinsonism (AR-JP) (11), accounting for nearly 50% of cases with autosomal recessive PD and early onset of the disease. 

Phrase: "In contrast to the rare dominant -synuclein mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ")"

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "accounting for nearly 50% of cases"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   753   C0000938:Accounting [Occupational Activity]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1551359:account [Idea or Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
   719 E C2741673:Account # [Clinical Attribute]
   719 E C2981730:Account [Classification]

Phrase: "with autosomal recessive PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0441748:Autosomal recessive [Intellectual Product]

Phrase: "and"

Phrase: "early onset of the disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0814120:early disease onset [Disease or Syndrome]
   806   C1833334:Early-onset [Finding]
   797   C0277793:disease onset [Temporal Concept]
   797   C0679245:early disease [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]
   760   C1279919:Early [Temporal Concept]
Processing 00000000.tx.25: Human Parkin consists of four known domains: an N-terminal ubiquitin-like domain (UBL) and two RING finger domains flanking a cysteine rich in-between RING finger (IBR) domain (Fig.1A). 

Phrase: "Human Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "consists of four known domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205309:Known [Qualitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: ":"

Phrase: "an N-terminal ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "(UBL)"

Phrase: "and"

Phrase: "two RING finger domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1521759:RING Finger Domains [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "a cysteine rich in-between RING finger"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   827   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   827   C1521759:Ring Finger [Cell Component]
   799   C0016129:Finger [Body Location or Region]
   799   C0521164:Ring [Spatial Concept]
   799   C1260969:Ring [Medical Device]
   799   C1281584:Finger [Body Part, Organ, or Organ Component]
   799   C1705184:Ring [Medical Device]
   743 E C0442015:Digital [Intellectual Product]
   743 E C1883674:Digital [Qualitative Concept]
   716 E C0549188:fingers [Quantitative Concept]
   706 E C0582802:Digit [Body Part, Organ, or Organ Component]
   706 E C1283912:Digit [Body Part, Organ, or Organ Component]
   706 E C3241971:Digit [Quantitative Concept]

Phrase: "(IBR) domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.26: The UBL domain has been implicated in proteasome binding (12), substrate recognition (13) and regulation of Parkin stability (14). 

Phrase: "The UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in proteasome binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1514525:Proteasome Binding [Molecular Function]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "substrate recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "regulation of Parkin stability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.27: Like many proteins with RING finger domains, Parkin acts as an E3 ubiquitin ligase in vitro (15). 

Phrase: "Like many proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with RING finger domains,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1521759:RING Finger Domains [Cell Component]
           Ring Finger
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
   734   C0230398:Finger, ring [Body Part, Organ, or Organ Component]

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "acts as an E3 ubiquitin ligase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   833   C1418270:E3 ubiquitin ligase [Gene or Genome]
   753   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C1537525:E3 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.28: E3 proteins function as components of the ubiquitin/proteasome system that controls degradation of misfolded and regulatory proteins (16). 

Phrase: "E3 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function as components of the ubiquitin/proteasome system"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   744   C0031843:function [Physiologic Function]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0449432:Components [Manufactured Object]
   744   C0449913:System [Functional Concept]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1325620:proteasome [Cell Component]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C1705273:Function [Intellectual Product]
   744   C1752727:Proteasome [Molecular Function]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "degradation of misfolded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: View larger version (88K): [in this window] [in a new window]  Figure1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(88K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure1."
Processing 00000000.tx.30: C. elegans PDR-1 is conserved in evolution. 

Phrase: "C. elegans PDR-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1418485:C-1 [Gene or Genome]
   861   C0162610:C ELEGANS [Eukaryote]
   812   C0154830:PDR [Disease or Syndrome]
   812   C1418444:PDR [Gene or Genome]
   812   C1553033:[c] [Quantitative Concept]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "conserved in evolution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015219:Evolution [Genetic Function]
Processing 00000000.tx.31: (A) Schematic comparison of human Parkin and C. elegans homolog PDR-1. 

Phrase: "(A) Schematic comparison of human Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "C. elegans homolog PDR-1."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   897   C1418485:C-1 [Gene or Genome]
   840   C0162610:C ELEGANS [Eukaryote]
   804   C0154830:PDR [Disease or Syndrome]
   804   C1334043:Homolog [Gene or Genome]
   804   C1418444:PDR [Gene or Genome]
   804   C1553033:[c] [Quantitative Concept]
   804   C1845050:PDR [Disease or Syndrome]
   704 E C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.32: The respective domains are boxed: UBL: ubiquitin-like domain; 

Phrase: "The respective domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0179400:Box [Manufactured Object]
   966   C1533124:Box [Medical Device]

Phrase: ":"

Phrase: "UBL"

Phrase: ":"

Phrase: "ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.33: UPD: unique Parkin domain; 

Phrase: "UPD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ":"

Phrase: "unique Parkin domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.34: RING: C3HC4 RING finger domains; 

Phrase: "RING"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521164:Ring [Spatial Concept]
  1000   C1260969:Ring [Medical Device]
  1000   C1705184:Ring [Medical Device]

Phrase: ":"

Phrase: "C3HC4 RING finger domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1521759:RING Finger Domains [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.35: IBR: C6HC in-between RING finger domain. 

Phrase: "IBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021334:IBR [Disease or Syndrome]

Phrase: ":"

Phrase: "C6HC in-between RING finger domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521759:Ring Finger Domain [Cell Component]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.36: Identity and similarity values for each domain are shown. 

Phrase: "Identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "similarity values for each domain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1710611:Value Domain [Conceptual Entity]
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.37: (B) PDR-1/Parkin protein alignment. 

Phrase: "(B) PDR-1/Parkin protein alignment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1706765:Alignment [Quantitative Concept]
   709   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   709   C1336694:b-PROTEIN [Gene or Genome]
   709   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.38: Cloning and sequencing of the C. elegans pdr-1 cDNA revealed an additional coding exon (exon 4) not recognized by gene predictions. 

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "sequencing of the C. elegans pdr-1 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1553778:Sequencing [Intellectual Product]
   744   C1561491:Sequencing [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an additional coding exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by gene predictions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0681842:predictions [Idea or Concept]
Processing 00000000.tx.39: Additionally, the cDNAs of pdr-1 from the related nematode species C. briggsae and C. remanei were cloned. 

Phrase: "Additionally,"

Phrase: "the cDNAs of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from the related nematode species C. briggsae"

Phrase: "and"

Phrase: "C. remanei"

Phrase: "were"

Phrase: "cloned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]
Processing 00000000.tx.40: Length of PDR-1/Parkin proteins: C. elegans: 386 amino acids; 

Phrase: "Length of PDR-1/Parkin proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: ":"

Phrase: "C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: ":"

Phrase: "386 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.41: C. briggsae: 385 amino acids; 

Phrase: "C. briggsae"

Phrase: ":"

Phrase: "385 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.42: C. remanei: 387 amino acids; 

Phrase: "C. remanei"

Phrase: ":"

Phrase: "387 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.43: D. melanogaster: 468 amino acids; 

Phrase: "D. melanogaster"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1034337:Melanogaster [Fungus]

Phrase: ":"

Phrase: "468 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.44: M. musculus: 464 amino acids; 

Phrase: "M. musculus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026845:Musculus [Tissue]
   861   C1053014:Musculus [Eukaryote]

Phrase: ":"

Phrase: "464 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.45: R. norvegicus: 465 amino acids; 

Phrase: "R. norvegicus"

Phrase: ":"

Phrase: "465 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.46: B. taurus: 465 amino acids; 

Phrase: "B. taurus"

Phrase: ":"

Phrase: "465 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.47: H. sapiens: 465 amino acids. 

Phrase: "H. sapiens"

Phrase: ":"

Phrase: "465 amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.48: Black shading indicates sequence identity, gray shading sequence similarity. 

Phrase: "Black shading"

Phrase: "indicates"

Phrase: "sequence identity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "gray shading sequence similarity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1710052:Sequence Similarity [Quantitative Concept]
   812   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.49: Asterisks indicate positions of familial PD missense mutations in human Parkin (26). 

Phrase: "Asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "positions of familial PD missense mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:positions [Spatial Concept]

Phrase: "in human Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.50: (C) Genomic organization and gene structure of pdr-1. 

Phrase: "(C) Genomic organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0029237:Organisation [Physiologic Function]
   827   C0029246:Organization [Organization]
   827   C0220885:organization [Qualitative Concept]
   827   C1300196:Organization [Functional Concept]
   827   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "gene structure of pdr-1."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1517495:Gene Structure [Gene or Genome]
   762 E C0017366:Structural gene [Gene or Genome]
   760   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.51: Coding exons are depicted as boxes, introns as lines. pdr-1, together with its downstream gene K08E3.8 forms an operon (depicted by an arrow) driven by a single promoter, whereas the upstream gene cyk-4 (ORF K08E3.6) is located in a head-to-head orientation. pdr-1 is trans-spliced to splice leader 1 (SL1), the downstream gene K08E3.8 is trans-spliced to SL2. 

Phrase: "Coding exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "depicted as boxes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0179400:boxes [Manufactured Object]
   790   C1638312:Boxes [Quantitative Concept]
   756 E C1533124:Box [Medical Device]

Phrase: "introns as lines. pdr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with its downstream gene K08E3.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017337:Gene [Gene or Genome]
   812   C0522506:Downstream [Spatial Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an operon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029073:Operon [Gene or Genome]

Phrase: "("

Phrase: "depicted by an arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "driven by a single promoter,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037179:Single [Population Group]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726   C0013126:Drive [Mental Process]

Phrase: "whereas"

Phrase: "the upstream gene cyk-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017337:Gene [Gene or Genome]
   812   C0522505:Upstream [Spatial Concept]

Phrase: "(ORF K08E3.6"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "located in a head-to-head orientation. pdr-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0018670:Head [Body Location or Region]
   742   C0029266:Orientation [Mental Process]
   742   C0154830:PDR [Disease or Syndrome]
   742   C1281590:Head [Body Part, Organ, or Organ Component]
   742   C1418444:PDR [Gene or Genome]
   742   C1704322:orientation [Spatial Concept]
   742   C1704972:Orientation [Spatial Concept]
   742   C1706305:Head [Manufactured Object]
   742   C1845050:PDR [Disease or Syndrome]
   742   C3539923:Orientation [Intellectual Product]

Phrase: "is"

Phrase: "trans-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]

Phrase: "spliced"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "splice leader 1 (SL1),"

Phrase: "the downstream gene K08E3.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017337:Gene [Gene or Genome]
   812   C0522506:Downstream [Spatial Concept]

Phrase: "is"

Phrase: "trans-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]

Phrase: "spliced to SL2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1417200:SL2 [Gene or Genome]
   790   C3538873:SL2 [Gene or Genome]
Processing 00000000.tx.52: As both genes are co-transcriptionally regulated, K08E3.8 served as an internal control in this study. 

Phrase: "As"

Phrase: "both genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "co-transcriptionally"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "K08E3.8"

Phrase: "served as an internal control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0597937:internal control [Mental Process]
   760   C0205102:Internal [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.53: Shown are promoter construct (Ppdr-1::gfp), translational gfp fusion (Ppdr-1::gfp::pdr-1) and the rescuing subclone [Rescue pdr-1(wt)]. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "promoter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "(Ppdr-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "translational gfp fusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Ppdr-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "the rescuing subclone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883178:Subclone [Cell]

Phrase: "[Rescue pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "]."
Processing 00000000.tx.54: Lines represent the genomic regions cloned into the respective constructs. 

Phrase: "Lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the genomic regions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "cloned into the respective constructs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0009013:cloned [Cell]
   726 E C1522642:Clone [Tissue]
   726   C2827421:Construct [Classification]
Processing 00000000.tx.55: The asterisk indicates the position of an engineered frame-shift mutation in the downstream gene of the rescuing clone. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "the position of an engineered frame-shift mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0733755:Position [Spatial Concept]

Phrase: "in the downstream gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "of the rescuing clone."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.56: The position and extent of the four analyzed pdr-1 deletions alleles (lg103, tm598, lg101 and tm395) are depicted by lines.  

Phrase: "The position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "extent of the four analyzed pdr-1 deletions alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439792:Extent [Spatial Concept]

Phrase: "(lg103,"

Phrase: "tm598,"

Phrase: "lg101"

Phrase: "and"

Phrase: "tm395"

Phrase: ")"

Phrase: "are"

Phrase: "depicted by lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205132:lines [Spatial Concept]
   756 E C1550648:Line [Substance]
   756 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.57: In cell culture experiments, it has been observed that expression of human parkin is up-regulated in response to unfolded protein stress (17). 

Phrase: "In cell culture experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that expression of human parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "up-regulated in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C0871261:Response [Organism Attribute]
   770   C1282911:Up [Spatial Concept]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "to unfolded protein stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.58: The accumulation of misfolded proteins in the lumen of the endoplasmic reticulum (ER) activates an intracellular signaling pathway, the unfolded protein response (UPR). 

Phrase: "The accumulation of misfolded proteins"

Phrase: "in the lumen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "of the endoplasmic reticulum (ER)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an intracellular signaling pathway,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2755994:intracellular signaling pathway [Cell Function]
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "the unfolded protein response (UPR)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.59: This adaptive response augments ER folding capacity by transcriptional induction of ER-resident chaperones, folding catalysts and protein degradation complexes, and additionally limits further accumulation of unfolded proteins in the ER by translational attenuation (18). 

Phrase: "This adaptive response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0231193:Adaptive [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "ER folding capacity by transcriptional induction of ER-resident chaperones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1516240:Capacity [Quantitative Concept]

Phrase: "folding"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]
   966 E C0332462:Fold [Spatial Concept]
   966 E C1880834:FOLD [Phenomenon or Process]

Phrase: "catalysts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175921:Catalysts [Phenomenon or Process]

Phrase: "and"

Phrase: "protein degradation complexes,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   896   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C1523872:protein complex [Cell Component]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
   734   C0597297:Protein Degradation [Molecular Function]
   734   C0597304:Protein Degradation [Molecular Function]
   734   C1623036:Protein Degradation [Molecular Function]

Phrase: "and"

Phrase: "additionally"

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "further accumulation of unfolded proteins"

Phrase: "in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "by translational attenuation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1157546:translational attenuation [Genetic Function]
   861   C0599946:Attenuation [Activity]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.60: Unfolded proteins in the ER are retro-translocated to the cytosol and turned over by the ER-associated degradation (ERAD) pathway, a process regulated by the UPR (19). 

Phrase: "Unfolded proteins in the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "retro-translocated to the cytosol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205095:Retro- [Spatial Concept]
   760   C0521438:RETRO [Spatial Concept]
   760   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "over by the ER-associated degradation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C3178997:Endoplasmic Reticulum-Associated Degradation [Molecular Function]
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   748   C0205136:Over [Spatial Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0332281:Associated [Qualitative Concept]
   748   C0699900:Degradation [Organism Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(ERAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1157980:ERAD [Molecular Function]

Phrase: ")"

Phrase: "pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "regulated by the UPR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.61: Both pathways are required for the coordinated disposal of misfolded proteins even in the absence of acute stress (20,21). 

Phrase: "Both pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "required for the coordinated disposal of misfolded proteins even"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0427184:Coordinated [Finding]
   742   C0700114:Coordinated [Functional Concept]
   742   C1514873:Required [Functional Concept]
   742   C1707797:Disposal [Activity]
   708 E C1707511:Coordinate [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of acute stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0848237:acute stress [Sign or Symptom]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.62: A variety of potential Parkin substrates, including the Pael-R receptor of the cytoplasmic membrane (22) and a rare, O-glycosylated form of -synuclein (13), have already been identified (reviewed in 23). 

Phrase: "A variety of potential Parkin substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the Pael-R receptor of the cytoplasmic membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0230664:Membrane receptor [Receptor]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "a rare, O-glycosylated form of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "("

Phrase: "reviewed in 23"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0282443:reviewed [Intellectual Product]
   790   C0450348:23 [Quantitative Concept]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.63: Moreover, Parkin has been shown to protect against neurotoxicity induced by diverse cellular insults including overexpression of some of its substrates (24,25). 

Phrase: "Moreover,"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect against neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "induced by diverse cellular insults"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0205263:Induced [Functional Concept]
   760   C1880371:Diverse [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "overexpression of some of its substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.64: It was shown that a hotspot of familial mutations (Fig.1B) occurs in the RINGIBRRING domains (26) and interferes with Parkin's ubiquitylation activity, inhibiting its neuroprotective function (15). 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a hotspot of familial mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0263214:hot spot [Disease or Syndrome]
   760   C1521990:Hot Spot [Spatial Concept]
   760   C2947985:Hot Spot [Pharmacologic Substance]
   760   C2986491:Hotspot [Nucleotide Sequence]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "occurs in the RINGIBRRING domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "interferes with Parkin's ubiquitylation activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0521102:Interferes with [Qualitative Concept]
           Interfere
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1519751:Ubiquitylation [Molecular Function]
   760   C1561536:*Activity [Idea or Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "its neuroprotective function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.65: Although loss of Parkin function is considered to be causative for AR-JP, it had been suggested that some disease-linked point mutations of Parkin may retain substantial catalytic activity, and, therefore, should not be considered complete null alleles (2731). 

Phrase: "Although"

Phrase: "loss of Parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "causative for AR-JP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]

Phrase: "it"

Phrase: "had"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "some disease-linked point mutations of Parkin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   748   C0026882:Mutations [Genetic Function]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "substantial catalytic activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "should"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "null alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2985437:Null Allele [Cell or Molecular Dysfunction]
   861   C0002085:Alleles [Gene or Genome]

Phrase: "(2731"

Phrase: ")."
Processing 00000000.tx.66: Moreover, some of these mutations decrease the solubility of the protein, and, thus, result in Parkin variants with altered intracellular localization and/or a tendency to misfolding, aggregation and aggresome-formation (27,3234). 

Phrase: "Moreover,"

Phrase: "some of these mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the solubility of the protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037628:Solubility [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "thus,"

Phrase: "result in Parkin variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "with altered intracellular localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1660749:intracellular localization [Cell Function]
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "and/or"

Phrase: "a tendency to misfolding,"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "aggresome-formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(27,"

Phrase: "3234"

Phrase: ")."
Processing 00000000.tx.67: Animal models generated so far, i.e. by simply deleting the parkin gene locus, did not show the expected severe neurotoxicity typical for the familial PD mutations. 

Phrase: "Animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "so far,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by simply"

Phrase: "deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880274:Delete [Activity]

Phrase: "the parkin gene locus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1708726:Gene Locus [Gene or Genome]
           Locus
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the expected severe neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "typical for the familial PD mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.68: As a possible explanation, compensatory pathways have been suggested that may take over degradation/detoxification of neurotoxic substrates (23). 

Phrase: "As a possible explanation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "compensatory pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "may"

Phrase: "take over degradation/detoxification of neurotoxic substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025516:Detoxification [Organism Function]
   748   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.69: Therefore, animal models recapitulating Parkin insolubility, aggregation and aggresome-formation, rather than complete gene knockouts, may thus provide an opportunity for analyzing Parkin misfunction. 

Phrase: "Therefore,"

Phrase: "animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "recapitulating"

Phrase: "Parkin insolubility,"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "aggresome-formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "rather than"

Phrase: "complete gene knockouts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0599772:Knockouts, Gene [Molecular Biology Research Technique]

Phrase: "may"

Phrase: "thus"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an opportunity for analyzing Parkin misfunction."
Processing 00000000.tx.70: In agreement with this notion, we identified the C. elegans homolog of human parkin, pdr-1, and characterized several pdr-1 mutants. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with this notion,"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the C. elegans homolog of human parkin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homolog [Gene or Genome]

Phrase: "pdr-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "characterized several pdr-1 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.71: In contrast to loss-of-function mutants of this gene locus, the in-frame deletion allele pdr-1(lg103) is hypersensitive for proteotoxic stress conditions. 

Phrase: "In contrast to loss-of-function mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "of this gene locus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708726:Gene Locus [Gene or Genome]
           Locus

Phrase: "the in-frame deletion allele pdr-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C0002085:Allele [Gene or Genome]
   799   C0080089:Frame [Nucleotide Sequence]
   799   C0154830:PDR [Disease or Syndrome]
   799   C0180979:Frame [Medical Device]
   799   C1418444:PDR [Gene or Genome]
   799   C1442161:Deletion [Cell or Molecular Dysfunction]
   799   C1511760:Deletion [Genetic Function]
   799   C1705858:Frame [Manufactured Object]
   799   C1845050:PDR [Disease or Syndrome]
   799   C1880274:Deletion [Activity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "is"

Phrase: "hypersensitive for proteotoxic stress conditions."
Processing 00000000.tx.72: Both cytosolic stress and ER dysfunction exert specific toxicity in pdr-1(lg103) mutants. 

Phrase: "Both cytosolic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "ER dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "specific toxicity in pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.73: PDR-1 is involved in and regulated by the UPR, and truncated PDR-1(aa24247) seems to sequester critical components of the ubiquitylation machinery. 

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "regulated by the UPR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "truncated PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "critical components of the ubiquitylation machinery."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.74: We show that this allele, when expressed in a human cell culture system, exhibits an increased tendency to form aggregates. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "when"

Phrase: "expressed in a human cell culture system,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1516329:Cell Culture System [Molecular Biology Research Technique]
   778   C0007585:Cell Culture [Laboratory Procedure]
   778   C0427861:human cell [Laboratory or Test Result]
   748   C0007634:Cell [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0086418:Human [Human]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0449913:System [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an increased tendency to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.75: We also found an increased tendency of -synuclein to co-localize in these aggregates. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an increased tendency of -synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-localize in these aggregates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205418:aggregates [Qualitative Concept]
   760   C0392752:localize [Spatial Concept]
Processing 00000000.tx.76: In the worm, the corresponding C. elegans parkin mutant pdr-1(lg103) confers a highly penetrant, temperature-sensitive lethality in combination with transgenic expression of the human -synuclein mutant A53T, but not of wild-type -synuclein. 

Phrase: "In the worm,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
   916 E C0040820:Worms NOS [Disease or Syndrome]
   907 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "the corresponding C. elegans parkin mutant pdr-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0154830:PDR [Disease or Syndrome]
   795   C0596988:Mutant [Cell or Molecular Dysfunction]
   795   C1418270:PARKIN [Gene or Genome]
   795   C1418444:PDR [Gene or Genome]
   795   C1845050:PDR [Disease or Syndrome]
   795   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(lg103"

Phrase: ")"

Phrase: "confers"

Phrase: "a highly penetrant, temperature-sensitive lethality in combination"

Phrase: "with transgenic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the human -synuclein mutant A53T,"

Phrase: "but"

Phrase: "not of wild-type -synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1518422:Not [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.77: Thus, by combining a neomorphic PDR-1/Parkin mutant similar to the aggregation-prone AR-JP variants, with an -synuclein mutation, we have generated an animal model with high-throughput capacity that allows screening for PD modifiers.  

Phrase: "Thus,"

Phrase: "by combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "a neomorphic PDR-1/Parkin mutant similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2348205:Similar [Qualitative Concept]

Phrase: "to the aggregation-prone AR-JP variants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0205419:variants [Qualitative Concept]
   710   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]

Phrase: "with an -synuclein mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "an animal model with high-throughput capacity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0599779:Animal Model [Animal]
   748   C0003062:Animal [Animal]
   748   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "screening for PD modifiers."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.78: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  C. elegans pdr-1 is the homolog of human parkin We identified a single C. elegans homolog of human parkin [predicted open reading frame (ORF) K08E3.7] and named it pdr-1 (Parkinson's disease-related gene-1). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "C. elegans pdr-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1418485:C-1 [Gene or Genome]
   861   C0162610:C ELEGANS [Eukaryote]
   812   C0154830:PDR [Disease or Syndrome]
   812   C1418444:PDR [Gene or Genome]
   812   C1553033:[c] [Quantitative Concept]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "the homolog of human parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homolog [Gene or Genome]

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a single C. elegans homolog of human parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homolog [Gene or Genome]

Phrase: "[predicted open reading frame (ORF) K08E3.7"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   861   C0079941:Open Reading Frame [Gene or Genome]
   827   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   799   C0034754:Reading [Daily or Recreational Activity]
   799   C0175566:Open [Spatial Concept]
   799   C0180979:Frame [Medical Device]
   799   C0681842:Predicted [Idea or Concept]
   799   C1705179:Reading [Finding]
   799   C1705858:Frame [Manufactured Object]
   799   C1882327:%{Predicted} [Quantitative Concept]
   727 E C0547049:Openness [Spatial Concept]

Phrase: "]"

Phrase: "and"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "it pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(Parkinson's disease-related gene-1"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   847   C1425075:MALS-1 [Gene or Genome]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   825   C1416989:MAL gene [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0017337:Gene [Gene or Genome]
   804   C0439849:Related [Qualitative Concept]
   804   C0445223:Related [Finding]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C0080103:Relation [Family Group]
   733 E C0869014:Relations [Social Behavior]
   704   C1021144:Parkinsonia [Plant]

Phrase: ")."
Processing 00000000.tx.79: It encodes a 386 amino acid protein, PDR-1, and shares the characteristic domain organization with human Parkin along with 28% overall sequence identity and 41% similarity (Fig.1A and B). 

Phrase: "It"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a 386 amino acid protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PDR-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "the characteristic domain organization with human Parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
   748   C0220885:organization [Qualitative Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1522486:Organization [Professional or Occupational Group]

Phrase: "along with 28% overall sequence identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0424215:Identity [Mental Process]
   812   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "41% similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2348205:Similarity [Qualitative Concept]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.80: To examine the expression pattern of C. elegans pdr-1, wild-type animals (N2) transgenic for different green fluorescent protein (gfp) reporter constructs (Fig.1C) were analyzed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the expression pattern of C. elegans pdr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "wild-type animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: ")"

Phrase: "transgenic for different green fluorescent protein (gfp) reporter constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003069:Transgenic [Animal]

Phrase: "(Fig.1C"

Phrase: ")"

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.81: Expression starts in embryogenesis (Fig.2A) and is maintained throughout development (Fig.2B) until adulthood (Fig.2CH). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "starts in embryogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013936:Embryogenesis [Organ or Tissue Function]
   790   C0439659:Start [Temporal Concept]

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "maintained throughout development"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1314677:Maintained [Functional Concept]
   790   C1527148:Development [Functional Concept]
   756 E C0024501:Maintain [Activity]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "until"

Phrase: "adulthood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700597:Adulthood [Temporal Concept]

Phrase: "(Fig.2CH"

Phrase: ")."
Processing 00000000.tx.82: The translational fusion gfp::pdr-1 is highly expressed in most neurons (Fig.2BE), where it localizes to both cell bodies and processes (Fig.2B and D). 

Phrase: "The translational fusion gfp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   875   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in most neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(Fig.2BE"

Phrase: ")"

Phrase: ","

Phrase: "where"

Phrase: "it"

Phrase: "localizes to both cell bodies"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C0599444:bodies cell [Cell Component]
   773 E C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:bodies [Human]
   760   C0392752:localize [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.83: GFP staining is cytoplasmic and in most cases excluded from the nucleus (Fig.2C). 

Phrase: "GFP staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and in most cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "excluded from the nucleus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "(Fig.2C"

Phrase: ")."
Processing 00000000.tx.84: A strong GFP signal was observed in all muscle cells (Fig.2B and EH), and is also detectable in other, probably all, tissues. 

Phrase: "A strong GFP signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "observed in all muscle cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0596981:Muscle Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0026845:Muscle [Tissue]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "and"

Phrase: "EH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "also detectable in other,"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "all,"

Phrase: "tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.85: Northern blot analyses using total RNA from each single developmental stage of C. elegans confirmed the temporal expression pattern of pdr-1 observed with gfp reporter constructs. 

Phrase: "Northern blot analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA from each single developmental stage of C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the temporal expression pattern of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "observed with gfp reporter constructs."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1441672:Observed [Functional Concept]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]
   714   C2827421:Construct [Classification]
Processing 00000000.tx.86: Beginning at the larval L2 stage, pdr-1 transcript levels are up-regulated and reach a maximum in adulthood (Fig.2I), suggesting developmental dynamics in pdr-1 function. 

Phrase: "Beginning at the larval L2 stage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439659:Beginning [Temporal Concept]

Phrase: "pdr-1 transcript levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0441889:Levels [Qualitative Concept]
   812   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "and"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a maximum in adulthood"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0806909:Maximum [Quantitative Concept]
   770   C1552615:maximum [Quantitative Concept]
   770   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "(Fig.2I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552166:2i [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "developmental dynamics in pdr-1 function."
Processing 00000000.tx.87: View larger version (70K): [in this window] [in a new window]  Figure2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(70K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure2."
Processing 00000000.tx.88: pdr-1 is ubiquitously expressed and developmentally regulated. 

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: "and"

Phrase: "developmentally"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.89: (AH) Transgenic expression of different gfp reporter constructs in N2 wild-type animals (for constructs, see Fig.1C). 

Phrase: "(AH) Transgenic expression of different gfp reporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs in N2 wild-type animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0003070:Animals, Wild [Animal]
   753   C0003062:Animals [Animal]
   753   C0332307:Type [Qualitative Concept]
   753   C0441960:N2 [Finding]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C2827421:Construct [Classification]

Phrase: "("

Phrase: "for constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig.1C"

Phrase: ")."
Processing 00000000.tx.90: In all the 11 independent transgenic lines analyzed, gfp expression patterns, although mosaic, were almost identical. 

Phrase: "In all"

Phrase: "the 11 independent transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0003069:Transgenic [Animal]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "gfp expression patterns,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   836   C1317658:Protein pattern [Clinical Attribute]
   804   C0449774:Patterns [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "although"

Phrase: "mosaic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439750:Mosaic [Spatial Concept]
  1000   C0700058:Mosaic [Intellectual Product]
  1000   C2987512:Mosaic [Organism]

Phrase: "were"

Phrase: "almost identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.91: (A) Embryo expressing gfp in almost all cells. 

Phrase: "(A) Embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]

Phrase: "expressing"

Phrase: "gfp in almost"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]

Phrase: "all cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.92: (B) L2 larval gfp expression in pharyngeal and anal muscles (big arrows) as well as in neurons of the ventral nerve cord (small arrows). 

Phrase: "(B) L2 larval gfp expression in pharyngeal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1171362:protein expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "anal muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0026845:Muscles [Tissue]
   861   C1995013:Muscles [Body Part, Organ, or Organ Component]
   777 E C0442025:Muscular [Spatial Concept]

Phrase: "(big arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "as well as in neurons of the ventral nerve cord"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0027740:Nerve [Tissue]
   739   C0027757:NERVE [Tissue]
   739   C0027882:Neurons [Cell]
   739   C0205170:Well [Qualitative Concept]
   739   C1280541:Nerve [Body Part, Organ, or Organ Component]
   739   C1550235:Cord [Body Part, Organ, or Organ Component]
   739   C1552938:cord [Quantitative Concept]
   739   C1704448:Ventral [Spatial Concept]
   739   C1706500:Cord [Manufactured Object]
   739   C3146287:Well [Manufactured Object]

Phrase: "(small arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.93: (C) Cytoplasmatic localization of the translational fusion GFP::PDR-1 in a neuron. 

Phrase: "(C) Cytoplasmatic localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "of the translational fusion GFP::PDR-1"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   804   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   804   C0154830:PDR [Disease or Syndrome]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   804   C1418444:PDR [Gene or Genome]
   804   C1519614:Translational [Genetic Function]
   804   C1845050:PDR [Disease or Syndrome]
   733 E C0040712:Translation [Intellectual Product]
   733 E C0597295:translation [Molecular Function]

Phrase: "in a neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.94: (D) GFP::PDR-1 localization in cell bodies (small arrows) and processes of head neurons. 

Phrase: "("

Phrase: "D)"

Phrase: "GFP::PDR-1 localization in cell bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0242821:bodies [Human]
   795   C1995017:Bodies [Cell Component]
   785   C0599444:Cell body [Cell Component]
   785   C2752549:cell body [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]

Phrase: "(small arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "processes of head neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   786   C0085103:neuron process [Cell Component]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.95: (E) Pharyngeal muscles (big arrow) and neurons of the head (small arrows). 

Phrase: "(E) Pharyngeal muscles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0031346:Pharyngeal Muscles [Body Part, Organ, or Organ Component]
   827   C0026845:Muscles [Tissue]
   827   C1995013:Muscles [Body Part, Organ, or Organ Component]
   743 E C0442025:Muscular [Spatial Concept]

Phrase: "(big arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "neurons of the head"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(small arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.96: (F) Body-wall muscles. 

Phrase: "(F) Body-wall muscles."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0026845:Muscles [Tissue]
   812   C1995013:Muscles [Body Part, Organ, or Organ Component]
   729 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.97: (G) Vulval muscles (ventral view). 

Phrase: "(G) Vulval muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026845:Muscles [Tissue]
   827   C1995013:Muscles [Body Part, Organ, or Organ Component]
   743 E C0442025:Muscular [Spatial Concept]

Phrase: "(ventral view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.98: (H) Vulval muscles (lateral view). 

Phrase: "(H) Vulval muscles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026845:Muscles [Tissue]
   827   C1995013:Muscles [Body Part, Organ, or Organ Component]
   743 E C0442025:Muscular [Spatial Concept]

Phrase: "(lateral view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.99: The vulva opening is marked by an asterisk. 

Phrase: "The vulva opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175566:Opening [Spatial Concept]
   861   C1882151:Opening [Spatial Concept]

Phrase: "is"

Phrase: "marked by an asterisk."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   770   C2945706:asterisk [Conceptual Entity]
Processing 00000000.tx.100: (I) Northern blot analyses show co-transcriptional regulation of pdr-1 and K08E3.8 during all developmental stages, from embryogenesis (eggs) throughout larval stages (L1L4) until adulthood (adult). 

Phrase: "(I) Northern blot analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "co-transcriptional regulation of pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1158770:Transcriptional Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "K08E3.8 during all developmental stages,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0870411:Developmental stages [Temporal Concept]
   753   C0458003:Developmental [Qualitative Concept]
   753   C0678723:Developmental [Organism Function]
   753   C1306673:Stages [Qualitative Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]

Phrase: "from embryogenesis (eggs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "throughout larval stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "(L1L4"

Phrase: ")"

Phrase: "until"

Phrase: "adulthood (adult)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700597:Adulthood [Temporal Concept]
Processing 00000000.tx.101: pdr-1 and K08E3.8 transcript levels are up-regulated beginning in L2 and strongly increasing in L3. 

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "K08E3.8 transcript levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0441889:Levels [Qualitative Concept]
   812   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "beginning in L2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439659:Beginning [Temporal Concept]

Phrase: "and"

Phrase: "strongly"

Phrase: "increasing in L3."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0442808:Increasing [Functional Concept]
   790   C1179700:L3 [Body Location or Region]
   790   C1419655:L3 [Gene or Genome]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.102: All transcription levels indicated are relative to young adult levels and were adjusted for equal loading with the corresponding ama-1 (large subunit of RNA polymerase II) level.  

Phrase: "All transcription levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "are"

Phrase: "relative to young adult levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "adjusted for equal loading"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205163:Equal [Qualitative Concept]
   770   C0456081:Adjusted [Functional Concept]
   770   C1549782:Equal [Idea or Concept]
   770   C1708715:Loading [Activity]

Phrase: "with the corresponding ama-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002461:AMA [Professional Society]
   827   C0279755:AMA [Therapeutic or Preventive Procedure]
   827   C2825862:AMA [Laboratory Procedure]

Phrase: "(large subunit of RNA polymerase II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1335231:RNA POLYMERASE II, LARGE SUBUNIT [Gene or Genome]
   753   C1711351:Subunit [Quantitative Concept]

Phrase: ")"

Phrase: "level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.103: PDR-1 acts as an E3 ubiquitin ligase in a conserved ubiquitylation complex To investigate the role of PDR-1 protein in C. elegans, we screened for its interaction partners using the yeast two-hybrid system. 

Phrase: "PDR-1 acts as an E3 ubiquitin ligase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in a conserved ubiquitylation complex To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of PDR-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in C. elegans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "we"

Phrase: "screened for its interaction partners"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0682323:partners [Family Group]
   760   C1704675:Interaction [Functional Concept]
   726   C0220908:screen [Health Care Activity]
   726   C1305399:screen [Functional Concept]
   726   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid system."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.104: PDR-1 specifically interacts and cooperates with C. elegans UBC-2, UBC-18 and UBC-15 (Fig.3A), homologs of the human E2 enzymes UbcH4/5, UbcH7/8 and Ubc6, respectively (35). 

Phrase: "PDR-1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "interacts"

Phrase: "and"

Phrase: "cooperates with C. elegans UBC-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1421267:UBC [Gene or Genome]
   753   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "UBC-18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "UBC-15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.3A"

Phrase: ")"

Phrase: ","

Phrase: "homologs of the human E2 enzymes UbcH4/5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1334043:Homolog [Gene or Genome]

Phrase: "UbcH7/8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421286:UBCH7 [Gene or Genome]

Phrase: "and"

Phrase: "Ubc6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425009:UBC6 [Gene or Genome]

Phrase: "respectively"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.105: Additionally, we identified CHN-1 (36) (Fig.3A), the homolog of human E4 enzyme CHIP, that has been shown previously to interact with human Parkin and to enhance its E3 ligase activity (22). 

Phrase: "Additionally,"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "CHN-1"

Phrase: "(36"

Phrase: ")"

Phrase: "(Fig.3A"

Phrase: ")"

Phrase: ","

Phrase: "the homolog of human E4 enzyme CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homolog [Gene or Genome]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously to"

Phrase: "interact with human Parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its E3 ligase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0077678:E3 Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.106: E4 enzymes such as CHN-1/CHIP function as ubiquitin-chain elongation factors that ensure efficient multi-ubiquitylation of substrates (37). 

Phrase: "E4 enzymes such as CHN-1/CHIP function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]

Phrase: "as ubiquitin-chain elongation factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086206:Elongation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "efficient multi-ubiquitylation of substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519751:Ubiquitylation [Molecular Function]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.107: Furthermore, we found an association of PDR-1 with RPT-2, a regulatory subunit of the C. elegans 26S proteasome (Fig.3A). 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an association of PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with RPT-2,"

Phrase: "a regulatory subunit of the C. elegans 26S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.108: These yeast two-hybrid interactions of PDR-1 were confirmed by GST-pull-down experiments (Fig.3B). 

Phrase: "These yeast two-hybrid interactions of PDR-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0599647:Two Hybrid [Molecular Biology Research Technique]
   744   C0020205:Hybrid [Organism]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0205448:Two [Quantitative Concept]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   711   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "confirmed by GST-pull-down experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0580846:pull [Finding]
   753   C0681814:Experiments [Research Activity]
   753   C0750484:Confirmed [Idea or Concept]
   719 E C1456348:Confirm [Qualitative Concept]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.109: View larger version (38K): [in this window] [in a new window]  Figure3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure3."
Processing 00000000.tx.110: PDR-1 physically associates with a conserved C. elegans degradation machinery and mediates E3 ubiquitin ligase activity. 

Phrase: "PDR-1 physically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "associates with a conserved C. elegans degradation machinery"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0243125:degradation [Functional Concept]
   744   C0337076:machinery [Manufactured Object]
   744   C0699900:Degradation [Organism Function]
   744   C0750490:Associate [Idea or Concept]
   744   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "E3 ubiquitin ligase activity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C1150685:ubiquitin-ligase activity [Molecular Function]
   875   C1325411:ubiquitin activity [Molecular Function]
   861   C1150651:ligase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   756   C1418270:E3 ubiquitin ligase [Gene or Genome]
Processing 00000000.tx.111: (A) GAL4 yeast two-hybrid interactions studies of C. elegans PDR-1. 

Phrase: "(A) GAL4 yeast two-hybrid interactions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0599647:Two Hybrid [Molecular Biology Research Technique]
   799   C0020205:Hybrid [Organism]
   799   C0036025:yeast [Fungus]
   799   C0043392:Yeast [Food]
   799   C0043393:Yeast [Fungus]
   799   C0205448:Two [Quantitative Concept]
   799   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   766   C1704675:Interaction [Functional Concept]

Phrase: "studies of C. elegans PDR-1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0154830:PDR [Disease or Syndrome]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C1418444:PDR [Gene or Genome]
   753   C1845050:PDR [Disease or Syndrome]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.112: Growth analysis of yeast cells expressing the indicated combinations of control (), PDR-1 and its associated proteins, to test for interaction-dependent activation of HIS3 and ADE2 genes. 

Phrase: "Growth analysis of yeast cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "expressing"

Phrase: "the indicated combinations of control"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "its associated proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for interaction-dependent activation of HIS3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0201781:Activation test [Laboratory Procedure]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1704675:Interaction [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "ADE2 genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.113: Equal concentrations of the respective yeast strains were spotted in doublets on appropriate selective medium plates. 

Phrase: "Equal concentrations of the respective yeast strains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "spotted in doublets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0329155:Spot [Fish]
   756   C1427618:SPOT [Gene or Genome]
   756   C1705203:Spot [Conceptual Entity]

Phrase: "on appropriate selective medium plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.114: PDR-1 specifically interacts with C. elegans E2 enzymes UBC-18/UbcH7/8, UBC-2/Ubch4/5 and UBC-15/Ubc6, but not with UBC-6, UBC-7 or UBC-14, homologs of S. cerevisiae Ubc7. 

Phrase: "PDR-1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "interacts"

Phrase: "with C. elegans E2 enzymes UBC-18/UbcH7/8,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0162610:C ELEGANS [Eukaryote]
   793   C0014442:Enzymes [Enzyme,Organic Chemical]
   793   C0014445:enzymes [Functional Concept]
   793   C1421267:UBC [Gene or Genome]
   793   C1421286:UBCH7 [Gene or Genome]
   793   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1553033:[c] [Quantitative Concept]
   793   C3539520:E2 [Gene or Genome]

Phrase: "UBC-2/Ubch4/5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "UBC-15/Ubc6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425009:UBC6 [Gene or Genome]

Phrase: "but"

Phrase: "not with UBC-6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1421267:UBC [Gene or Genome]
   770   C1518422:Not [Functional Concept]
   770   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "UBC-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "UBC-14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homologs of S. cerevisiae Ubc7."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1334043:Homolog [Gene or Genome]
Processing 00000000.tx.115: In addition, PDR-1 associates with the E4 enzyme CHN-1/CHIP and with the proteasomal subunit RPT-2/P26s4. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "associates with the E4 enzyme CHN-1/CHIP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0600596:Chip [Research Device]
   744   C0750490:Associate [Idea or Concept]
   744   C1706221:Associate [Professional or Occupational Group]

Phrase: "and with the proteasomal subunit RPT-2/P26s4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1515981:And [Idea or Concept]
   744   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.116: (B) PDR-1 GST-pull-down experiments with recombinant proteins analyzed by Coomassie blue staining followed by autoradiography. 

Phrase: "(B) PDR-1 GST-pull-down experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0681814:Experiments [Research Activity]
   762 E C1706386:Experiment [Conceptual Entity]
   712 E C1517586:Experimental [Qualitative Concept]

Phrase: "with recombinant proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514798:recombinant [Organism]

Phrase: "analyzed by Coomassie blue staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]

Phrase: "followed by autoradiography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0004400:Autoradiography [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.117: Immobilized GST-fused UBC-18/UbcH7/8, UBC-2/UbcH4/5 and CHN-1/CHIP are able to bind and pull down in vitro translated PDR-1, labeled with 35S methionine/cysteine. 

Phrase: "Immobilized GST-fused UBC-18/UbcH7/8,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0699952:Fused [Functional Concept]
   795   C1421267:UBC [Gene or Genome]
   795   C1421286:UBCH7 [Gene or Genome]
   795   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C1414861:FUSE [Gene or Genome]
   762 E C1708111:Fuse [Manufactured Object]

Phrase: "UBC-2/UbcH4/5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "CHN-1/CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600596:Chip [Research Device]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "pull down in vitro translated PDR-1,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0021135:In Vitro [Intellectual Product]
   818   C1533691:in vitro [Qualitative Concept]
           vitro
   818   C2827718:In Vitro [Functional Concept]
   795   C0040710:translated [Occupational Activity]
   795   C0154830:PDR [Disease or Syndrome]
   795   C0580846:pull [Finding]
   795   C1418444:PDR [Gene or Genome]
   795   C1845050:PDR [Disease or Syndrome]
   740   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   740   C2626739:Lanugo [Eukaryote]

Phrase: "labeled with 35S methionine/cysteine."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.118: GST alone was used as a negative control. 

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "used as a negative control."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.119: (C) In vitro self-ubiquitylation of PDR-1. 

Phrase: "(C) In vitro self-ubiquitylation of PDR-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitylation [Molecular Function]
Processing 00000000.tx.120: The entire ubiquitylation system was reconstituted using purified proteins. 

Phrase: "The entire ubiquitylation system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "reconstituted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "purified proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.121: Baculoviral GST::myc::PDR-1 was incubated with the combination of ubiquitin, E1 and the C. elegans E2 enzyme UBC-2 or human E2 UbcH7, as well as the E4 enzyme CHN-1, as indicated, and analyzed by western blotting using anti-myc antibody. 

Phrase: "Baculoviral GST::myc::PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0079005:Baculoviral [Virus]
   804   C0154830:PDR [Disease or Syndrome]
   804   C1418444:PDR [Gene or Genome]
   804   C1845050:PDR [Disease or Syndrome]

Phrase: "was"

Phrase: "incubated with the combination of ubiquitin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205195:Combination [Qualitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1947911:Combination [Physical Object]

Phrase: "E1"

Phrase: "and"

Phrase: "the C. elegans E2 enzyme UBC-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0050322:c 2 [Lipid]
   858   C1420639:E2-2 [Gene or Genome]
   799   C1421267:UBC [Gene or Genome]
   799   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "human E2 UbcH7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421286:UBCH7 [Gene or Genome]

Phrase: "as well as"

Phrase: "the E4 enzyme CHN-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "and"

Phrase: "analyzed by western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.122: Efficient self-ubiquitylation of PDR-1 requires E1, E2 (C. elegans UBC-2 or human UbcH7) and the E4 enzyme CHN-1.  

Phrase: "Efficient self-ubiquitylation of PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "requires"

Phrase: "E1,"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "(C. elegans UBC-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0050322:c 2 [Lipid]
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "human UbcH7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421286:UBCH7 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the E4 enzyme CHN-1."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.123: Self-ubiquitylation is characteristic for RING finger containing E3 ligases (38). 

Phrase: "Self-ubiquitylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitylation [Molecular Function]

Phrase: "is"

Phrase: "characteristic for RING finger containing E3 ligases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristic [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.124: To confirm the enzymatic activities of PDR-1, we performed an assay in which self-ubiquitylation in the absence of a specific substrate occurs on the ubiquitin ligase itself. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the enzymatic activities of PDR-1,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C2267219:Enzymatic Activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "an assay in which self-ubiquitylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a specific substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "occurs on the ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "itself."
Processing 00000000.tx.125: In conjunction with the complete set of E1, E2 and E4 enzymes from C. elegans, and even in concert with human E2 enzyme UbcH7, a known binding partner of human Parkin (13), PDR-1 shows self-ubiquitylation (Fig.3C). 

Phrase: "In conjunction with the complete set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of E1,"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E4 enzymes from C. elegans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "even in concert"

Phrase: "with human E2 enzyme UbcH7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1421286:UBCH7 [Gene or Genome]

Phrase: "a known binding partner of human Parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0243122:binding [Functional Concept]
   748   C0682323:Partner [Family Group]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "self-ubiquitylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitylation [Molecular Function]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: In this assay, only a minor fraction of PDR-1 was ubiquitylated. 

Phrase: "In this assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor fraction of PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C3642197:Fraction of 1 [Quantitative Concept]
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "ubiquitylated."
Processing 00000000.tx.127: This was not necessarily surprising, as the self-ubiquitylation activity of human Parkin was also generally weaker than its poly-ubiquitylation activity on defined substrate proteins, and in some cases had required a more sensitive mode of detection using I125-labeled ubiquitin (15). 

Phrase: "This"

Phrase: "was"

Phrase: "not necessarily surprising,"

Phrase: "as"

Phrase: "the self-ubiquitylation activity of human Parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0020115:Human Activity [Activity]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also generally weaker than its poly-ubiquitylation activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0004093:Weak [Sign or Symptom]
   711   C1762617:Weak [Qualitative Concept]

Phrase: "on defined substrate proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and in some cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "a more sensitive mode of detection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "I125-labeled ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.128: In summary, these biochemical data demonstrate that PDR-1 acts as an E3 ligase in a highly conserved ubiquitylation complex. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these biochemical data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that PDR-1 acts as an E3 ligase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in a highly conserved ubiquitylation complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.129: We thus suggest that PDR-1 is the functional ortholog of human Parkin. 

Phrase: "We thus"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "the functional ortholog of human Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1335144:Ortholog [Gene or Genome]
Processing 00000000.tx.130: Molecular and biochemical analyses of mutant C. elegans pdr-1 alleles To further investigate the in vivo function of pdr-1, we analyzed four different deletion mutants represented by the alleles lg103, tm598, lg101 and tm395 that were isolated from UV/trimethylpsoralen-mutagenized C. elegans deletion libraries (Fig.4A and for overview see Fig.1C). 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "biochemical analyses of mutant C. elegans pdr-1 alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "To further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the in vivo function of pdr-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "four different deletion mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "represented by the alleles lg103,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002085:Alleles [Gene or Genome]
   726   C1882932:Represent [Activity]

Phrase: "tm598,"

Phrase: "lg101"

Phrase: "and"

Phrase: "tm395"

Phrase: "that"

Phrase: "were"

Phrase: "isolated from UV/trimethylpsoralen-mutagenized C. elegans deletion libraries"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   742   C0023621:Libraries [Manufactured Object,Organization]
   742   C0041625:UV [Natural Phenomenon or Process]
   742   C0162480:Trimethylpsoralen [Organic Chemical,Pharmacologic Substance]
   742   C0205409:Isolated [Functional Concept]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1548221:Isolated [Idea or Concept]
   742   C1880274:Deletion [Activity]
   742   C1961129:uV [Quantitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   708 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and for overview"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0814812:overview [Intellectual Product]
   790   C1515981:And [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig.1C"

Phrase: ")."
Processing 00000000.tx.131: Cloning of the corresponding mutant pdr-1 cDNAs by polymerase chain reactions with reverse-transcribed RNA (RTPCR) revealed that the alleles lg103 and tm598 carry in-frame deletions encoding the internally truncated PDR-1 proteins aa24247 and aa140263, respectively (Fig.4A). 

Phrase: "Cloning of the corresponding mutant pdr-1 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0009015:Cloning [Research Activity]

Phrase: "by polymerase chain reactions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Reactions, Polymerase Chain [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "with reverse-transcribed RNA (RTPCR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the alleles lg103"

Phrase: "and"

Phrase: "tm598"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "in-frame deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the internally truncated PDR-1 proteins aa24247"

Phrase: "and"

Phrase: "aa140263,"

Phrase: "respectively"

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.132: The allele lg103 fuses exons 1 and 5, whereas the allele tm598 fuses exons 3 and 5 of pdr-1. 

Phrase: "The allele lg103"

Phrase: "fuses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699952:fuse [Functional Concept]
  1000   C1414861:FUSE [Gene or Genome]
  1000   C1708111:Fuse [Manufactured Object]

Phrase: "exons 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "whereas"

Phrase: "the allele tm598"

Phrase: "fuses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699952:fuse [Functional Concept]
  1000   C1414861:FUSE [Gene or Genome]
  1000   C1708111:Fuse [Manufactured Object]

Phrase: "exons 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5 of pdr-1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0154830:PDR [Disease or Syndrome]
   770   C0439084:>5 [Quantitative Concept]
   770   C0728893:+5 [Quantitative Concept]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]
Processing 00000000.tx.133: Both these alleles delete the UPD and the first RING finger, but preserve the intact C-terminal IBR and second RING finger domain. 

Phrase: "Both"

Phrase: "these alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "delete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Delete [Activity]

Phrase: "the UPD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the first RING finger,"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   901   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   901   C1521759:Ring Finger [Cell Component]
   827   C0016129:Finger [Body Location or Region]
   827   C0521164:Ring [Spatial Concept]
   827   C1260969:Ring [Medical Device]
   827   C1281584:Finger [Body Part, Organ, or Organ Component]
   827   C1705184:Ring [Medical Device]
   771 E C0442015:Digital [Intellectual Product]
   771 E C1883674:Digital [Qualitative Concept]
   743 E C0549188:fingers [Quantitative Concept]
   734 E C0582802:Digit [Body Part, Organ, or Organ Component]
   734 E C1283912:Digit [Body Part, Organ, or Organ Component]
   734 E C3241971:Digit [Quantitative Concept]

Phrase: "but"

Phrase: "preserve"

Phrase: "the intact C-terminal IBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0021334:IBR [Disease or Syndrome]

Phrase: "and"

Phrase: "second RING finger domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1521759:Ring Finger Domain [Cell Component]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
   708   C0230388:Second finger [Body Part, Organ, or Organ Component]
Processing 00000000.tx.134: However, the allele lg103 additionally lacks the important UBL domain which is still present in the allele tm598 (Fig.4A). 

Phrase: "However,"

Phrase: "the allele lg103 additionally"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the important UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "still"

Phrase: "present in the allele tm598"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.135: In contrast, the alleles lg101 and tm395 remove most of the pdr-1 ORF and result in out-of-frame mutations creating a premature translational stop codon (Fig.4A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the alleles lg101"

Phrase: "and"

Phrase: "tm395"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "most of the pdr-1 ORF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0079941:Open Reading Frame [Gene or Genome]
   770   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   767   C1425057:MOST-1 [Gene or Genome]
   744   C0034754:Reading [Daily or Recreational Activity]
   744   C0154830:PDR [Disease or Syndrome]
   744   C0175566:Open [Spatial Concept]
   744   C0180979:Frame [Medical Device]
   744   C0205393:Most [Quantitative Concept]
   744   C1418444:PDR [Gene or Genome]
   744   C1705179:Reading [Finding]
   744   C1705858:Frame [Manufactured Object]
   744   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "result in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1274040:Result [Functional Concept]
   833   C1546471:Result [Idea or Concept]
   833   C2825142:Result [Finding]

Phrase: "out-of-frame mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "a premature translational stop codon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0242612:Premature Stop Codon [Nucleotide Sequence]
   861   C0242611:Stop Codon [Nucleotide Sequence]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.136: The deletion of allele lg103 was confirmed by northern blot analysis and revealed that the mutant gene is transcribed at a level comparable to wild-type. 

Phrase: "The deletion of allele lg103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "confirmed by northern blot analysis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the mutant gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678941:mutant gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "transcribed at a level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "comparable to wild-type."
Processing 00000000.tx.137: Importantly, transcription efficiency of the downstream gene K08E3.8 is unaffected by this deletion (Fig.4B). 

Phrase: "Importantly,"

Phrase: "transcription efficiency of the downstream gene K08E3.8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0013682:Efficiency [Quantitative Concept]

Phrase: "is"

Phrase: "unaffected by this deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: View larger version (55K): [in this window] [in a new window]  Figure4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure4."
Processing 00000000.tx.139: Molecular and biochemical analyses of pdr-1 mutants. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "biochemical analyses of pdr-1 mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
Processing 00000000.tx.140: (A) Detailed view of the pdr-1 deletions and the corresponding mutant gene products. 

Phrase: "(A) Detailed view of the pdr-1 deletions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1526904:View 1 [Functional Concept]
   744   C0449911:View [Spatial Concept]

Phrase: "and"

Phrase: "the corresponding mutant gene products."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.141: Coding exons are indicated as boxes, introns as lines. 

Phrase: "Coding exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "indicated as boxes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0179400:boxes [Manufactured Object]
   790   C1444656:Indicated [Finding]
   790   C1638312:Boxes [Quantitative Concept]
   756 E C1533124:Box [Medical Device]

Phrase: "introns as lines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.142: Encoded domains are color-boxed: blue: ubiquitin-like domain (UBL); 

Phrase: "Encoded domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "color-boxed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: ":"

Phrase: "blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ":"

Phrase: "ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(UBL"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.143: yellow: unique Parkin domain (UPD); 

Phrase: "yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ":"

Phrase: "unique Parkin domain (UPD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.144: red: C3HC4 RING finger domains (RING); 

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ":"

Phrase: "C3HC4 RING finger domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1521759:RING Finger Domains [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "(RING"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521164:Ring [Spatial Concept]
  1000   C1260969:Ring [Medical Device]
  1000   C1705184:Ring [Medical Device]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.145: green: C6HC in-between RING finger domain (IBR). 

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: "C6HC in-between RING finger domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521759:Ring Finger Domain [Cell Component]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "(IBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021334:IBR [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.146: The extent and the nature of the deletions as well as the resulting mutant proteins are listed. 

Phrase: "The extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "the nature of the deletions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "as well as"

Phrase: "the resulting mutant proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "listed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.147: In-frame deletions are indicated by dotted lines and early stops generated by out-of-frame deletions are marked by asterisks. 

Phrase: "In-frame deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: "are"

Phrase: "indicated by dotted lines"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205132:lines [Spatial Concept]
   770   C1444656:Indicated [Finding]
   737   C0872145:DOT [Therapeutic or Preventive Procedure]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "early stops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0450446:Stops [Manufactured Object]
   827 E C1947925:Stop [Activity]
   827 E C2746065:Stop [Temporal Concept]

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "out-of-frame deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "are"

Phrase: "marked by asterisks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0522501:Marked [Qualitative Concept]
   790   C1706089:Marked [Qualitative Concept]
   790   C2945706:asterisks [Conceptual Entity]
Processing 00000000.tx.148: For exact deletion breakpoints, see Materials and Methods. 

Phrase: "For exact deletion breakpoints,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.149: (B) Northern blot analysis of pdr-1 transcripts from wild-type and pdr-1(lg103) mutants. pdr-1(lg103) produces a truncated transcript at levels comparable to wild-type pdr-1. 

Phrase: "(B) Northern blot analysis of pdr-1 transcripts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants. pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0154830:PDR [Disease or Syndrome]
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "produces"

Phrase: "a truncated transcript at levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "comparable to wild-type pdr-1."
Processing 00000000.tx.150: Also the deletion pdr-1(lg103) does not affect co-transcription of the downstream gene K08E3.8. 

Phrase: "Also"

Phrase: "the deletion pdr-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1845050:PDR [Disease or Syndrome]
   827   C1880274:Deletion [Activity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "co-transcription of the downstream gene K08E3.8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.151: An act-1/actin-specific probe confirms slightly unequal loading (also see Fig.5B for normalized data). 

Phrase: "An act-1/actin-specific probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "slightly unequal loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]

Phrase: "(also"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig.5B for normalized data"

Phrase: ")."
Processing 00000000.tx.152: (C) GAL4 yeast two-hybrid interactions studies of the gene products from pdr-1 in-frame deletion alleles lg103 and tm598 (as described for wild-type PDR-1 in Fig.2A). 

Phrase: "(C) GAL4 yeast two-hybrid interactions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0599647:Two Hybrid [Molecular Biology Research Technique]
   799   C0020205:Hybrid [Organism]
   799   C0036025:yeast [Fungus]
   799   C0043392:Yeast [Food]
   799   C0043393:Yeast [Fungus]
   799   C0205448:Two [Quantitative Concept]
   799   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   766   C1704675:Interaction [Functional Concept]

Phrase: "studies of the gene products"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C1273305:Gene studies [Laboratory Procedure]
   773   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   773   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017337:Gene [Gene or Genome]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1514468:Products [Entity]
   760   C2603343:Study [Research Activity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "from pdr-1 in-frame deletion alleles lg103"

Phrase: "and"

Phrase: "tm598"

Phrase: "("

Phrase: "as"

Phrase: "described for wild-type PDR-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441729:Type 1 [Classification]
   753   C0154830:PDR [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418444:PDR [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552738:described [Idea or Concept]
   753   C1845050:PDR [Disease or Syndrome]

Phrase: "in Fig.2A"

Phrase: ")."
Processing 00000000.tx.153: Both truncated PDR-1 (aa24247) and PDR-1(aa140263) still associate with enzymes of the ubiquitylation machinery (UBC-2/UbcH4/5), but only PDR-1(aa140263) and PDR-1(aa1121Stop) are able to couple to the proteasome, whereas interaction of PDR-1(aa24247) with RPT-2 is abrogated. 

Phrase: "Both truncated PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "and"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: "still"

Phrase: "associate with enzymes of the ubiquitylation machinery"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]
   748   C0337076:machinery [Manufactured Object]
   748   C0750490:Associate [Idea or Concept]
   748   C1519751:Ubiquitylation [Molecular Function]
   748   C1706221:Associate [Professional or Occupational Group]

Phrase: "(UBC-2/UbcH4/5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "only PDR-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0154830:PDR [Disease or Syndrome]
   827   C0205171:Only [Quantitative Concept]
   827   C1418444:PDR [Gene or Genome]
   827   C1720467:Only [Intellectual Product]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: "and"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa1121Stop"

Phrase: ")"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "couple to the proteasome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010222:couple [Family Group]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1948027:Couple [Functional Concept]

Phrase: "whereas"

Phrase: "interaction of PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "with RPT-2"

Phrase: "is"

Phrase: "abrogated."
Processing 00000000.tx.154: (D) PDR-1(aa24247) GST-pull-down experiments with recombinant proteins (as described for wild-type PDR-1 in Fig.2B). 

Phrase: "("

Phrase: "D)"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "GST-pull-down experiments with recombinant proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "("

Phrase: "as"

Phrase: "described for wild-type PDR-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441729:Type 1 [Classification]
   753   C0154830:PDR [Disease or Syndrome]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418444:PDR [Gene or Genome]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552738:described [Idea or Concept]
   753   C1845050:PDR [Disease or Syndrome]

Phrase: "in Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.155: Immobilized GST-fused UBC-18/UbcH7/8, UBC-2/UbcH4/5 and CHN-1/CHIP are able to bind and pull down in vitro translated truncated PDR-1(aa24247), labeled with 35S methionine/cysteine. 

Phrase: "Immobilized GST-fused UBC-18/UbcH7/8,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0699952:Fused [Functional Concept]
   795   C1421267:UBC [Gene or Genome]
   795   C1421286:UBCH7 [Gene or Genome]
   795   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C1414861:FUSE [Gene or Genome]
   762 E C1708111:Fuse [Manufactured Object]

Phrase: "UBC-2/UbcH4/5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "CHN-1/CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600596:Chip [Research Device]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "pull down in vitro translated truncated PDR-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   812   C0021135:In Vitro [Intellectual Product]
   812   C1533691:in vitro [Qualitative Concept]
           vitro
   812   C2827718:In Vitro [Functional Concept]
   793   C0040710:translated [Occupational Activity]
   793   C0154830:PDR [Disease or Syndrome]
   793   C0580846:pull [Finding]
   793   C1418444:PDR [Gene or Genome]
   793   C1845050:PDR [Disease or Syndrome]
   737   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   737   C2626739:Lanugo [Eukaryote]

Phrase: "(aa24247"

Phrase: ")"

Phrase: ","

Phrase: "labeled with 35S methionine/cysteine."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.156: (E) Biochemical distribution of wild-type and mutant PDR-1 proteins in transfected human cells. 

Phrase: "(E) Biochemical distribution of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "mutant PDR-1 proteins in transfected human cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   750   C2263837:PDR protein [Molecular Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.157: Shown are representative anti-FLAG immunoblots of cell extracts sequentially prepared 48h post-transfection with Triton X-100 (S) and SDS (P) from HEK293T cells transiently transfected either with FLAG-tagged wild-type PDR-1 or various PDR-1 mutants (as indicated). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative anti-FLAG immunoblots of cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "sequentially prepared 48h post-transfection with Triton X-100"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1442464:48H [Temporal Concept]

Phrase: "("

Phrase: "S)"

Phrase: "and"

Phrase: "SDS ("

Phrase: "P) from HEK293T cells transiently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1179870:P cell [Cell]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "transfected"

Phrase: "either with FLAG-tagged wild-type PDR-1"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0441729:Type 1 [Classification]
   750   C1413560:TAG-1 [Gene or Genome]
   744   C0154830:PDR [Disease or Syndrome]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1418444:PDR [Gene or Genome]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708067:Flag [Functional Concept]
   744   C1708632:Tagged [Qualitative Concept]
   744   C1845050:PDR [Disease or Syndrome]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "various PDR-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")."
Processing 00000000.tx.158: The corresponding anti--actin immunoblots demonstrate equal loading. 

Phrase: "The corresponding anti--actin immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "demonstrate"

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.159: The experiments were performed in triplicates and repeated at least three times with similar results. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in triplicates"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   756   C0205174:Triplicate [Quantitative Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "repeated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.160: After 48h post-transfection, only truncated PDR-1(aa24247) was predominantly found in the insoluble fraction.  

Phrase: "After 48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "only truncated PDR-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0154830:PDR [Disease or Syndrome]
   812   C0205171:Only [Quantitative Concept]
   812   C1418444:PDR [Gene or Genome]
   812   C1720467:Only [Intellectual Product]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "was"

Phrase: "predominantly"

Phrase: "found in the insoluble fraction."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.161: Surprisingly, we found by in vitro and yeast two-hybrid assays that the gene products of the in-frame deletion mutants pdr-1(lg103) and pdr-1(tm598) are still able to interact with distinct proteins of the ubiquitylation machinery (Fig.4C and D). 

Phrase: "Surprisingly,"

Phrase: "we"

Phrase: "found by in vitro"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "yeast two-hybrid assays"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C1961118:Yeast Two-Hybrid Assays [Molecular Biology Research Technique]
   923   C0752172:Two-Hybrid Assays [Molecular Biology Research Technique]
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "that"

Phrase: "the gene products of the in-frame deletion mutants pdr-1"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   754   C0017260:Gene Deletion [Genetic Function]
   754   C0678941:gene mutants [Gene or Genome]
   754   C1418444:PDR gene [Gene or Genome]
   754   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
   738   C0017337:Gene [Gene or Genome]
   738   C1514468:Products [Entity]
   722   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   722   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "are"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "interact with distinct proteins of the ubiquitylation machinery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1519751:protein ubiquitylation [Molecular Function]
           Ubiquitylation
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0337076:machinery [Manufactured Object]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.162: Truncated PDR-1(aa24247), which bears the intact IBR and second RING finger domains, binds the same set of E2 and E4 enzymes as full-length PDR-1 (as shown in Fig.3A and B). 

Phrase: "Truncated PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "bears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004897:Bear [Mammal]

Phrase: "the intact IBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021334:IBR [Disease or Syndrome]

Phrase: "and"

Phrase: "second RING finger domains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1521759:RING Finger Domains [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
   708   C0230388:Second finger [Body Part, Organ, or Organ Component]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the same set of E2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "E4 enzymes as full-length PDR-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "shown in Fig.3A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.163: Similarly, PDR-1(aa140263), which shows the same C-terminal domains, is also still able to associate with the E2 enzyme UBC-2 (Fig.4C). 

Phrase: "Similarly,"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same C-terminal domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "also still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]

Phrase: "associate with the E2 enzyme UBC-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C1420639:E2-2 [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0750490:Associate [Idea or Concept]
   748   C1421267:UBC [Gene or Genome]
   748   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1706221:Associate [Professional or Occupational Group]
   748   C3539520:E2 [Gene or Genome]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: However, association of truncated PDR-1(aa24247) with the proteasomal subunit RPT-2 is disrupted (Fig.4C), as this mutant protein lacks an intact UBL domain that is essential for coupling to the proteasome (12). 

Phrase: "However,"

Phrase: "association of truncated PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "with the proteasomal subunit RPT-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1711351:Subunit [Quantitative Concept]
   741   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   741   C1325620:proteasome [Cell Component]
   741   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "this mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "an intact UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "essential for coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "to the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.165: In agreement with this, truncated PDR-1(aa140263) and PDR-1(aa1121Stop) which preserve an intact UBL domain are still able to associate with the proteasome (Fig.4C). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with this,"

Phrase: "truncated PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: "and"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa1121Stop"

Phrase: ")"

Phrase: "which"

Phrase: "preserve"

Phrase: "an intact UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "associate with the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0750490:Associate [Idea or Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1706221:Associate [Professional or Occupational Group]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.166: Truncated PDR-1(aa24247) encoded by the pdr-1(lg103) mutant is prone to aggregation As pathogenic parkin point mutations have been shown to decrease the stability of the corresponding protein and/or tend to aggregate, we next tested the solubility of the C. elegans wild-type and mutant PDR-1 variants by transgenic expression in HEK293T cells (Fig.4E). 

Phrase: "Truncated PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "encoded by the pdr-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0154830:PDR [Disease or Syndrome]
   760   C0679058:encoded [Mental Process]
   760   C1418444:PDR [Gene or Genome]
   760   C1845050:PDR [Disease or Syndrome]
   760   C2700640:Encoded [Activity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "prone to aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033422:Prone [Spatial Concept]

Phrase: "As pathogenic parkin point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   812   C0026882:Mutations [Genetic Function]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the stability of the corresponding protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2350440:Protein Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "and/or"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the solubility of the C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037628:Solubility [Qualitative Concept]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant PDR-1 variants by transgenic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "in HEK293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: For this purpose, cells were transiently transfected with FLAG::pdr-1 constructs and extracts were prepared at different time points. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1708067:Flag [Functional Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared at different time points."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   773   C2348792:Time Point [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1521827:Prepare [Functional Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.168: All PDR-1 proteins could be extracted in a soluble form 24h post-transfection. 

Phrase: "All PDR-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C2263837:PDR protein [Molecular Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "extracted in a soluble form 24h post-transfection."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0456696:/24h [Temporal Concept]
   744   C0687676:Post [Temporal Concept]
   744   C1442770:24H [Temporal Concept]
   744   C1522492:Form [Functional Concept]
   744   C1704687:Post [Manufactured Object]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]
Processing 00000000.tx.169: However, after 48h post-transfection, only wild-type protein and mutant PDR-1 derived from alleles tm598 and tm395 could be solubilized in Triton X-100, whereas the majority of truncated PDR-1(aa24247), derived from the allele lg103, was insoluble and could only be solubilized after SDS treatment. 

Phrase: "However,"

Phrase: "after"

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "only wild-type protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mutant PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0154830:PDR [Disease or Syndrome]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "derived from alleles tm598"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002085:Alleles [Gene or Genome]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "tm395"

Phrase: "could"

Phrase: "be"

Phrase: "solubilized in Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0242759:Triton [Geographic Area]

Phrase: "whereas"

Phrase: "the majority of truncated PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "(aa24247"

Phrase: ")"

Phrase: ","

Phrase: "derived from the allele lg103,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "insoluble"

Phrase: "and"

Phrase: "could"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "be"

Phrase: "solubilized after SDS treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.170: Recently, it was shown that many of the disease-linked point mutations in parkin produce alterations in the solubility of the protein that influences its detergent extraction property and localization (27,32,34,39,40). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "many of the disease-linked point mutations"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0026882:Mutations [Genetic Function]
   748   C0439064:Many [Quantitative Concept]
   748   C0747726:many [Conceptual Entity]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "produce"

Phrase: "alterations in the solubility of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "that"

Phrase: "influences"

Phrase: "its detergent extraction property"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871161:Property [Qualitative Concept]
   827   C1882134:Property [Conceptual Entity]
   827   C2347695:Property [Entity]

Phrase: "and"

Phrase: "localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "(27,"

Phrase: "32,"

Phrase: "34,"

Phrase: "39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.171: We suggest that pdr-1 (lg103), but not the other three alleles we tested, shows a similar behavior like these PD-associated human Parkin mutants. 

Phrase: "We"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the other three alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a similar behavior like these PD-associated human Parkin mutants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0004927:Behavior [Individual Behavior]
   739   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.172: The pdr-1(lg103) mutant is hypersensitive to ER stress conditions All pdr-1 mutants are viable and display no obvious morphological defects or alterations in motility, egg-laying behavior, brood size or life span under standard growth conditions. 

Phrase: "The pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "hypersensitive to ER stress"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "All pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "no obvious morphological defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "or"

Phrase: "alterations in motility,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1515926:Alteration [Idea or Concept]

Phrase: "egg-laying behavior,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]
   734   C0029957:egg-laying [Organism Function]
   734   C1622979:Egg Laying [Organism Function]

Phrase: "brood size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "or"

Phrase: "life span under standard growth conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0870809:life span [Group Attribute]
   753   C0376558:Life [Idea or Concept]
   753   C1711300:Span [Conceptual Entity]
   753   C2700613:Span [Quantitative Concept]
Processing 00000000.tx.173: Furthermore, we could not detect any influence of the mutations on the survival of the dopaminergic neurons in the worms (Fig.7A) as judged by the continued expression of an integrated marker that expresses gfp under the control of a dopaminergic neuron-specific promoter [dopamine transporter Pdat-1::gfp (41)]. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any influence of the mutations"

Phrase: "on the survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "of the dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "as"

Phrase: "judged by the continued expression of an integrated marker"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0005516:Marker [Clinical Attribute]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0549178:Continued [Idea or Concept]
   708   C0221191:Judge [Professional or Occupational Group]

Phrase: "that"

Phrase: "expresses"

Phrase: "gfp under the control of a dopaminergic neuron-specific promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0332583:Green [Qualitative Concept]

Phrase: "[dopamine transporter Pdat-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "(41"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.174: View larger version (27K): [in this window] [in a new window]  Figure7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure7."
Processing 00000000.tx.175: Combining overexpression of human -synuclein A53T with pdr-1 (lg103) results in developmental arrest and lethality. 

Phrase: "Combining overexpression of human -synuclein A53T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "with pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "results in developmental arrest"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1848980:Developmental arrest [Finding]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C0458003:Developmental [Qualitative Concept]
   770   C0678723:Developmental [Organism Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0311403:Inhibited [Qualitative Concept]
   715 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "lethality."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]
Processing 00000000.tx.176: (A) Photos show pdr-1 (lg103) mutant animals overexpressing -synuclein WT or A53T mutation from integrated arrays. 

Phrase: "(A) Photos"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "or"

Phrase: "A53T mutation from integrated arrays."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.177: Worms were analyzed after growth from synchronized eggs at 20C. 

Phrase: "Worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed after growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C0936012:Analyzed [Research Activity]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]

Phrase: "from synchronized eggs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "at 20C."
Processing 00000000.tx.178: Ectopic expression of -synuclein WT in pdr-1(lg103) mutant background showed no effect on survival/development of the animals. 

Phrase: "Ectopic expression of -synuclein WT in pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C2362085:WT-1 [Gene or Genome]
   744   C2700323:WT [Fish]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no effect on survival/development of the animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.179: In contrast, expression of -synuclein A53T in pdr-1(lg103) mutant background resulted in a dramatic lethality/arrest. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "expression of -synuclein A53T in pdr-1"

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "resulted in a dramatic lethality/arrest."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0237477:Arrest [Temporal Concept]
   753   C0392351:arrest [Governmental or Regulatory Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.180: The enlarged sector shows a 3-fold magnified view on pdr-1 (lg103);

Phrase: "The enlarged sector"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1708237:Sector [Geographic Area]
   789 E C0439741:Sectoral [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a 3-fold magnified view on pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1526904:View 1 [Functional Concept]
   744   C0449911:View [Spatial Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.181: Is[-synuclein A53T] arrested at early larval stages. 

Phrase: "Is[-synuclein A53T"

Phrase: "]"

Phrase: "arrested at early larval stages."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C2363430:early stages [Temporal Concept]
   781 E C1517886:Early Stage [Classification]
   760   C0018790:arrested [Disease or Syndrome]
   760   C0237477:Arrested [Temporal Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1306673:Stages [Qualitative Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C0392351:arrest [Governmental or Regulatory Activity]
   726 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.182: Expression of -synuclein in pdr-1 mutant background did not accelerate or enhance loss of dopaminergic neurons as judged by integrated co-injection marker Pdat-1::gfp. 

Phrase: "Expression of -synuclein in pdr-1 mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "or"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "loss of dopaminergic neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3550005:Loss of dopaminergic neurons [Finding]
   881   C0598940:Loss of neurons [Finding]
           neuron loss
   777 E C1850496:Neuronal loss [Finding]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "as"

Phrase: "judged by integrated co-injection marker Pdat-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0005516:Marker [Clinical Attribute]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]
   711   C0221191:Judge [Professional or Occupational Group]

Phrase: ":"

Phrase: ":"

Phrase: "gfp."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.183: Scale bar: 0.1mm. 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "0.1mm."
Processing 00000000.tx.184: (BD) Survival of pdr-1 mutants overexpressing -synuclein WT and A53T mutation is temperature-dependent. 

Phrase: "(BD) Survival of pdr-1 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "and"

Phrase: "A53T mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "temperature-dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
Processing 00000000.tx.185: The Y-axis depicts the percentage of dead/arrested animals after growth from synchronized eggs at different temperatures. 

Phrase: "The Y-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "depicts"

Phrase: "the percentage of dead/arrested animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "after growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "from synchronized eggs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "at different temperatures."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]
Processing 00000000.tx.186: Shown are mean values of 1015 independent experimental groupsSEM, the total numbers of animals analyzed is listed above each column (n). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "mean values of 1015 independent experimental groupsSEM,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0042295:Values [Qualitative Concept]
   748   C0444504:Mean [Quantitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "the total numbers of animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "is"

Phrase: "listed above each column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "(n)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.187: (B) Only -synuclein A53T overexpressed in specifically pdr-1(lg103) animals results in weak but significant lethality/arrest at 15C. 

Phrase: "(B) Only -synuclein A53T"

Phrase: "overexpressed in specifically pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0154830:PDR [Disease or Syndrome]
   760   C1418444:PDR [Gene or Genome]
   760   C1845050:PDR [Disease or Syndrome]
   726   C1514559:overexpress [Genetic Function]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "results in weak"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004093:Weak [Sign or Symptom]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1762617:Weak [Qualitative Concept]
   790   C2825142:Result [Finding]

Phrase: "but"

Phrase: "significant lethality/arrest at 15C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237477:Arrest [Temporal Concept]
   760   C0392351:arrest [Governmental or Regulatory Activity]
Processing 00000000.tx.188: (C) -synuclein A53T-induced lethality/arrest in pdr-1(lg103) is dramatically enhanced at 20C. 

Phrase: "(C) -synuclein A53T-induced lethality/arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0237477:Arrest [Temporal Concept]
   799   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "is"

Phrase: "dramatically"

Phrase: "enhanced at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2349975:Enhanced [Activity]
Processing 00000000.tx.189: (D) Increasing temperature to 25C did not induce arrest/lethality in other pdr-1 alleles overexpressing mutant -synuclein.  

Phrase: "("

Phrase: "D)"

Phrase: "Increasing temperature to 25C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "arrest/lethality in other pdr-1 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2350165:Alleles, Lethal [Gene or Genome]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "mutant -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.190: Next, we challenged pdr-1 mutants with a variety of stressors. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "challenged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "pdr-1 mutants with a variety of stressors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.191: For this purpose, we treated worms with the reducing agents DTT, -mercaptoethanol, as well as with tunicamycin, a specific inhibitor of N-linked glycosylation that leads to accumulation of unfolded proteins in the ER. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "worms with the reducing agents DTT, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0018889:WORM [Disease or Syndrome]
   753   C0018893:Worm [Eukaryote]
   753   C0040820:Worms NOS [Disease or Syndrome]

Phrase: "mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "as well as with tunicamycin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "a specific inhibitor of N-linked glycosylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "that"

Phrase: "leads to accumulation of unfolded proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0181586:leads [Medical Device]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.192: In mammals and C. elegans, accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR) that is mediated by three transducers: the proteinkinase and site-specific endoribonuclease IRE1; 

Phrase: "In mammals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "and"

Phrase: "C. elegans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "accumulation of misfolded proteins"

Phrase: "in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the unfolded protein response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "mediated by three transducers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040661:Transducers [Medical Device]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0205449:Three [Quantitative Concept]
   737 E C1705162:Transducer [Manufactured Object]

Phrase: ":"

Phrase: "the proteinkinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "site-specific endoribonuclease IRE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1414444:IRE1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.193: the eukaryotic translation initiation factor 2 kinase, PERK/PEK; 

Phrase: "the eukaryotic translation initiation factor 2 kinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0013729:Eukaryotic Initiation Factor-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PERK/PEK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.194: and the transcriptional activator ATF6. 

Phrase: "and"

Phrase: "the transcriptional activator ATF6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412622:ATF6 [Gene or Genome]
   734   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.195: C. elegans encodes single homologs of each stress sensor, ire-1, pek-1 and atf-6, and mutants are sensitive to elevated ER stress. 

Phrase: "C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "single homologs of each stress sensor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1334043:Homolog [Gene or Genome]

Phrase: "ire-1,"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "and"

Phrase: "atf-6,"

Phrase: "and"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "sensitive to elevated ER stress."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.196: An intact UPR is absolutely required for normal development as ire-1(v33) loss-of-function mutant suffers from developmental defects and a reduced brood size, whereas pek-1(ok275) and atf-6(RNAi) loss-of-function mutants are indistinguishable from wild-type animals. 

Phrase: "An intact UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1155342:Unfolded Protein Response [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "absolutely"

Phrase: "required for normal development"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1821244:Normal development [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0243107:development [Physiologic Function]
   770   C0439166:% normal [Quantitative Concept]
   770   C0678723:Development [Organism Function]
   770   C1514873:Required [Functional Concept]
   770   C1527148:Development [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "as ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "suffers from developmental defects"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   816   C0000768:Developmental defect [Congenital Abnormality]
   770   C0243067:defects [Functional Concept]
   770   C0458003:Developmental [Qualitative Concept]
   770   C0678723:Developmental [Organism Function]
   770   C0683278:suffer [Mental or Behavioral Dysfunction]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "a reduced brood size,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "whereas"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "and"

Phrase: "atf-6"

Phrase: "(RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136031:RNAi [Genetic Function]

Phrase: ")"

Phrase: "loss-of-function mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "indistinguishable from wild-type animals."
Processing 00000000.tx.197: In conclusion, C. elegans, IRE-1 is the central regulator of the UPR, whereas PEK-1 and ATF-6 provide redundant protection against ER stress (4244). 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "C. elegans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "IRE-1"

Phrase: "is"

Phrase: "the central regulator of the UPR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0182953:REGULATOR [Medical Device]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]

Phrase: "whereas"

Phrase: "PEK-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "and"

Phrase: "ATF-6"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "redundant protection against ER stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "(4244"

Phrase: ")."
Processing 00000000.tx.198: N2 wild-type animals were unaffected by stress treatments, whereas pdr-1(lg103) mutants grown in the presence of any of these ER stress-inducing chemicals displayed severe developmental defects and lethality at early larval stages. 

Phrase: "N2 wild-type animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0003070:Animals, Wild [Animal]
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "unaffected by stress treatments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "whereas"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "grown in the presence of any of these ER stress-inducing chemicals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   766   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   750   C0014239:Endoplasmic Reticulum [Cell Component]
   735   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   735   C0038435:Stress [Finding]
   735   C0205263:Inducing [Functional Concept]
   735   C0220806:Chemicals [Chemical]
   735   C0392148:Presence [Therapeutic or Preventive Procedure]
   702 E C3272558:Chemical [Intellectual Product]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "severe developmental defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0000768:Developmental defect [Congenital Abnormality]
   827   C0243067:defects [Functional Concept]
   793 E C1457869:Defect [Functional Concept]
   793 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "lethality at early larval stages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1836107:Early lethality [Finding]
Processing 00000000.tx.199: The majority of pdr-1(lg103) mutant animals died or arrested at, or prior to, the larval L3 stage (Fig.5A). 

Phrase: "The majority of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: "or"

Phrase: "arrested at,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   833   C0018790:arrested [Disease or Syndrome]
   833   C0237477:Arrested [Temporal Concept]
   799 E C0392351:arrest [Governmental or Regulatory Activity]
   761 E C0311403:Inhibited [Qualitative Concept]
   761 E C3463820:Inhibiting [Activity]
   740 E C0521111:Retarded [Qualitative Concept]

Phrase: "or prior to,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332152:Prior to [Temporal Concept]
           Prior
   790   C2826257:PRIOR [Event]

Phrase: "the larval L3 stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.200: This result is similar to the behavior of ire-1(v33) and pek-1(ok275) mutants that are defective in the proper execution of the UPR pathway (42). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "similar to the behavior of ire-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "are"

Phrase: "defective in the proper execution of the UPR pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0332452:Defective [Functional Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.201: Surprisingly, none of the other three analyzed pdr-1 deletion alleles showed a comparably strong phenotype (Fig.5A). 

Phrase: "Surprisingly,"

Phrase: "none of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456148:None [Quantitative Concept]
   790   C0549184:None [Quantitative Concept]

Phrase: "other three analyzed pdr-1 deletion alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Alleles [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a comparably strong phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.202: View larger version (81K): [in this window] [in a new window]  Figure5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure5."
Processing 00000000.tx.203: The in-frame deletion pdr-1(lg103) causes hypersensitivity to ER stress. 

Phrase: "The in-frame deletion pdr-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0080089:Frame [Nucleotide Sequence]
   804   C0154830:PDR [Disease or Syndrome]
   804   C0180979:Frame [Medical Device]
   804   C1418444:PDR [Gene or Genome]
   804   C1442161:Deletion [Cell or Molecular Dysfunction]
   804   C1511760:Deletion [Genetic Function]
   804   C1705858:Frame [Manufactured Object]
   804   C1845050:PDR [Disease or Syndrome]
   804   C1880274:Deletion [Activity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hypersensitivity to ER stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020517:Hypersensitivity [Pathologic Function]
   760   C0520946:Hypersensitivity [Finding]
Processing 00000000.tx.204: (A) pdr-1(lg103) mutants are specifically hypersensitive to ER stress. 

Phrase: "(A) pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "specifically hypersensitive to ER stress."
Processing 00000000.tx.205: Photos show ER-stressed worms, treated with 1.5g/ml tunicamycin, after 3 days growth from synchronized eggs at 20C. 

Phrase: "Photos"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "ER-stressed worms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0018889:WORM [Disease or Syndrome]
   812   C0018893:Worm [Eukaryote]
   812   C0040820:Worms NOS [Disease or Syndrome]
   740   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   712 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "treated with 1.5g/ml tunicamycin,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "after"

Phrase: "3 days growth from synchronized eggs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "at 20C."
Processing 00000000.tx.206: Most of the N2 wild-type animals reach adulthood, whereas most of the ire-1(v33) and pek-1(ok275) mutant animals either arrest or die. pdr-1(lg103) animals, in contrast to other pdr-1 deletion alleles, show the same ER stress hypersensitivity as mutants of the UPR. 

Phrase: "Most of the N2 wild-type animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1883559:Wild Type [Organism Attribute]
   774   C0003070:Animals, Wild [Animal]
   748   C0003062:Animals [Animal]
   748   C0205393:Most [Quantitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0441960:N2 [Finding]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "adulthood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700597:Adulthood [Temporal Concept]

Phrase: "whereas"

Phrase: "most of the ire-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1425057:MOST-1 [Gene or Genome]
   760   C0205393:Most [Quantitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "mutant animals either arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0237477:Arrest [Temporal Concept]
   812   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "die. pdr-1"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]
   771   C0011065:Expired [Organism Function]
   771   C0231800:Expired [Organ or Tissue Function]
   771   C1704631:Expire [Idea or Concept]
   743 E C0184532:dying [Organism Function]
   743 E C1546956:Died [Finding]
   743 E C1553404:terminated [Idea or Concept]
   743 E C2348570:Terminated [Functional Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "in contrast to other pdr-1 deletion alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same ER stress hypersensitivity as mutants of the UPR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   749   C1817976:hypersensitivity response [Pathologic Function]
   735   C0020517:Hypersensitivity [Pathologic Function]
   735   C0520946:Hypersensitivity [Finding]
Processing 00000000.tx.207: All untreated pdr-1 control mutants showed no lethality/arrest. 

Phrase: "All untreated pdr-1 control mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no lethality/arrest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]
Processing 00000000.tx.208: Scale bar: 0.5mm. 

Phrase: "Scale bar"

Phrase: ":"

Phrase: "0.5mm."
Processing 00000000.tx.209: (B and C) Quantitative analyses of survival/arrest (as described in Fig.4A). 

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C) Quantitative analyses of survival/arrest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0038953:Survival Analyses [Research Activity]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "described in Fig.4A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0450373:4a [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1552738:described [Idea or Concept]
   770   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.210: Shown are mean valuesSEM of dead/arrested worms. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "mean valuesSEM of dead/arrested worms."
Processing 00000000.tx.211: The total numbers of animals analyzed from the indicated strains is listed above each column (n). 

Phrase: "The total numbers of animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "analyzed from the indicated strains"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0080194:Strains [Injury or Poisoning]
   760   C0456178:strains [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1444656:Indicated [Finding]
   726 E C1518614:Strain [Organism]
   726 E C2987481:Strain [Mental Process]

Phrase: "is"

Phrase: "listed above each column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "(n)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.212: (B) Only homozygous pdr-1(lg103) mutants are hypersensitive to tunicamycin, but compound heterozygous pdr-1(lg103)/pdr-1(tm598) animals also show a significantly increased sensitivity compared with the respective heterozygous alleles. 

Phrase: "(B) Only homozygous pdr-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0019904:Homozygous [Organism Attribute]
   804   C0154830:PDR [Disease or Syndrome]
   804   C0205171:Only [Quantitative Concept]
   804   C1418444:PDR [Gene or Genome]
   804   C1720467:Only [Intellectual Product]
   804   C1845050:PDR [Disease or Syndrome]
   804   C2347469:/B [Quantitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "hypersensitive to tunicamycin,"

Phrase: "but"

Phrase: "compound heterozygous pdr-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0019425:Heterozygous [Organism Attribute]
   812   C0154830:PDR [Disease or Syndrome]
   812   C0205198:Compound [Qualitative Concept]
   812   C1418444:PDR [Gene or Genome]
   812   C1706082:Compound [Chemical]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "/pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "animals also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a significantly increased sensitivity"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   901   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]

Phrase: "compared with the respective heterozygous alleles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002085:Alleles [Gene or Genome]
   753   C0019425:Heterozygous [Organism Attribute]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.213: Heterozygous and compounds were obtained by crossing the respective pdr-1 mutants either with wild-type or homozygous pdr-1(lg103) males. 

Phrase: "Heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "were"

Phrase: "obtained by crossing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the respective pdr-1 mutants either with wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "homozygous pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019904:Homozygous [Organism Attribute]
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "males."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]
Processing 00000000.tx.214: (C) Rescue of the pdr-1(lg103) tunicamycin-sensitive phenotype. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rescue of the pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0154830:PDR [Disease or Syndrome]
   760   C1418444:PDR [Gene or Genome]
   760   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "tunicamycin-sensitive phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.215: Wild-type copies of pdr-1, expressed from independent transgenic arrays in the mutant background pdr-1(lg103);byEx417-422[Rescue pdr-1(wt)] significantly restored survival, even at higher tunicamycin concentration (2.5g/ml).  

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "copies of pdr-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]
   770   C1948062:Copies [Manufactured Object]

Phrase: "expressed from independent transgenic arrays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003069:Transgenic [Animal]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   726   C1510941:Array [Spatial Concept]

Phrase: "in the mutant background pdr-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0154830:PDR [Disease or Syndrome]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]
   812   C1418444:PDR [Gene or Genome]
   812   C1706907:Background [Conceptual Entity]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ";byEx417-422"

Phrase: "[Rescue pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(wt)] significantly restored survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]

Phrase: "even at higher tunicamycin concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "(2.5g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.216: We quantified the stress-sensitive phenotype of pdr-1 (lg103) mutants after treatment with low concentrations (1.5g/ml) of tunicamycin. 

Phrase: "We"

Phrase: "quantified"

Phrase: "the stress-sensitive phenotype of pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants after treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596988:mutants [Cell or Molecular Dysfunction]
   716   C0001758:After-Treatment [Health Care Activity]

Phrase: "with low concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(1.5g/ml) of tunicamycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.217: A stress-inducible Phsp-4::gfp transcriptional reporter (43) was used in all experiments to monitor efficient induction of the UPR. 

Phrase: "A stress-inducible Phsp-4"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0038435:Stress [Finding]
   812   C0205263:Inducible [Functional Concept]
   812   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   741 E C0231297:Stressful [Functional Concept]

Phrase: ":"

Phrase: ":"

Phrase: "gfp transcriptional reporter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0335038:Reporter [Professional or Occupational Group]
   804   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   804   C1705915:Reporter [Conceptual Entity]
   804   C1709908:Reporter [Group]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(43"

Phrase: ")"

Phrase: "was"

Phrase: "used in all experiments to"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "efficient induction of the UPR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.218: C. elegans hsp-4 is a homolog of the mammalian ER chaperone BiP. 

Phrase: "C. elegans hsp-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162610:C ELEGANS [Eukaryote]
   812   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "a homolog of the mammalian ER chaperone BiP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1334043:Homolog [Gene or Genome]
Processing 00000000.tx.219: At this concentration of tunicamycin, the overwhelming majority of wild-type animals matured to fertile adults, whereas most of ire-1(v33) and pek-1(ok275) mutant animals arrested during development and died, indicating increased stress sensitivity of mutants in the UPR. 

Phrase: "At this concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of tunicamycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the overwhelming majority of wild-type animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "matured to fertile adults,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   786   C0682054:adult mature [Age Group]
   770   C0001675:Adults [Age Group]
   770   C0015895:Fertile [Organism Function]
   737   C0205286:Mature [Temporal Concept]
   737 E C1706450:Adult [Human]

Phrase: "whereas"

Phrase: "most of ire-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1425057:MOST-1 [Gene or Genome]
   770   C0205393:Most [Quantitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "arrested during development"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   805   C1848980:Developmental arrest [Finding]
   790   C0018790:arrested [Disease or Syndrome]
   790   C0237477:Arrested [Temporal Concept]
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   756 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0311403:Inhibited [Qualitative Concept]
   718 E C0458003:Developmental [Qualitative Concept]
   718 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "died"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0011065:Died [Organism Function]
  1000   C1546956:Died [Finding]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1553404:terminated [Idea or Concept]
   907 E C2348570:Terminated [Functional Concept]

Phrase: ","

Phrase: "indicating"

Phrase: "increased stress sensitivity of mutants"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   797   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "in the UPR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.220: Almost 70% of homozygous pdr-1(lg103) animals showed ER stress hypersensitivity like ire-1 and pek-1 mutants (Fig.5B). 

Phrase: "Almost 70% of homozygous pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019904:Homozygous [Organism Attribute]
   753   C0154830:PDR [Disease or Syndrome]
   753   C1418444:PDR [Gene or Genome]
   753   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "ER stress hypersensitivity like ire-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020517:Hypersensitivity [Pathologic Function]
   748   C0520946:Hypersensitivity [Finding]

Phrase: "and"

Phrase: "pek-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.221: As in our experiments pdr-1(lg103) behaved differently than the other C. elegans parkin alleles, it is possible that this mutation confers a neomorphic or a toxic gain-of-misfunction phenotype. 

Phrase: "As in our experiments pdr-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0154830:PDR [Disease or Syndrome]
   753   C0681814:Experiments [Research Activity]
   753   C1418444:PDR [Gene or Genome]
   753   C1845050:PDR [Disease or Syndrome]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "behaved"

Phrase: "differently than the"

Phrase: "other C. elegans parkin alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "confers"

Phrase: "a neomorphic"

Phrase: "or"

Phrase: "a toxic gain-of-misfunction phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.222: In agreement with such a model is our finding that the mutant protein PDR-1(aa24247) retains its capacity to interact with the E4 enzyme CHN-1/CHIP and with E2 enzymes, but fails to interact with the proteasome (Fig.4C and D), and, moreover, shows a tendency to aggregate (Fig.4E). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with such"

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the mutant protein PDR-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0154830:PDR [Disease or Syndrome]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]
   812   C1418444:PDR [Gene or Genome]
   812   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "its capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "interact with the E4 enzyme CHN-1/CHIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0600596:Chip [Research Device]

Phrase: "and with E2 enzymes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014442:Enzymes [Enzyme,Organic Chemical]
   770   C0014445:enzymes [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C3539520:E2 [Gene or Genome]

Phrase: "but"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "moreover,"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a tendency to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.223: To test this assumption, we first monitored effects of pdr-1 gene doses by analyzing single-heterozygous and compound-heterozygous mutants (i.e. with different mutations on both alleles). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this assumption,"

Phrase: "we first monitored effects of pdr-1 gene doses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "by analyzing single-heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "compound-heterozygous mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on both alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.224: Although homozygous pdr-1(lg103) mutants showed the highest sensitivity upon ER stress, the combination of the two in-frame deletion alleles lg103 and tm598 also resulted in a significantly increased sensitivity. 

Phrase: "Although"

Phrase: "homozygous pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019904:Homozygous [Organism Attribute]
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the highest sensitivity upon ER stress,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1441604:High sensitivity [Laboratory Procedure]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "the combination of the two in-frame deletion alleles lg103"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205195:Combination [Qualitative Concept]
   739   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "tm598 also"

Phrase: "resulted in a significantly increased sensitivity."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   790   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C0442805:Increased [Functional Concept]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2349185:Sensitivity [Qualitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.225: Notably, the presence of one wild-type copy of pdr-1, either genomic in a pdr-1(lg103)/+ heterozygote or from a transgenic array, was sufficient to restore viability and fertility (Fig.5B and C). 

Phrase: "Notably,"

Phrase: "the presence of one wild-type copy of pdr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "either genomic in a pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017428:Genomic [Gene or Genome]
   753   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "(lg103"

Phrase: ")"

Phrase: "/+ heterozygote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygote [Organism Attribute]

Phrase: "or from a transgenic array,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003069:Transgenic [Animal]
   760   C1510941:Array [Spatial Concept]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "restore"

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "fertility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015895:Fertility [Organism Function]
  1000   C0200069:Fertility [Diagnostic Procedure]
  1000   C2986895:Fertility [Idea or Concept]

Phrase: "(Fig.5B"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.226: In conclusion, like the majority of familial parkin mutants in AR-JP, pdr-1(lg103) is recessive. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "like the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of familial parkin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in AR-JP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "is"

Phrase: "recessive."
Processing 00000000.tx.227: PDR-1 is involved in, and regulated by, the UPR Next, we tested the genetic interactions between pdr-1 mutants and the UPR mutants ire-1(v33), pek-1(ok275) and atf-6(ok551). 

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "involved in,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "regulated by,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "the UPR Next,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1155342:Unfolded Protein Response [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the genetic interactions between pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the UPR mutants ire-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1155342:Unfolded Protein Response [Molecular Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0596988:mutants [Cell or Molecular Dysfunction]
   799   C0871261:Response [Organism Attribute]
   799   C1704632:Response [Finding]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "and"

Phrase: "atf-6"

Phrase: "(ok551"

Phrase: ")."
Processing 00000000.tx.228: To do this, we counted the progeny of the corresponding single and double mutants (Fig.6A). 

Phrase: "To do"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "this,"

Phrase: "we"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "the progeny of the corresponding single"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680063:Progeny [Family Group]

Phrase: "and"

Phrase: "double mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.229: pdr-1 mutants have a brood size similar to wild-type, whereas ire-1(v33) single mutants have significantly less progeny. 

Phrase: "pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "a brood size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "similar to wild-type,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "whereas"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "single mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "significantly less progeny."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Progeny [Family Group]
Processing 00000000.tx.230: Strikingly, ire-1(v33);pdr-1(lg103) and ire-1(v33);pdr-1 (tm598) double mutants showed a dramatically reduced brood size with respect to each single mutant. 

Phrase: "Strikingly,"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a dramatically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "brood size with respect to each single mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0456389:size [Spatial Concept]
Processing 00000000.tx.231: As already observed in the tunicamycin stress assay, the allele lg103 confers a stronger phenotype as the second in-frame deletion tm598. 

Phrase: "As"

Phrase: "already"

Phrase: "observed in the tunicamycin stress assay,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0038435:Stress [Finding]
   753   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243073:assay [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "the allele lg103"

Phrase: "confers"

Phrase: "a stronger phenotype as the second in-frame deletion tm598."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031437:Phenotype [Organism Attribute]
   739   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.232: Notably, complete loss of pdr-1 function in the ire-1 mutant background, i.e. in the double mutant ire-1(v33);pdr-1 (tm395), had no effect on the brood size. 

Phrase: "Notably,"

Phrase: "complete loss of pdr-1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in the ire-1 mutant background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the double mutant ire-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205173:Double [Functional Concept]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]
   812   C1705764:Double [Activity]
   812   C1705765:Double [Qualitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm395"

Phrase: ")"

Phrase: ","

Phrase: "had"

Phrase: "no effect on the brood size."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1301751:No effect [Qualitative Concept]
   783   C0814843:effect size [Quantitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.233: In contrast, both pek-1(ok275) and atf-6(ok551) single mutants, as well as pek-1(ok275);pdr-1(lg103) or atf-6(ok551);pdr-1(lg103) double mutants had brood sizes similar to wild-type. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "both pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "and"

Phrase: "atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: "single mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "or"

Phrase: "atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "brood"

Phrase: "sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:SIZES [Spatial Concept]

Phrase: "similar to wild-type."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.234: Previous experiments suggested that ire-1(v33) represents a null allele. 

Phrase: "Previous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a null allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2985437:Null Allele [Cell or Molecular Dysfunction]
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.235: Therefore, the most simple explanation for the strong synergistic effect of the ire-1(v33);pdr-1(lg103) and ire-1 (v33);pdr-1(tm598) double mutants is that both genes act in parallel pathways of the UPR. 

Phrase: "Therefore,"

Phrase: "the most simple explanation for the strong synergistic effect of the ire-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0681841:Explanation [Intellectual Product]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "that"

Phrase: "both genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in parallel pathways of the UPR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.236: View larger version (34K): [in this window] [in a new window]  Figure6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure6."
Processing 00000000.tx.237: PDR-1 is involved in and regulated by the UPR. 

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "regulated by the UPR."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.238: (A) pdr-1(lg103) and pdr-1(tm598) genetically interact with ire-1(v33). 

Phrase: "(A) pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "genetically"

Phrase: "interact with ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.239: The table depicts the absolute (meanSEM) and relative (% SEM) brood sizes of pdr-1 mutants as well as of ire-1(v33), pek-1(ok275) and atf-6(ok551), single and double mutants at 20C. 

Phrase: "The table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: "depicts"

Phrase: "the absolute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205344:Absolute [Qualitative Concept]

Phrase: "(meanSEM"

Phrase: ")"

Phrase: "and"

Phrase: "relative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080103:Relative [Family Group]
  1000   C0205345:Relative [Qualitative Concept]
  1000   C1547039:*Relative [Quantitative Concept]

Phrase: "(% SEM) brood sizes of pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:SIZES [Spatial Concept]

Phrase: "as well as of ire-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "and"

Phrase: "atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: ","

Phrase: "single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "double mutants at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.240: The total numbers of animals scored are listed (n). 

Phrase: "The total numbers of animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "are"

Phrase: "listed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]

Phrase: "(n)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.241: pdr-1 mutations show only minor effects on brood size, as compared with wild-type. ire-1(v33);pdr-1(lg103) and ire-1(v33);pdr-1(tm598) double mutants show a dramatically reduced brood size, compared with the respective single mutants, most likely as a result of a synergistic effect of both single mutations. 

Phrase: "pdr-1 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "only minor effects on brood size,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0814843:effect size [Quantitative Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "compared with wild-type. ire-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441729:Type 1 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a dramatically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "brood size,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "compared with the respective single mutants,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1707455:Compared [Activity]

Phrase: "most likely as a result of a synergistic effect of both single mutations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0750501:most likely [Idea or Concept]
   735   C0332148:Likely [Qualitative Concept]
   735   C0750492:Likely [Idea or Concept]
Processing 00000000.tx.242: (B) pdr-1 transcription is regulated by the UPR. 

Phrase: "(B) pdr-1 transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "regulated by the UPR."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.243: Northern blot analyses of total RNA from mutants of the UPR show reduced transcript levels of pdr-1 in ire-1(v33) and pek-1(ok275) mutants, but elevated levels in atf-6 (ok551) mutants, relative to wild-type. 

Phrase: "Northern blot analyses of total RNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           RNA blot analysis
   767   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "from mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "of the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reduced transcript levels of pdr-1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   753   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "elevated levels in atf-6"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(ok551"

Phrase: ")"

Phrase: "mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "relative to wild-type."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.244: ER stress markers hsp-4 and xbp-1, the C. elegans homologs of mammalian transcription factor XBP1, were used as control genes. 

Phrase: "ER stress markers hsp-4"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   827   C0014239:Endoplasmic Reticulum [Cell Component]
   799   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   799   C0038435:Stress [Finding]
   766   C0005516:Marker [Clinical Attribute]
   727 E C0231297:Stressful [Functional Concept]
   727   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "xbp-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825104:XBP-1 [Amino Acid, Peptide, or Protein]

Phrase: "the C. elegans homologs of mammalian transcription factor XBP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1334043:Homolog [Gene or Genome]

Phrase: "were"

Phrase: "used as control genes."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0017337:Genes [Gene or Genome]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.245: Both showed a reduction of their transcriptional rate in ire-1(v33) and pek-1(ok275) mutants, whereas levels in atf-6(ok551) and pdr-1(lg103) mutants were equal to wild-type. pdr-1 transcription levels are unaffected in pdr-1(lg103) mutants compared with N2 wild-type. 

Phrase: "Both"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a reduction of their transcriptional rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "whereas"

Phrase: "levels in atf-6"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(ok551"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "equal to wild-type. pdr-1 transcription levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205163:Equal To [Qualitative Concept]
           Equal
   744   C1549782:Equal [Idea or Concept]

Phrase: "are"

Phrase: "unaffected in pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "compared with N2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441960:N2 [Finding]
   790   C1707455:Compared [Activity]

Phrase: "wild-type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.246: Wild-type levels of each transcript were set to 1.0-fold induction. 

Phrase: "Wild-type levels of each transcript"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "set to 1.0-fold induction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036849:Set [Mental Process]
   753   C0205263:Induction [Functional Concept]
   753   C0332462:Fold [Spatial Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]
   753   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.247: An act-1/actin-specific probe was used to adjust for equal loading. 

Phrase: "An act-1/actin-specific probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0182400:Probe [Medical Device]
   804   C1704681:Probe [Gene or Genome]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adjust for equal loading."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205163:Equal [Qualitative Concept]
   770   C1549782:Equal [Idea or Concept]
   770   C1708715:Loading [Activity]
Processing 00000000.tx.248: The mean values of relative transcript levelSEM of 314 independent quantifications are shown.  

Phrase: "The mean values of relative transcript levelSEM of 314 independent quantifications"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   738   C0042295:Values [Qualitative Concept]
   738   C0444504:Mean [Quantitative Concept]
   738   C2347634:Mean [Quantitative Concept]
   738   C2348143:Mean [Quantitative Concept]
   737   C0205345:Relative Value [Qualitative Concept]
   704 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.249: To position pdr-1 functionally, we analyzed pdr-1 transcript levels in the background of UPR mutants. 

Phrase: "To position pdr-1 functionally,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0154830:PDR [Disease or Syndrome]
   812   C0733755:Position [Spatial Concept]
   812   C1418444:PDR [Gene or Genome]
   812   C1845050:PDR [Disease or Syndrome]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "pdr-1 transcript levels in the background of UPR mutants."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   736   C0441889:Levels [Qualitative Concept]
   736   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0428479:Protein level [Laboratory or Test Result]
   734   C0456947:Level 1 [Intellectual Product]
   734   C1547597:Response level [Idea or Concept]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.250: The pdr-1 transcription in pdr-1(lg103) animals is not affected, arguing against an auto-regulatory role on the transcript level. 

Phrase: "The pdr-1 transcription in pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "arguing against an auto-regulatory role"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035820:Role [Social Behavior]
   753   C0220905:regulatory [Regulation or Law]
   753   C1441488:Auto [Laboratory Procedure]
   753   C1704735:Regulatory [Conceptual Entity]
   753   C1705810:Role [Conceptual Entity]

Phrase: "on the transcript level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.251: However, in pdr-1(lg103) mutants the UPR remained un-induced, but was still inducible by exogenous stress, as judged by hsp-4 expression in vivo and by northern blot analyses (Fig.6B). 

Phrase: "However,"

Phrase: "in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "remained"

Phrase: "un-induced,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041701:UN [Organization]
   861   C0205263:Induced [Functional Concept]
   861   C1704620:UN [Organism Attribute]

Phrase: "but"

Phrase: "was"

Phrase: "still inducible by exogenous stress,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Inducible [Functional Concept]
   760   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "judged by hsp-4 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   726   C0221191:Judge [Professional or Occupational Group]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and by northern blot analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C1515981:And [Idea or Concept]
   760   C1709269:Northern [Spatial Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "(Fig.6B"

Phrase: ")."
Processing 00000000.tx.252: Transcript levels of pdr-1 were reduced in ire-1(v33) and pek-1(ok275) loss-of-function alleles, and were as strongly up-regulated in the constitutive active atf-6(ok551) mutant background (Fig.6B). 

Phrase: "Transcript levels of pdr-1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced in ire-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: "loss-of-function alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "were"

Phrase: "as"

Phrase: "strongly"

Phrase: "up-regulated in the constitutive active atf-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Active [Functional Concept]
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1282911:Up [Spatial Concept]

Phrase: "(ok551"

Phrase: ")"

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "(Fig.6B"

Phrase: ")."
Processing 00000000.tx.253: We conclude that parkin expression is controlled by all three regulators of the unfolded protein response, and may therefore be positioned downstream of the UPR transducers IRE-1, PEK-1 and ATF-6. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that parkin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "controlled by all three regulators of the unfolded protein response,"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   760   C0332298:Controlled by [Functional Concept]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0182953:regulators [Medical Device]
   739   C0205449:Three [Quantitative Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2587213:Controlled [Functional Concept]
   739   C2911692:Response [Mental Process]
   706 E C0243148:control [Qualitative Concept]
   706 E C1550141:Control [Substance]
   706 E C1704734:Regulator [Medical Device]
   706 E C1704735:Regulator [Conceptual Entity]
   706 E C1882979:Control [Conceptual Entity]
   706 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "positioned downstream of the UPR transducers IRE-1,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040661:Transducers [Medical Device]
   739   C0522506:Downstream [Spatial Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
   706   C0733755:Position [Spatial Concept]
   706 E C1705162:Transducer [Manufactured Object]

Phrase: "PEK-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "and"

Phrase: "ATF-6."
Processing 00000000.tx.254: Overexpression of -synuclein A53T mutation in pdr-1(lg103) mutants leads to developmental arrest and lethality Accumulation of -synuclein in Lewy bodies is one of the hallmarks of sporadic PD and of its hereditary forms caused by mutations in the -synuclein gene. 

Phrase: "Overexpression of -synuclein A53T mutation in pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "leads to developmental arrest"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1848980:Developmental arrest [Finding]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C0458003:Developmental [Qualitative Concept]
   770   C0678723:Developmental [Organism Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0311403:Inhibited [Qualitative Concept]
   715 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "lethality Accumulation of -synuclein in Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "one of the hallmarks of sporadic PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "and of its hereditary forms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C0439660:Hereditary [Functional Concept]
   760   C1515981:And [Idea or Concept]
   726 E C1522492:Form [Functional Concept]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the -synuclein gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.255: We wanted to test whether a genetic link between pdr-1 dysfunction and -synuclein aggregation exists in C. elegans. 

Phrase: "We"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "a genetic link between pdr-1 dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "and -"

Phrase: "synuclein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "exists in C. elegans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.256: As the C. elegans genome does not encode an obvious homolog of -synuclein, we expressed genomically integrated copies (to enhance expression levels) of human wild-type and mutant -synuclein from a pan-neuronal promoter [Paex-3::-synuclein, gift of G. 

Phrase: "As the C. elegans genome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017428:Genome [Gene or Genome]
   827   C2338314:Genome [Conceptual Entity]
   734   C0162610:C ELEGANS [Eukaryote]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "an obvious homolog of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "expressed"

Phrase: "genomically integrated copies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1948062:Copies [Manufactured Object]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant -synuclein from a pan-neuronal promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[Paex-3"

Phrase: ":"

Phrase: ":-"

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "gift of G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0423899:Gifted [Finding]
Processing 00000000.tx.257: Wong, Kuopio (10)] in pdr-1 mutant background. 

Phrase: "Wong,"

Phrase: "Kuopio"

Phrase: "(10"

Phrase: ")"

Phrase: "]"

Phrase: "in pdr-1 mutant background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.258: Recently, a neurotoxic effect after overexpression of -synuclein in the eight dopaminergic neurons of C. elegans had been reported (45). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a neurotoxic effect after overexpression of -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0235032:Neurotoxic effect [Injury or Poisoning]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in the eight dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:Dopaminergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "had"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.259: In wild-type background, we did not observe any morphological phenotype on overexpressing wild-type or mutant -synuclein. 

Phrase: "In wild-type background,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706907:Background [Conceptual Entity]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any morphological phenotype on overexpressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.260: In contrast, the -synuclein A53T mutant caused developmental defects and a temperature-sensitive lethal phenotype in pdr-1(lg103), whereas wild-type -synuclein was inconspicuous in this genetic background (Fig.7A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the -synuclein A53T mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "developmental defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0000768:Developmental defect [Congenital Abnormality]
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "a temperature-sensitive lethal phenotype in pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031437:Phenotype [Organism Attribute]
   744   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(lg103"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "was"

Phrase: "inconspicuous in this genetic background"

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.261: At 15C, 15% of pdr-1(lg103) mutants expressing -synuclein A53T arrested at early larval stages (Fig.7B). 

Phrase: "At 15C,"

Phrase: "15% of pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "expressing -"

Phrase: "synuclein A53T"

Phrase: "arrested at early larval stages"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   797   C2363430:early stages [Temporal Concept]
   781 E C1517886:Early Stage [Classification]
   760   C0018790:arrested [Disease or Syndrome]
   760   C0237477:Arrested [Temporal Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1306673:Stages [Qualitative Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C0392351:arrest [Governmental or Regulatory Activity]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "(Fig.7B"

Phrase: ")."
Processing 00000000.tx.262: At 20C, this lethal phenotype became fully penetrant (Fig.7C). 

Phrase: "At 20C,"

Phrase: "this lethal phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "became"

Phrase: "fully penetrant"

Phrase: "(Fig.7C"

Phrase: ")."
Processing 00000000.tx.263: In contrast, even at 25C expression of -synuclein A53T did not cause a phenotype in other pdr-1 alleles, and expression of wild-type -synuclein was inconspicuous in any pdr-1 mutant background. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "even at 25C expression of -synuclein A53T"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a phenotype in other pdr-1 alleles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "expression of wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "inconspicuous in any pdr-1 mutant background."
Processing 00000000.tx.264: In none of the pdr-1 mutants we observed death of dopaminergic neurons, as judged from the gfp expression pattern of an integrated Pdat-1::gfp marker (Fig.7A). 

Phrase: "In none"

Phrase: "of the pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "death of dopaminergic neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2754100:neuron death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "as"

Phrase: "judged from the gfp expression pattern of an integrated Pdat-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   766   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   750   C1171362:protein expression [Genetic Function]
   749   C1317658:Protein pattern [Clinical Attribute]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0185117:Expression [Therapeutic or Preventive Procedure]
   735   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   735   C0332583:Green [Qualitative Concept]
   735   C0449774:Pattern [Spatial Concept]
   702   C0221191:Judge [Professional or Occupational Group]

Phrase: ":"

Phrase: ":"

Phrase: "gfp marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0005516:Marker [Clinical Attribute]
   756   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.265: Cytotoxicity is dependent on -synuclein A53T and pdr-1(lg103) expression level The incidence of PD increases exponentially with age in humans. 

Phrase: "Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "is"

Phrase: "dependent on -synuclein A53T"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "expression level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "The incidence of PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "exponentially with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.266: The lack of a phenotype upon expression of -synuclein in C. elegans may be the consequence of the short lifespan (generally less than 20 days) of these animals. 

Phrase: "The lack of a phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "upon expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in C. elegans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]

Phrase: "may"

Phrase: "be"

Phrase: "the consequence of the short lifespan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "(generally less than 20 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0439228:days [Temporal Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "of these animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.267: The increase of transgenic -synuclein expression could potentially phenocopy the situation seen in old patients. 

Phrase: "The increase of transgenic -synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "potentially phenocopy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678921:Phenocopy [Organism Attribute]

Phrase: "the situation"

Phrase: "seen in old patients."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205397:Seen [Qualitative Concept]
   770   C0580836:Old [Temporal Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.268: Therefore, we used genetic tools to monitor the consequences of different levels of -synuclein accumulation in various mutant backgrounds. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genetic tools to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0336791:Tool [Manufactured Object]
   793   C2827396:Tool [Manufactured Object]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the consequences of different levels of -synuclein accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in various mutant backgrounds."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.269: For this purpose, we crossed the pdr-1 mutants into strains that expressed -synuclein wild-type or A53T mutation from varying genomic copies (Fig.8A). 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "we"

Phrase: "crossed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205203:Crossed [Spatial Concept]
   966 E C2828360:Cross [Conceptual Entity]

Phrase: "the pdr-1 mutants into strains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "expressed -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "A53T mutation from varying genomic copies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0026882:genomic mutation [Genetic Function]
           Mutation
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Fig.8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.270: Several results from these experiments are noteworthy. 

Phrase: "Several results from these experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "are"

Phrase: "noteworthy."
Processing 00000000.tx.271: First, only strong expression of -synuclein A53T (two copies of the transgene) resulted in a strong phenotype in pdr-1 (lg103). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "only strong expression of -synuclein A53T"

Phrase: "(two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "copies of the transgene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0282641:Transgene [Gene or Genome]
   770   C1948062:Copies [Manufactured Object]

Phrase: ")"

Phrase: "resulted in a strong phenotype"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0442821:Strong [Qualitative Concept]
   760   C1285572:Phenotype [Laboratory Procedure]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")."
Processing 00000000.tx.272: Secondly, similar to the results we had obtained after exposing the animals to ER stress, only a homozygous pdr-1(lg103) mutant background or, to some extent, a trans-heterozygous pdr-1(lg103)/pdr-1(tm598) genetic background resulted in a phenotype in -synuclein A53T expressing worms. 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "similar to the results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "we"

Phrase: "had"

Phrase: "obtained after exposing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332157:exposing [Clinical Attribute]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the animals to ER stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a homozygous pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019904:Homozygous [Organism Attribute]
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "or"

Phrase: ","

Phrase: "to some extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "a trans-heterozygous pdr-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0019425:Heterozygous [Organism Attribute]
   812   C0154830:PDR [Disease or Syndrome]
   812   C1418444:PDR [Gene or Genome]
   812   C1845050:PDR [Disease or Syndrome]
   812   C2826298:TRANS [Idea or Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "/pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "resulted in a phenotype in -synuclein A53T expressing worms."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0018889:WORM [Disease or Syndrome]
   742   C0018893:Worm [Eukaryote]
   742   C0031437:Phenotype [Organism Attribute]
   742   C0040820:Worms NOS [Disease or Syndrome]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1285572:Phenotype [Laboratory Procedure]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]
Processing 00000000.tx.273: Thirdly, a single copy of the wild-type pdr-1 or of the alleles lg101 or tm395 was sufficient to prevent the establishment of a phenotype, even in animals that expressed two copies of -synuclein A53T (Fig.8A). 

Phrase: "Thirdly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Thirdly [Quantitative Concept]

Phrase: "a single copy of the wild-type pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   742   C1948062:Copy [Manufactured Object]

Phrase: "or of the alleles lg101"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "or"

Phrase: "tm395"

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the establishment of a phenotype,"

Phrase: "even in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "expressed"

Phrase: "two copies of -synuclein A53T"

Phrase: "(Fig.8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.274: View larger version (28K): [in this window] [in a new window]  Figure8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure8."
Processing 00000000.tx.275: Dosage-dependent cytotoxicity of pdr-1(lg103) and -synuclein A53T. 

Phrase: "Dosage-dependent cytotoxicity of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and -"

Phrase: "synuclein A53T."
Processing 00000000.tx.276: Survival/arrest analyses of heterozygous mutants and the hypermorphic atf-6 background (as described in Fig.6). 

Phrase: "Survival/arrest analyses of heterozygous mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0038953:Survival Analyses [Research Activity]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the hypermorphic atf-6 background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "("

Phrase: "as"

Phrase: "described in Fig.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1552738:described [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.277: (A) At 20C, only -synuclein A53T expressed from both integrated copies confers cytotoxicity in specifically homozygous pdr-1(lg103) mutant background, and, although milder, in pdr-1(lg103)/pdr-1(tm598) compound heterozygous mutants carrying both in-frame deletions. 

Phrase: "(A) At 20C,"

Phrase: "only -synuclein A53T"

Phrase: "expressed from both integrated copies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948062:Copies [Manufactured Object]

Phrase: "confers"

Phrase: "cytotoxicity in specifically homozygous pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "although"

Phrase: "milder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945599:Mild [Qualitative Concept]

Phrase: "in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "/pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "compound heterozygous mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "both in-frame deletions."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]
Processing 00000000.tx.278: (B) pdr-1(lg103);atf-6(ok551) double mutants overexpressing -synuclein A53T mutation show a significantly enhanced lethality/developmental arrest already at 15C.  

Phrase: "(B) pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]
   827   C2347469:/B [Quantitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: ";atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein A53T mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a significantly enhanced lethality/developmental arrest already at 15C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1848980:Developmental arrest [Finding]
   742   C0237477:Arrest [Temporal Concept]
   742   C0392351:arrest [Governmental or Regulatory Activity]
   742   C0458003:Developmental [Qualitative Concept]
   742   C0678723:Developmental [Organism Function]
Processing 00000000.tx.279: Our previous experiments have suggested that pdr-1(lg103) might cause a neomorphic phenotype (see Figs47). 

Phrase: "Our previous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a neomorphic phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Figs47"

Phrase: ")."
Processing 00000000.tx.280: If this were the case, then further increasing the expression level of this mutant should result in an aggravation of the -synuclein lethal phenotype. 

Phrase: "If"

Phrase: "this"

Phrase: "were"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883708:Then [Temporal Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression level of this mutant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "should"

Phrase: "result in an aggravation of the -synuclein lethal phenotype."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0031437:Phenotype [Organism Attribute]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1274040:Result [Functional Concept]
   742   C1285572:Phenotype [Laboratory Procedure]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   742   C3151529:Lethal [Finding]
Processing 00000000.tx.281: To test this hypothesis, we analyzed the consequences of -synuclein A53T expression in the pdr-1 (lg103);atf-6(ok551) double mutant background (Fig.8B), as we have shown that the atf-6(ok551) mutant enhances the transcription rate of pdr-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the consequences of -synuclein A53T expression in the pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(lg103"

Phrase: ")"

Phrase: ";atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "(Fig.8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the transcription rate of pdr-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.282: Lethality/arrest was strongly enhanced already at 15C with respect to the pdr-1(lg103) single mutant. 

Phrase: "Lethality/arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "strongly"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "already at 15C"

Phrase: "with respect to the pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "single mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.283: We conclude that lethality results from the expression of mutant -synuclein in the sensitized background of recessive toxic gain-of-function alleles of the C. elegans parkin pdr-1. 

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]

Phrase: "results from the expression of mutant -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in the sensitized background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "of recessive toxic gain-of-function alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   878   C0683223:recessive allele [Gene or Genome]
   799   C0002085:Alleles [Gene or Genome]

Phrase: "of the C. elegans parkin pdr-1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1418485:C-1 [Gene or Genome]
   840   C0162610:C ELEGANS [Eukaryote]
   804   C0154830:PDR [Disease or Syndrome]
   804   C1418270:PARKIN [Gene or Genome]
   804   C1418444:PDR [Gene or Genome]
   804   C1553033:[c] [Quantitative Concept]
   804   C1845050:PDR [Disease or Syndrome]
   804   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.284: As -synuclein was expressed from a pan-neuronal promotor, lethality seems to be caused by a neuron-specific toxicity. 

Phrase: "As -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed from a pan-neuronal promotor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0085999:Pan [Mammal]
   753   C0086860:promotor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0521390:Neuronal [Immunologic Factor]

Phrase: "lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "caused by a neuron-specific toxicity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0027882:Neuron [Cell]
   753   C0040539:toxicity [Qualitative Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
   753   C1552740:specific [Intellectual Product]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.285: Blocking the UPR is not sufficient for causing -synuclein-mediated toxicity The aggravation of a mutant -synuclein phenotype by pdr-1 (lg103) could either be caused by blocking the ER stress response or by an effect of the mutant protein that does not involve its role in the UPR. 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "not sufficient for causing -synuclein-mediated toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205410:Sufficient [Qualitative Concept]

Phrase: "The aggravation of a mutant -synuclein phenotype"

Phrase: "by pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "could"

Phrase: "either"

Phrase: "be"

Phrase: "caused by blocking"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0233660:Blocking [Mental or Behavioral Dysfunction]
   790   C0332206:Blocking [Functional Concept]
   756   C0015127:cause [Functional Concept]
   756 E C0028778:Block [Pathologic Function]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "the ER stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0149784:stress response [Physiologic Function]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   756   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]

Phrase: "or by an effect of the mutant protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "its role in the UPR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.286: To distinguish between these two possibilities, we analyzed -synuclein-expressing animals, in which individual genes of the UPR had been mutated, as well as animals treated with exogenous ER stress. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between these two possibilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "we"

Phrase: "analyzed -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "synuclein-expressing animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "in which individual genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "of the UPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "had"

Phrase: "been"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "as well as"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "treated with exogenous ER stress."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0038435:Stress [Finding]
   753   C0205101:Exogenous [Spatial Concept]
   753   C0205228:Exogenous [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.287: Expression of neither wild-type -synuclein nor the A53T variant caused a detectable phenotype in the ire-1 (v33) mutant (Fig.9A). 

Phrase: "Expression of neither wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "nor"

Phrase: "the A53T variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a detectable phenotype in the ire-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig.9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.288: Furthermore, animals expressing -synuclein are not sensitive to tunicamycin treatment (Fig.9B). 

Phrase: "Furthermore,"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "expressing -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "not sensitive to tunicamycin treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "(Fig.9B"

Phrase: ")."
Processing 00000000.tx.289: Consistent with the latter finding, -synuclein-expressing strains did not induce the UPR, as monitored by northern and hsp-4::gfp expression analyses in vivo (data not shown). 

Phrase: "Consistent with the latter finding, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   762   C0332529:Consistency finding [Qualitative Concept]

Phrase: "synuclein-expressing strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0080194:Strains [Injury or Poisoning]
   827   C0456178:strains [Intellectual Product]
   793 E C1518614:Strain [Organism]
   793 E C2987481:Strain [Mental Process]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the UPR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "as"

Phrase: "monitored by northern"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1709269:Northern [Spatial Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "hsp-4"

Phrase: ":"

Phrase: ":"

Phrase: "gfp expression analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   873   C1882495:Protein Expression Analysis [Laboratory Procedure]
   836   C1514534:Protein Analysis [Molecular Biology Research Technique]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.290: We conclude from these results that the phenotype caused by the combination of -synuclein A53T expression and pdr-1 toxic gain-of-function mutations is not mediated by the impairment of an ER stress pathway. 

Phrase: "We"

Phrase: "conclude from these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "that"

Phrase: "the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "caused by the combination of -synuclein A53T expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205195:Combination [Qualitative Concept]
   744   C1947911:Combination [Physical Object]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "pdr-1 toxic gain-of-function mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediated by the impairment of an ER stress pathway."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0038435:Stress [Finding]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0684336:Impairment [Pathologic Function]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.291: This conclusion is further substantiated by the inconspicuous behavior of pdr-1 mutants and -synuclein-expressing strains in assays testing increased oxidative and heat stress. 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "substantiated by the inconspicuous behavior of pdr-1 mutants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0004927:Behavior [Individual Behavior]
   742   C0154830:PDR [Disease or Syndrome]
   742   C0596988:mutants [Cell or Molecular Dysfunction]
   742   C1418444:PDR [Gene or Genome]
   742   C1845050:PDR [Disease or Syndrome]
   742   C2707008:Behavior [Clinical Attribute]

Phrase: "and -"

Phrase: "synuclein-expressing strains in assays"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0080194:Strains [Injury or Poisoning]
   760   C0456178:strains [Intellectual Product]
   726 E C1518614:Strain [Organism]
   726 E C2987481:Strain [Mental Process]

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "increased oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "heat stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0282507:heat stress [Injury or Poisoning]
   861   C0018837:Heat [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.292: Unlike mev-1 (kn1) (encoding a mutant version of a cytochrome b subunit) or ire-1(v33) strains, respectively, pdr-1 mutants and -synuclein strains were not sensitive against paraquat and short heat-shock treatment (2h 35C) and showed no discernable phenotype (Fig.9C and D). 

Phrase: "Unlike mev-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556642:MeV [Quantitative Concept]
   861   C1881830:meV [Quantitative Concept]

Phrase: "(kn1"

Phrase: ")"

Phrase: "("

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a mutant version of a cytochrome b subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333052:Version [Functional Concept]
   744   C2607870:Version [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "strains,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "respectively,"

Phrase: "pdr-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and -"

Phrase: "synuclein strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "not sensitive against paraquat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332324:Sensitive [Functional Concept]
   770   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "short heat-shock treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0203597:heat treatment [Therapeutic or Preventive Procedure]
   861   C0013806:shock treatment [Therapeutic or Preventive Procedure]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "(2h 35C"

Phrase: ")"

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no discernable phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Fig.9C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.293: View larger version (43K): [in this window] [in a new window]  Figure9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure9."
Processing 00000000.tx.294: Cytotoxicity of -synuclein A53T expression is independent of ER, oxidative and heat stress pathways. 

Phrase: "Cytotoxicity of -synuclein A53T expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is independent of ER,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   806   C0332291:Independent of [Functional Concept]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]

Phrase: "oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "heat stress pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   734   C0282507:heat stress [Injury or Poisoning]
Processing 00000000.tx.295: The Y-axis depicts the percentage of dead/arrested animals. 

Phrase: "The Y-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "depicts"

Phrase: "the percentage of dead/arrested animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.296: Shown are mean valuesSEM, the total numbers of animals analyzed is listed above each column (n). 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "mean valuesSEM,"

Phrase: "the total numbers of animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "is"

Phrase: "listed above each column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "(n)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.297: (A) Overexpression of -synuclein WT and A53T in ire-1(v33) mutant background did not affect survival at any temperature tested. 

Phrase: "(A) Overexpression of -synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2700323:WT [Fish]

Phrase: "and"

Phrase: "A53T in ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "mutant background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "survival at any temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.298: Survival was tested 3 days after synchronization of eggs at the temperatures depicted. 

Phrase: "Survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "3 days after synchronization of eggs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1442459:3 Days [Temporal Concept]
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "at the temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039476:Temperatures [Quantitative Concept]
   966 E C0005903:temperature [Organism Attribute]

Phrase: "depicted."
Processing 00000000.tx.299: (B) Exogenous ER stress had no effect on viability and development of mutants overexpressing human -synuclein WT or A53T. 

Phrase: "(B) Exogenous ER stress"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   897   C0718778:B-Stress [Pharmacologic Substance,Vitamin]
   884   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   840   C0014239:Endoplasmic Reticulum [Cell Component]
   804   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   804   C0038435:Stress [Finding]
   733 E C0231297:Stressful [Functional Concept]
   733   C0598268:Endoplasm [Cell Component]

Phrase: "had"

Phrase: "no effect on viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "development of mutants"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human -synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2700323:WT [Fish]

Phrase: "or"

Phrase: "A53T."
Processing 00000000.tx.300: Plates contained 1.5g/ml tunicamycin. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "1.5g/ml tunicamycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.301: (C) mev-1(kn1) animals used as controls arrest early in development when treated with paraquat. 

Phrase: "(C) mev-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1418485:C-1 [Gene or Genome]
   827   C0556642:MeV [Quantitative Concept]
   827   C1553033:[c] [Quantitative Concept]
   827   C1881830:meV [Quantitative Concept]

Phrase: "(kn1"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "used as controls"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "early in development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1279919:Early [Temporal Concept]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "when"

Phrase: "treated with paraquat."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.302: In contrast, oxidative stress did not affect viability and development of pdr-1 mutants or animals expressing human -synuclein WT or A53T. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "development of pdr-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "or"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "expressing"

Phrase: "human -synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2700323:WT [Fish]

Phrase: "or"

Phrase: "A53T."
Processing 00000000.tx.303: Survival was analyzed after 3 days exposure of synchronized L1 larvae to 2mM paraquat at 20C. 

Phrase: "Survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "analyzed after 3 days exposure of synchronized L1 larvae"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   742   C0023047:Larvae [Eukaryote]
   742   C0274281:Exposure, NOS [Injury or Poisoning]
   742   C0332157:Exposure [Clinical Attribute]
   742   C0439228:days [Temporal Concept]
   742   C0439580:Synchronized [Temporal Concept]
   742   C0441918:L1 [Finding]
   742   C0936012:Analyzed [Research Activity]
   742   C1179698:L1 [Body Location or Region]
   742   C1416177:L1 [Gene or Genome]
   708 E C0332173:/day [Temporal Concept]
   708 E C0439505:/day [Temporal Concept]

Phrase: "to 2mM paraquat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "at 20C."
Processing 00000000.tx.304: (D) Heat-shock treatment of pdr-1 mutants and worms overexpressing human -synuclein WT or A53T mutation for 2h at 35C. 

Phrase: "("

Phrase: "D)"

Phrase: "Heat-shock treatment of pdr-1 mutants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0013806:shock treatment [Therapeutic or Preventive Procedure]
   774   C0203597:heat treatment [Therapeutic or Preventive Procedure]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human -synuclein WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2700323:WT [Fish]

Phrase: "or"

Phrase: "A53T mutation for 2h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "at 35C."
Processing 00000000.tx.305: Heat stress on synchronized L2 larvae had no effect on development or survival of mutant worms.  

Phrase: "Heat stress on synchronized L2 larvae"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0282507:heat stress [Injury or Poisoning]
   753   C0018837:Heat [Natural Phenomenon or Process]
   753   C0038435:Stress [Finding]

Phrase: "had"

Phrase: "no effect on development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "survival of mutant worms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
Processing 00000000.tx.306: Co-expression of -synuclein A53T and PDR-1 variants enhances aggregate formation To understand the reason for the synergistic effect of pdr-1 (lg103) and -synuclein A53T, we co-expressed C. elegans Parkin variants and human -synuclein in HEK293T cells and monitored the localization of the proteins by antibody stainings. 

Phrase: "Co-expression of -synuclein A53T"

Phrase: "and"

Phrase: "PDR-1 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "aggregate formation To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the reason for the synergistic effect of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392360:Reason [Idea or Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and -"

Phrase: "synuclein A53T,"

Phrase: "we"

Phrase: "co-expressed"

Phrase: "C. elegans Parkin variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "human -synuclein in HEK293T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the localization of the proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0597704:protein localisation [Cell Function]
   781   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "by antibody stainings."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0487602:Stainings [Laboratory Procedure]
   827 E C1704680:Staining [Finding]
Processing 00000000.tx.307: In agreement with in vitro data (see Fig.4E), we found that only PDR-1(aa242247) showed altered localization and was prone to aggregation in human cell culture, whereas wild-type protein and the other PDR-1/Parkin derivatives showed uniform cellular distribution (Fig.10A). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with in vitro data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that only PDR-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0154830:PDR [Disease or Syndrome]
   827   C0205171:Only [Quantitative Concept]
   827   C1418444:PDR [Gene or Genome]
   827   C1720467:Only [Intellectual Product]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa242247"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "altered localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "was"

Phrase: "prone to aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033422:Prone [Spatial Concept]

Phrase: "in human cell culture,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0427861:human cell [Laboratory or Test Result]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "whereas"

Phrase: "wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the other PDR-1/Parkin derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243072:derivatives [Chemical Viewed Structurally]
   779 E C1527240:Derivative [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "uniform cellular distribution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1710545:Uniform Distribution [Quantitative Concept]
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "(Fig.10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.308: These data suggest that the C-terminal IBR and RING2 domains in combination with the deletion of the UBL domain result in PDR-1/Parkin mislocalization and aggregation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the C-terminal IBR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021334:IBR [Disease or Syndrome]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "and"

Phrase: "RING2 domains in combination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "with the deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "of the UBL domain result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "in PDR-1/Parkin mislocalization"

Phrase: "and"

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.309: Co-transfection of -synuclein wild-type did not alter the localization of any of the PDR-1 variants. 

Phrase: "Co-transfection of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the localization of any of the PDR-1 variants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
Processing 00000000.tx.310: In all cases, -synuclein wild-type was uniformly distributed within the cells. 

Phrase: "In all cases, -"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "uniformly"

Phrase: "distributed within the cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1704711:Distributed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.311: In contrast, combined expression of -synuclein A53T with PDR-1 wild-type, or either of the two in-frame PDR-1 deletion variants aa24247 or aa140263, resulted in aggregation of both proteins. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "combined expression of -synuclein A53T with PDR-1 wild-type,"

Phrase: "or"

Phrase: "either of the two in-frame PDR-1 deletion variants aa24247"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0080089:Frame [Nucleotide Sequence]
   738   C0154830:PDR [Disease or Syndrome]
   738   C0180979:Frame [Medical Device]
   738   C0205419:variants [Qualitative Concept]
   738   C0205448:Two [Quantitative Concept]
   738   C1418444:PDR [Gene or Genome]
   738   C1442161:Deletion [Cell or Molecular Dysfunction]
   738   C1511760:Deletion [Genetic Function]
   738   C1705858:Frame [Manufactured Object]
   738   C1845050:PDR [Disease or Syndrome]
   738   C1880274:Deletion [Activity]

Phrase: "or"

Phrase: "aa140263,"

Phrase: "resulted in aggregation of both proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.312: However, expression of -synuclein A53T together with the C-terminal PDR-1 deletion amino acids 1199Stop did not affect localization and thus did not result in aggregate-like structures. 

Phrase: "However,"

Phrase: "expression of -synuclein A53T"

Phrase: "together with the C-terminal PDR-1 deletion amino acids 1199Stop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   705   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "thus"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in aggregate-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205418:Aggregate [Qualitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "like structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.313: These data indicate that the cysteine-rich C-terminus of PDR-1 mediates -synuclein A53T-dependent aggregation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cysteine-rich C-terminus of PDR-1"

Phrase: "mediates -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "synuclein A53T-dependent aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332621:Aggregation [Functional Concept]
   812   C0439168:% aggregation [Quantitative Concept]
   741 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.314: View larger version (54K): [in this window] [in a new window]  Figure10. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure10."
Processing 00000000.tx.315: -synuclein A53T, but not wild-type -synuclein, enhances aggregation of the transgenically expressed PDR-1 in HEK293T cells. 

Phrase: "-synuclein A53T,"

Phrase: "but"

Phrase: "not wild-type -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "aggregation of the transgenically expressed PDR-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]

Phrase: "in HEK293T cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.316: (A) The full-length or truncated forms of C. elegans PDR-1 were expressed in HEK293T cells alone or in combination with -synuclein WT or -synuclein A53T. 

Phrase: "(A)"

Phrase: "The full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "or"

Phrase: "truncated forms of C. elegans PDR-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "expressed in HEK293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with -synuclein WT or -synuclein A53T."
Processing 00000000.tx.317: All PDR-1 constructs were fused to FLAG epitope tag represented by green labeling, -synuclein expression is shown in red. 

Phrase: "All PDR-1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "fused to FLAG epitope tag"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0003316:Epitope [Immunologic Factor]
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C0699952:Fused [Functional Concept]
   760   C1708067:Flag [Functional Concept]
   760   C1710492:TAG [Gene or Genome]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "represented by green labeling, -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332583:Green [Qualitative Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737   C1882932:Represent [Activity]

Phrase: "synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "shown in red."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.318: After single transfection only PDR-1(aa24247), corresponding to pdr-1(lg103), formed subcellular aggregates in HEK293T cells. 

Phrase: "After single transfection only PDR-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0037179:Single [Population Group]
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   804   C0087136:single [Finding]
   804   C0154830:PDR [Disease or Syndrome]
   804   C0205171:Only [Quantitative Concept]
           Single
   804   C1418444:PDR [Gene or Genome]
   804   C1720467:Only [Intellectual Product]
   804   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: ","

Phrase: "corresponding to pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ","

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "subcellular aggregates in HEK293T cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.319: Both wild-type and mutant A53T -synuclein co-localizes with the aggregates. 

Phrase: "Both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-localizes with the aggregates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205418:aggregates [Qualitative Concept]
   760   C0392752:localize [Spatial Concept]
Processing 00000000.tx.320: In contrast, expression of -synuclein A53T resulted in enhanced aggregation of both wild-type PDR-1 and PDR-1(aa140263) (corresponding to allele tm598), whereas PDR-1 variants expression only UBL and UPD domains were not affected. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "expression of -synuclein A53T"

Phrase: "resulted in enhanced aggregation of both wild-type PDR-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C1883559:Wild Type [Organism Attribute]
   757   C0441729:Type 1 [Classification]
   739   C0154830:PDR [Disease or Syndrome]
   739   C0332307:Type [Qualitative Concept]
   739   C0332621:Aggregation [Functional Concept]
   739   C0439168:% aggregation [Quantitative Concept]
   739   C0445392:Wild [Intellectual Product]
   739   C1418444:PDR [Gene or Genome]
   739   C1547052:*Type [Quantitative Concept]
   739   C1845050:PDR [Disease or Syndrome]
   739   C2349975:Enhanced [Activity]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "and"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: "("

Phrase: "corresponding to allele tm598"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0002085:Allele [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "PDR-1 variants expression only UBL"

Phrase: "and"

Phrase: "UPD domains"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.321: (B) The aggregation of PDR-1 variants were investigated biochemically after co-expression in HEK293 with -synuclein wild-type (w) or the -synuclein A53T mutant (m) as described for Figure4. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The aggregation of PDR-1 variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "were"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "biochemically"

Phrase: "after"

Phrase: "co-expression in HEK293"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(w)"

Phrase: "or"

Phrase: "the -synuclein A53T mutant (m)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "as"

Phrase: "described for Figure4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.322: The formation of 1% Triton X-100 resistant aggregates of the full-length and in-frame deleted aa140263 variants of PDR-1 was significantly enhanced after co-expression of -synuclein A53T but not of -synuclein wild-type. 

Phrase: "The formation of 1% Triton X-100 resistant aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "of the full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "in-frame deleted aa140263 variants of PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced after co-expression of -synuclein A53T"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C2349975:Enhanced [Activity]

Phrase: "but"

Phrase: "not of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild-type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.323: The aggregation of the in-frame deleted variant aa24247 of PDR-1 was only slightly increased after co-expression of -synuclein A53T compared with the wild-type variant of -synuclein. 

Phrase: "The aggregation of the in-frame deleted variant aa24247 of PDR-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0332621:Aggregation [Functional Concept]
   736   C0439168:% aggregation [Quantitative Concept]

Phrase: "was"

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "increased after co-expression of -synuclein A53T"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "compared with the wild-type variant of -synuclein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205419:Variant [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707455:Compared [Activity]
Processing 00000000.tx.324: No aggregation of -synuclein A53T or -synuclein wild-type was observed after co-transfection with PDR-1(aa1199Stop), suggesting that this allele represents a strong loss-of-function or null allele.  

Phrase: "No aggregation of -synuclein A53T or -synuclein"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "observed after co-transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C1441672:Observed [Functional Concept]

Phrase: "with PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa1199Stop"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a strong loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "or"

Phrase: "null allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2985437:Null Allele [Cell or Molecular Dysfunction]
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.325: In addition, the solubility of the PDR-1 derivatives was tested in cellular extracts. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the solubility of the PDR-1 derivatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0037628:Solubility [Qualitative Concept]

Phrase: "was"

Phrase: "tested in cellular extracts."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
   737   C2828366:Extract [Substance]
Processing 00000000.tx.326: Similar to human Parkin in a previous report (27), C. elegans PDR-1 in an -synuclein-expressing background is observed both in the Triton X-soluble and Triton X-insoluble fractions (Fig.10B). 

Phrase: "Similar to human Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "C. elegans PDR-1 in an -synuclein-expressing background"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0162610:C ELEGANS [Eukaryote]
   762   C1418485:C-1 [Gene or Genome]
   742   C0154830:PDR [Disease or Syndrome]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1418444:PDR [Gene or Genome]
   742   C1553033:[c] [Quantitative Concept]
   742   C1706907:Background [Conceptual Entity]
   742   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "both in the Triton X-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0238767:Both [Spatial Concept]
   760   C0242759:Triton [Geographic Area]
   760   C1706086:Both [Qualitative Concept]

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "Triton X-insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.10B"

Phrase: ")."
Processing 00000000.tx.327: The shift of PDR-1 wild-type and aa140263 to the insoluble fraction in an -synuclein A53T background correlates with its aggregation (compare Fig.10A). 

Phrase: "The shift of PDR-1 wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "aa140263 to the insoluble fraction"

Phrase: "in an -synuclein A53T background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706907:Background [Conceptual Entity]

Phrase: "correlates with its aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig.10A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553642:10a [Medical Device]

Phrase: ")."
Processing 00000000.tx.328: No A53T-dependent increase of the insoluble fraction was observed for PDR-1(aa24247) that already forms aggresome-like structures without co-expression of -synuclein (compare Figs4E and 10B).  

Phrase: "No A53T-dependent increase of the insoluble fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed for PDR-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "that already"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "aggresome-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167059:aggresome [Cell Component]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "without co-expression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Figs4E"

Phrase: "and"

Phrase: "10B"

Phrase: ")."
Processing 00000000.tx.329: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Many different mutations in human parkin have been associated with particularly severe recessive forms of PD resulting in the clinical and pathological heterogeneity (26). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Many different mutations in human parkin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "associated with particularly severe recessive forms of PD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0205082:Severe [Qualitative Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "resulting in the clinical"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0205210:Clinical [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "pathological heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.330: However, the biochemical mechanisms leading to AR-JP are poorly understood. 

Phrase: "However,"

Phrase: "the biochemical mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0678659:biochemical mechanisms [Molecular Function]
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to AR-JP"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   882   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   820   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   790   C0441748:Autosomal recessive [Intellectual Product]
   790   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0332152:Leading [Temporal Concept]
   753   C0596142:autosomal [Cell Component]
   753   C1522538:Leading [Functional Concept]
   753   C3146221:Juvenile [Age Group]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.331: Although complete loss of Parkin function is considered to be causative for disease, at least some disease-linked point mutants of Parkin have been described to retain substantial biochemical activity (2731) and additionally lead to Parkin protein aggregation and aggresome formation (28,29,3234,39,40,46). 

Phrase: "Although"

Phrase: "complete loss of Parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "causative for disease,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "some disease-linked point mutants of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "substantial biochemical activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(2731"

Phrase: ")"

Phrase: "and"

Phrase: "additionally"

Phrase: "lead to Parkin protein aggregation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "aggresome formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(28,"

Phrase: "29,"

Phrase: "3234,"

Phrase: "39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.332: In contrast, Parkin animal models generated so far are exclusively based on complete knockout strategies, although there is growing evidence that the disease-linked mutations may alter several properties of Parkin function, not all of them can be phenocopied by abolishing the expression of this E3 ligase (27). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Parkin animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599779:Models, Animal [Animal]
   827   C0003062:Animal [Animal]
   827   C3161035:Models [Intellectual Product]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "are"

Phrase: "exclusively"

Phrase: "based on complete knockout strategies,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205197:Complete [Qualitative Concept]
   760   C0560617:knock out [Injury or Poisoning]
   760   C0679199:strategies [Mental Process]
   760   C0725685:COMPLEAT [Food]
   760   C1522225:Knock-out [Experimental Model of Disease]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "although"

Phrase: "there"

Phrase: "is"

Phrase: "growing"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the disease-linked mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "several properties of Parkin function,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "phenocopied by abolishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0678921:Phenocopy [Organism Attribute]

Phrase: "the expression of this E3 ligase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.333: This may explain the weak phenotypes observed in several mouse knockout strains of parkin (reviewed in 3), compared with the severe cellular effects in humans. 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "the weak phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "observed in several mouse knockout"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0206745:Knock-Out Mouse [Mammal]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1441672:Observed [Functional Concept]
   760   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "strains of parkin"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   790   C0080194:Strain [Injury or Poisoning]
   790   C0456178:strain [Intellectual Product]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1518614:Strain [Organism]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2987481:Strain [Mental Process]
   734 E C0180860:Filter [Manufactured Object]
   734 E C0581406:Filter [Medical Device]
   734 E C1522664:Filter [Intellectual Product]
   734 E C1704449:Filter [Conceptual Entity]
   734 E C1704684:Filter [Medical Device]
   734 E C1875155:FILTER [Medical Device]
   706 E C0442694:Straining [Physiologic Function]

Phrase: "("

Phrase: "reviewed in 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "compared with the severe cellular effects"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0205082:Severe [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C1707455:Compared [Activity]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.334: Interestingly, none of the proposed Parkin substrates are stabilized in parkin knockout mice (4749), implying that either the bona fide substrates have not been identified yet, or that the protection/detoxification mechanism to which Parkin contributes does not depend on the degradation of toxic substrates. 

Phrase: "Interestingly,"

Phrase: "none of the proposed Parkin substrates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1441414:PROPOSED [Idea or Concept]
   753   C1553874:Proposed [Qualitative Concept]
   753   C1578820:Proposed [Idea or Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "stabilized in parkin knockout mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0206745:Knock-out Mice [Mammal]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0184512:Stabilized [Qualitative Concept]
   760   C0560617:knock out [Injury or Poisoning]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1522225:Knock-out [Experimental Model of Disease]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(4749"

Phrase: ")"

Phrase: ","

Phrase: "implying"

Phrase: "that either"

Phrase: "the bona fide substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "yet,"

Phrase: "or"

Phrase: "that"

Phrase: "the protection/detoxification mechanism to which Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depend on the degradation of toxic substrates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0243125:degradation [Functional Concept]
   748   C0600688:toxic [Injury or Poisoning]
   748   C0699900:Degradation [Organism Function]
   748   C0725813:depend [Medical Device]
   748   C1407029:Toxic [Qualitative Concept]
   714   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.335: Alternatively, at least partially redundant pathways for removal of Parkin substrates might exist. 

Phrase: "Alternatively,"

Phrase: "at least partially redundant pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "for removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of Parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "might"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.336: Consistently, the Parkin substrate synphilin-1 has been shown to be ubiquitylated by other E3 ligases (5053) that might compensate for Parkin loss-of-function. 

Phrase: "Consistently,"

Phrase: "the Parkin substrate synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
   861   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "ubiquitylated by other E3 ligases"

Phrase: "(5053"

Phrase: ")"

Phrase: "that"

Phrase: "might"

Phrase: "compensate for Parkin loss-of-function."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0031843:function [Physiologic Function]
   753   C0205432:compensate [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1517945:Loss [Quantitative Concept]
   753   C1705273:Function [Intellectual Product]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.337: In contrast, a protein exerting a partial loss-of-function or an altered localization or regulation (i.e. caused by a loss of only one functional domain) might be more deleterious to the cell, in particular, under stress conditions. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exerting [Organism Function]

Phrase: "a partial loss-of-function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "or"

Phrase: "an altered localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "or"

Phrase: "regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "caused by a loss of only one functional domain"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0205171:Only [Quantitative Concept]
   742   C0205245:Functional [Functional Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0542341:Functional [Functional Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1720467:Only [Intellectual Product]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C2700217:Functional [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]

Phrase: ")"

Phrase: "might"

Phrase: "be"

Phrase: "more deleterious to the cell,"

Phrase: "in particular,"

Phrase: "under stress conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.338: Therefore, animal models that are generated to further study the disease mechanism and to screen for genetic of pharmacological modification might be based on parkin neomorphic or partial loss-of-function mutants similar to the disease-linked alleles rather than on knocking out/down Parkin activity. 

Phrase: "Therefore,"

Phrase: "animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the disease mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "screen for genetic of pharmacological modification"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0813145:Genetic screen [Diagnostic Procedure]
   783   C1518613:Genetic Modification [Research Activity]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   753   C0205464:pharmacological [Functional Concept]
   753   C0220908:screen [Health Care Activity]
   753   C0314603:Genetic [Functional Concept]
   753   C0392747:Modification [Functional Concept]
   753   C1305399:screen [Functional Concept]
   753   C1554963:modification [Qualitative Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "might"

Phrase: "be"

Phrase: "based on parkin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1418270:PARKIN [Gene or Genome]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "neomorphic"

Phrase: "or"

Phrase: "partial loss-of-function mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "similar to the disease-linked alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "rather than on knocking out/"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0560617:knocking out [Injury or Poisoning]
   790 E C1522225:Knock-out [Experimental Model of Disease]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]

Phrase: "down Parkin activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.339: We, for the first time, describe such a model in this study. 

Phrase: "We,"

Phrase: "for the first time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "describe"

Phrase: "such a model in this study."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.340: Like other RING finger containing proteins, Parkin is an E3 ubiquitin ligase which targets several substrates for degradation, including, as proposed, -synuclein (13). 

Phrase: "Like other RING finger containing proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   906   C1313794:RING Finger Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an E3 ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "several substrates for degradation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "as"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: ", -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.341: Here we show that the C. elegans protein PDR-1 is the ortholog of human Parkin, as it interacts with enzymes of the ubiquitin/proteasome pathway and mediates E3 activity in a fully synthetic in vitro assay (Fig.3C). 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the C. elegans protein PDR-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C1418485:C-1 [Gene or Genome]
   853   C0055817:c protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0162610:C ELEGANS [Eukaryote]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0154830:PDR [Disease or Syndrome]
   804   C1418444:PDR [Gene or Genome]
   804   C1553033:[c] [Quantitative Concept]
   804   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "the ortholog of human Parkin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1335144:Ortholog [Gene or Genome]

Phrase: "as"

Phrase: "it"

Phrase: "interacts with enzymes of the ubiquitin/proteasome pathway"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   776   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   770   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   750   C0598390:enzyme pathway [Molecular Function]
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1325620:proteasome [Cell Component]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   735 E C1523807:proteasomal pathway [Molecular Function]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "E3 activity in a fully synthetic in vitro assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.342: Like human Parkin (13,22,46), PDR-1 specifically cooperates with E2 and E4 enzymes involved in cytosolic protein stress response and the ERAD pathway (Fig.3A and B). 

Phrase: "Like human Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(13,"

Phrase: "22,"

Phrase: "46"

Phrase: ")"

Phrase: ","

Phrase: "PDR-1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "cooperates with E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E4 enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "involved in cytosolic protein stress response"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0149784:stress response [Physiologic Function]
   783   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0038435:Stress [Finding]
   753   C0871261:Response [Organism Attribute]
   753   C1314939:Involved [Functional Concept]
   753   C1383501:Cytosolic [Cell Component]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the ERAD pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3178997:ERAD Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(Fig.3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.343: Our data are consistent with Parkin/PDR-1 having several roles in the removal of proteotoxic stress: it contributes to the UPR and participates in the cytosolic stress response. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with Parkin/PDR-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "having"

Phrase: "several roles in the removal of proteotoxic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]

Phrase: ":"

Phrase: "it"

Phrase: "contributes to the UPR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1155342:response to unfolded protein [Molecular Function]
           Unfolded Protein Response
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C1880177:Contribute [Activity]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "participates in the cytosolic stress response."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0149784:stress response [Physiologic Function]
   753   C0038435:Stress [Finding]
   753   C0871261:Response [Organism Attribute]
   753   C1383501:Cytosolic [Cell Component]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.344: We have analyzed and compared two PDR-1/Parkin loss-of-function alleles and two in-frame deletions encoding truncated proteins in biochemical, genetic and pharmacological tests, and showed that only the toxic gain-of-misfunction mutant pdr-1(lg103) is hypersensitive to distinct proteotoxic stress conditions. 

Phrase: "We"

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "compared two PDR-1/Parkin loss-of-function alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "two in-frame deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1880274:Deletions [Activity]
   779 E C1442161:Deletion [Cell or Molecular Dysfunction]
   779 E C1511760:Deletion [Genetic Function]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "truncated proteins in biochemical, genetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "pharmacological tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the toxic gain-of-misfunction mutant pdr-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0154830:PDR [Disease or Syndrome]
   795   C0596988:Mutant [Cell or Molecular Dysfunction]
   795   C0600688:toxic [Injury or Poisoning]
   795   C1407029:Toxic [Qualitative Concept]
   795   C1418444:PDR [Gene or Genome]
   795   C1517378:Gain [Quantitative Concept]
   795   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "is"

Phrase: "hypersensitive to distinct proteotoxic stress conditions."
Processing 00000000.tx.345: PDR-1 is part of the UPR pathway UPR is an intracellular signaling pathway that mediates an adaptation to ER stress at both transcriptional and translational levels. 

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "is"

Phrase: "part of the UPR pathway UPR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1292711:Part of [Spatial Concept]
   739   C0449719:Part [Spatial Concept]
   739   C1709471:Part [Quantitative Concept]

Phrase: "is"

Phrase: "an intracellular signaling pathway"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2755994:intracellular signaling pathway [Cell Function]
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "an adaptation to ER stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0000934:adaptation [Organism Function]
   753   C0392673:Adaptation [Biologic Function]

Phrase: "at both transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and"

Phrase: "translational levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.346: It augments folding and degradation capacity and also acts by reducing the protein load in the ER (18). 

Phrase: "It"

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "degradation capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "also"

Phrase: "acts by reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0392756:Reducing [Qualitative Concept]

Phrase: "the protein load in the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1550025:Load [Idea or Concept]
   748   C1704782:Load [Manufactured Object]
   748   C1708715:Load [Activity]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.347: Treatment with tunicamycin, an inhibitor of N-linked glycosylation, results in high amounts of unfolded proteins in the ER lumen and thus is a potent inducer of the UPR pathway. 

Phrase: "Treatment with tunicamycin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "an inhibitor of N-linked glycosylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "results in high amounts of unfolded proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205250:High [Qualitative Concept]
   748   C1265611:amounts [Quantitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C2825142:Result [Finding]

Phrase: "in the ER lumen"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1166837:Endoplasmic reticulum lumen [Cell Component]
  1000   C2338598:Endoplasmic reticulum lumen [Body Space or Junction]
   827   C0524461:Lumen [Body Space or Junction]
   827   C1282864:Lumen [Body Space or Junction]
   827   C1301906:Lumen [Qualitative Concept]
   827   C1551056:Lumen [Quantitative Concept]
   755 E C0524462:Luminal [Spatial Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "and"

Phrase: "thus"

Phrase: "is"

Phrase: "a potent inducer of the UPR pathway."
Processing 00000000.tx.348: We found that particularly one parkin allele, pdr-1(lg103), an in-frame deletion resulting in a PDR-1 protein without functional UBL and RING1 domains, is sensitive toward tunicamycin treatment. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that particularly one parkin allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ","

Phrase: "an in-frame deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "resulting in a PDR-1 protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332294:Resulting in [Functional Concept]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C2263837:PDR protein [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0154830:PDR [Disease or Syndrome]
   753   C0678226:resulting [Functional Concept]
   753   C1418444:PDR [Gene or Genome]
   753   C1845050:PDR [Disease or Syndrome]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "without functional UBL"

Phrase: "and"

Phrase: "RING1 domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "sensitive toward tunicamycin treatment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332324:Sensitive [Functional Concept]
   770   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.349: These animals specifically suffer from severe developmental defects and lethality (Fig.5), but they are, at the same time, not more sensitive than wild-type to heat or oxidative stress (Fig.9C and D). 

Phrase: "These animals specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "suffer from severe developmental defects"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0000768:Developmental defect [Congenital Abnormality]
   760   C0205082:Severe [Qualitative Concept]
   760   C0243067:defects [Functional Concept]
   760   C0458003:Developmental [Qualitative Concept]
   760   C0678723:Developmental [Organism Function]
   760   C0683278:suffer [Mental or Behavioral Dysfunction]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "they"

Phrase: "are"

Phrase: ","

Phrase: "at the same time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "not more sensitive than wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332324:Sensitive [Functional Concept]
   753   C1550474:sensitive [Idea or Concept]

Phrase: "to heat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Fig.9C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.350: The hypersensitivity of pdr-1(lg103) animals against ER stress is similar to the phenotype of mutants defective in the UPR, which is required for normal development in C. elegans. 

Phrase: "The hypersensitivity of pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020517:Hypersensitivity [Pathologic Function]
   760   C0520946:Hypersensitivity [Finding]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals against ER stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "similar to the phenotype of mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "defective in the UPR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332452:Defective [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "required for normal development"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1821244:Normal development [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0243107:development [Physiologic Function]
   770   C0439166:% normal [Quantitative Concept]
   770   C0678723:Development [Organism Function]
   770   C1514873:Required [Functional Concept]
   770   C1527148:Development [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "in C. elegans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]
Processing 00000000.tx.351: Tunicamycin-treated mutants, or non-treated double mutants of the pathway, including ire-1;pek-1, xbp-1;pek-1 or xbp-1;atf-6(RNAi) animals, typically arrest at the L2/L3 larval stages due to the degeneration of the intestine (42). 

Phrase: "Tunicamycin-treated mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "non-treated double mutants of the pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ire-1"

Phrase: ";pek-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "xbp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825104:XBP-1 [Amino Acid, Peptide, or Protein]

Phrase: ";pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "or"

Phrase: "xbp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825104:XBP-1 [Amino Acid, Peptide, or Protein]

Phrase: ";atf-6"

Phrase: "(RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136031:RNAi [Genetic Function]

Phrase: ")"

Phrase: "animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "typically"

Phrase: "arrest at the L2/L3 larval stages"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   757   C0332411:L2 stage [Finding]
   748   C0237477:Arrest [Temporal Concept]
   748   C0392351:arrest [Governmental or Regulatory Activity]
   748   C1179699:L2 [Body Location or Region]
   748   C1179700:L3 [Body Location or Region]
   748   C1306673:Stages [Qualitative Concept]
   748   C1418789:L2 [Gene or Genome]
   748   C1419655:L3 [Gene or Genome]
   748   C1825810:L2 [Gene or Genome]
   748   C3538854:L2 [Gene or Genome]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "due to the degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "of the intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.352: At L2, the C. elegans intestine induces high-level synthesis of secretory proteins which in the absence of proper UPR function make the animals more susceptible toward ER stress (42). 

Phrase: "At L2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1179699:L2 [Body Location or Region]
  1000   C1418789:L2 [Gene or Genome]
  1000   C1825810:L2 [Gene or Genome]
  1000   C3538854:L2 [Gene or Genome]

Phrase: "the C. elegans intestine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021853:Intestine [Body Part, Organ, or Organ Component]
   827   C1708548:INTESTINE [Tissue]
   734   C0162610:C ELEGANS [Eukaryote]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "high-level synthesis of secretory proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0597295:Protein Synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   731 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "which in the absence of proper UPR function"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   757   C0815043:function protein [Amino Acid, Peptide, or Protein]
   757   C1527118:Protein Function [Molecular Function]
   739   C0031843:function [Physiologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332197:absence [Quantitative Concept]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C0871261:Response [Organism Attribute]
   739   C1689985:Absence [Anatomical Abnormality]
   739   C1704632:Response [Finding]
   739   C1705273:Function [Intellectual Product]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "more susceptible toward ER stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231204:Susceptible [Functional Concept]
   753   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.353: Here we show that PDR-1 contributes to this anti-stress response, and is consequently up-regulated in the L2/L3 larval stages (Fig.2I). 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "contributes to this anti-stress response,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0149784:response to stress [Physiologic Function]
           stress response
   753   C0038435:Stress [Finding]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C1880177:Contribute [Activity]
   753   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "is"

Phrase: "consequently"

Phrase: "up-regulated in the L2/L3 larval stages"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   750   C0332411:L2 stage [Finding]
   744   C0547043:Up [Spatial Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C1179699:L2 [Body Location or Region]
   744   C1179700:L3 [Body Location or Region]
   744   C1282911:Up [Spatial Concept]
   744   C1306673:Stages [Qualitative Concept]
   744   C1418789:L2 [Gene or Genome]
   744   C1419655:L3 [Gene or Genome]
   744   C1825810:L2 [Gene or Genome]
   744   C3538854:L2 [Gene or Genome]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "(Fig.2I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552166:2i [Medical Device]

Phrase: ")."
Processing 00000000.tx.354: Our results indicate that specifically the in-frame deletions pdr-1(lg103) and pdr-1(tm598) genetically interact with ire-1 rather with pek-1 or atf-6, as a synergistic effect was only observed in the ire-1(v33);pdr-1(lg103) and ire-1 (v33);pdr-1(tm598) double mutants (Fig.6A). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that specifically"

Phrase: "the in-frame deletions pdr-1"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   804   C0080089:Frame [Nucleotide Sequence]
   804   C0154830:PDR [Disease or Syndrome]
   804   C0180979:Frame [Medical Device]
   804   C1418444:PDR [Gene or Genome]
   804   C1705858:Frame [Manufactured Object]
   804   C1845050:PDR [Disease or Syndrome]
   804   C1880274:Deletions [Activity]
   771 E C1442161:Deletion [Cell or Molecular Dysfunction]
   771 E C1511760:Deletion [Genetic Function]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "genetically"

Phrase: "interact with ire-1 rather"

Phrase: "with pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "or"

Phrase: "atf-6,"

Phrase: "as"

Phrase: "a synergistic effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   861   C2986495:Synergistic [Qualitative Concept]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in the ire-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.355: This suggests that pdr-1 may act to some extent in parallel to ire-1 signaling, perhaps by directly contributing to either the pek-1 or atf-6 pathway. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "may"

Phrase: "act to some extent in parallel to ire-1 signaling,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0037083:Signaling [Cell Function]
   739   C0079613:ACT [Therapeutic or Preventive Procedure]
   739   C0439792:Extent [Spatial Concept]
   739   C2348042:Parallel [Qualitative Concept]
   739   C2826345:PARALLEL [Research Activity]
   739   C3537152:signaling [Biologic Function]

Phrase: "perhaps by directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]

Phrase: "contributing to either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880177:Contributing [Activity]

Phrase: "the pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "or"

Phrase: "atf-6 pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.356: IRE-1 and PEK-1 pathways have indeed been shown to provide redundant protection against ER stress (42). 

Phrase: "IRE-1"

Phrase: "and"

Phrase: "PEK-1 pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "have"

Phrase: "indeed"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "redundant protection against ER stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.357: Moreover, we found that transcription of pdr-1 is controlled by all three signaling pathways IRE-1, PEK-1 and ATF-6 (Fig.6B) Therefore, PDR-1 can be positioned downstream of the UPR transducers. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that transcription of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "controlled by all three signaling pathways IRE-1,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   770   C0332298:Controlled by [Functional Concept]
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
           Signaling
   754 E C0086982:Signaling Pathway [Molecular Function]
   744   C0205449:Three [Quantitative Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C2587213:Controlled [Functional Concept]
   744   C3537152:signaling [Biologic Function]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1710082:Signal [Phenomenon or Process]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]

Phrase: "PEK-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "and"

Phrase: "ATF-6"

Phrase: "(Fig.6B"

Phrase: ")"

Phrase: "Therefore,"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "can"

Phrase: "be"

Phrase: "positioned downstream of the UPR transducers."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C1155342:Unfolded Protein Response [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040661:Transducers [Medical Device]
   744   C0522506:Downstream [Spatial Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   711   C0733755:Position [Spatial Concept]
   711 E C1705162:Transducer [Manufactured Object]
Processing 00000000.tx.358: Unfolded proteins in the ER are retro-translocated to the cytosol and turned over by the ERAD pathway which function is regulated by the UPR (19). 

Phrase: "Unfolded proteins in the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "retro-translocated to the cytosol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205095:Retro- [Spatial Concept]
   760   C0521438:RETRO [Spatial Concept]
   760   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "over by the ERAD pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C3178997:ERAD Pathway [Molecular Function]
   760   C0205136:Over [Spatial Concept]
   760   C1157980:ERAD [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "which"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "regulated by the UPR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.359: Mutations in ERAD genes and in the recently identified C. elegans abu gene family (activated in blocked UPR) also result in synthetic lethality in combination with defective UPR mutants, but are, in contrast to pdr-1, themselves activators of the UPR (20,21). 

Phrase: "Mutations in ERAD genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and in the recently identified C. elegans abu gene family"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1517488:Gene Family [Gene or Genome]
   739   C0015576:Family [Family Group]
   739   C0017337:Gene [Gene or Genome]
   739   C0205396:Identified [Qualitative Concept]
   739   C0332185:Recently [Temporal Concept]
   739   C1515981:And [Idea or Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   739   C1704727:Family [Conceptual Entity]

Phrase: "("

Phrase: "activated in blocked UPR"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0028778:Blocked [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C1879547:Activated [Activity]
   753   C2911692:Response [Mental Process]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "also"

Phrase: "result in synthetic lethality"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1883254:synthetic [Activity]
   770   C2825142:Result [Finding]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with defective UPR mutants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596988:mutants [Cell or Molecular Dysfunction]
   717   C1155342:Unfolded Protein Response [Molecular Function]

Phrase: "but"

Phrase: "are"

Phrase: ","

Phrase: "in contrast to pdr-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "themselves activators of the UPR"

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.360: Taken together, these data suggest a general role for PDR-1/Parkin in the UPR pathway. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a general role for PDR-1/Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the UPR pathway."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1155342:Unfolded Protein Response [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0871261:Response [Organism Attribute]
   812   C1704259:Pathway [Molecular Function]
   812   C1704632:Response [Finding]
   812   C1705987:Pathway [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.361: Interestingly, there are several indications for a role of ER stress and the UPR in the pathophysiology of PD (54,55). 

Phrase: "Interestingly,"

Phrase: "there"

Phrase: "are"

Phrase: "several indications for a role of ER stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0392360:Indications [Idea or Concept]
   708 E C3146298:Indication [Functional Concept]

Phrase: "and"

Phrase: "the UPR in the pathophysiology of PD (54,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.362: For example, it was shown that some PD mimetics like 6-OHDA, MPP+ and rotenone specifically induce ER stress and activate the UPR in cultured neuronal cells (56). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "some PD mimetics like 6-OHDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0920591:mimetics [Biomedical Occupation or Discipline]

Phrase: "MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]

Phrase: "and"

Phrase: "rotenone specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "ER stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the UPR in cultured neuronal cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1155342:Unfolded Protein Response [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.363: The biochemistry of stress induction is most likely very similar in C. elegans, as we could recently demonstrate the susceptibility of worms to MPP+ treatment and the amelioration of neurotoxicity by anti-PD drugs (57). 

Phrase: "The biochemistry of stress induction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "is"

Phrase: "most likely very similar in C. elegans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "as"

Phrase: "we"

Phrase: "could"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrate"

Phrase: "the susceptibility of worms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to MPP+ treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "the amelioration of neurotoxicity"

Phrase: "by anti-PD drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.364: Overexpression of the -synuclein A53T variant is toxic in the background of pdr-1(lg103) Accumulation of the cytosolic protein -synuclein in Lewy bodies is a hallmark of PD, and mutations result in autosomal dominant familial forms. 

Phrase: "Overexpression of the -synuclein A53T variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "toxic in the background of pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0600688:toxic [Injury or Poisoning]
   748   C1407029:Toxic [Qualitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "Accumulation of the cytosolic protein -synuclein"

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "is"

Phrase: "a hallmark of PD,"

Phrase: "and"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "result in autosomal dominant familial forms."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0443147:Autosomal dominant [Intellectual Product]
   773   C1832428:Familial form [Finding]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C0596142:autosomal [Cell Component]
   753   C1274040:Result [Functional Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.365: The A53T mutation enhances aggregation of -synuclein by accelerated fibril formation. 

Phrase: "The A53T mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "aggregation of -synuclein by accelerated fibril formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.366: This in turn impairs the proteolytic system and increases the sensitivity of cells to proteasome inhibition (reviewed in 58). 

Phrase: "This in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "impairs"

Phrase: "the proteolytic system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the sensitivity of cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "("

Phrase: "reviewed in 58"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.367: Here we demonstrated that expression of human mutant -synuclein (A53T), but not of wild-type (10), also exerts a cytotoxic effect in C. elegans pdr-1(lg103) animals that results in developmental arrest and lethality (Fig.7). 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that expression of human mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A53T"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not of wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1518422:Not [Functional Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a cytotoxic effect in C. elegans pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   744   C1280500:Effect [Qualitative Concept]
   744   C1511636:cytotoxic [Functional Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "results in developmental arrest"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1848980:Developmental arrest [Finding]
   770   C0237477:Arrest [Temporal Concept]
   770   C0392351:arrest [Governmental or Regulatory Activity]
   770   C0458003:Developmental [Qualitative Concept]
   770   C0678723:Developmental [Organism Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0311403:Inhibited [Qualitative Concept]
   715 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "lethality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C3151529:Lethal [Finding]

Phrase: "(Fig.7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.368: This phenotype is similar to the ER stress-induced one and is dependent on temperature and on the gene dose of the -synuclein A53T (Figs7BD and 8A). 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "similar to the ER stress-induced one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "dependent on temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "and on the gene dose of the -synuclein A53T"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0017337:Gene [Gene or Genome]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178602:Dose [Quantitative Concept]
   742   C0869039:Dose [Quantitative Concept]
   742   C1114758:Dose # [Clinical Attribute]
   742   C1515981:And [Idea or Concept]

Phrase: "(Figs7BD"

Phrase: "and"

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.369: The fact that this phenotype in C. elegans already arises on the second to third day after fertilization is remarkable, given that -synuclein aggregation in mice is only toxic after months (59). 

Phrase: "The fact"

Phrase: "that"

Phrase: "this phenotype in C. elegans already"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "arises on the second"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]

Phrase: "to third day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "after fertilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015914:Fertilisation [Organism Function]

Phrase: "is"

Phrase: "remarkable,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that -synuclein aggregation in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "is"

Phrase: "only toxic after months"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.370: Probably due to the short lifespan of the animals (less than 20 days), this toxicity was only observed in animals that combined expression of both mutant -synuclein and the aggregation-prone Parkin encoded by pdr-1(lg103). 

Phrase: "Probably due to the short lifespan of the animals"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0003062:Animals [Animal]
   742   C0750492:Probably [Idea or Concept]
   742   C0870809:life span [Group Attribute]
   742   C1282927:short [Qualitative Concept]
   742   C1806781:Short [Quantitative Concept]
   742   C2350002:Short [Quantitative Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "(less than 20 days"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0439228:days [Temporal Concept]
   770   C0547044:Less [Qualitative Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "this toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C1441672:Observed [Functional Concept]

Phrase: "that combined expression of both mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the aggregation-prone Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "encoded by pdr-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0154830:PDR [Disease or Syndrome]
   770   C0679058:encoded [Mental Process]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]
   770   C2700640:Encoded [Activity]

Phrase: "(lg103"

Phrase: ")."
Processing 00000000.tx.371: Our results revealed neither increased mRNA nor elevated protein levels of chaperones in pdr-1(lg103) animals or worms overexpressing -synuclein, that would have indicated an elevated stress level as a consequence of this mutation/expression (Fig.6B and data not shown). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "neither increased mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "nor"

Phrase: "elevated protein levels of chaperones"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0748024:elevated protein [Finding]
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "or"

Phrase: "worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "overexpressing -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "would"

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "an elevated stress level as a consequence of this mutation/expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1319127:Level of stress [Finding]
           Stress level
   754   C3244092:expression level [Idea or Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1547707:Level [Geographic Area]
   738   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig.6B"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.372: As -synuclein is a cytosolic protein and accumulates in C. elegans neurons, both in the cytoplasm and axonal processes (data not shown), toxicity most likely resembles a cytosolic mechanism. 

Phrase: "As -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a cytosolic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "accumulates in C. elegans neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "both in the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "axonal processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "toxicity most likely"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   827   C0750492:Likely [Idea or Concept]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "resembles"

Phrase: "a cytosolic mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.373: Consistently, this effect is independent of the ER stress response and the UPR signaling pathway (Fig.9A and B). 

Phrase: "Consistently,"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is independent of the ER stress response"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   770   C0149784:stress response [Physiologic Function]
   770   C0332291:Independent of [Functional Concept]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0038435:Stress [Finding]
   744   C0085862:Independent [Idea or Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1299583:Independent [Finding]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "the UPR signaling pathway"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0037083:signaling pathway [Cell Function]
   840   C0086982:Signaling Pathway [Molecular Function]
   823 E C0037080:Signal Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C1155342:Unfolded Protein Response [Molecular Function]

Phrase: "(Fig.9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.374: Expression of mutant -synuclein in wild-type worms treated with tunicamycin or in ire-1-deficient worms did not impair development or viability. 

Phrase: "Expression of mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in wild-type worms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0018889:WORM [Disease or Syndrome]
   827   C0018893:Worm [Eukaryote]
   827   C0040820:Worms NOS [Disease or Syndrome]
   734   C1883559:Wild Type [Organism Attribute]
   727 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "treated with tunicamycin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or in ire-1-deficient worms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011155:Deficient [Functional Concept]
   753   C0018889:WORM [Disease or Syndrome]
   753   C0018893:Worm [Eukaryote]
   753   C0040820:Worms NOS [Disease or Syndrome]
   753   C1636779:% deficient [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "or"

Phrase: "viability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]
Processing 00000000.tx.375: Moreover, in -synuclein-expressing animals the ER stress marker hsp-4/BiP was not induced (data not shown). 

Phrase: "Moreover,"

Phrase: "in -synuclein-expressing animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "the ER stress marker hsp-4/BiP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1415761:BIP [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.376: Thus, pdr-1(lg103) exacerbates mutant -synuclein-induced toxicity in an UPR-independent way. 

Phrase: "Thus,"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "mutant -synuclein-induced toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]

Phrase: "in an UPR-independent way."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1155342:Unfolded Protein Response [Molecular Function]
Processing 00000000.tx.377: Our PDR-1 mutants, similar to the parkin mutants tested recently (27,40), have differential solubility properties in transfected cells. 

Phrase: "Our PDR-1 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "similar to the parkin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(27,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "differential solubility properties in transfected cells."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]
Processing 00000000.tx.378: PDR-1(aa242247) is unique because it is already mostly detergent-insoluble and forms intracellular, aggresome-like structures in the absence of transgenic co-expression of -synuclein. 

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa242247"

Phrase: ")"

Phrase: "is"

Phrase: "unique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "already mostly detergent-insoluble"

Phrase: "and"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "intracellular, aggresome-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167059:aggresome [Cell Component]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of transgenic co-expression of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.379: Aggregate formation of PDR-1 derivatives containing the C-terminal IBR and RING2 domains is induced by -synuclein A53T co-expression. 

Phrase: "Aggregate formation of PDR-1 derivatives"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the C-terminal IBR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021334:IBR [Disease or Syndrome]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "and"

Phrase: "RING2 domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "induced by -synuclein A53T co-expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205263:Induced [Functional Concept]
Processing 00000000.tx.380: The second RING finger had been implicated in substrate binding of synphilin-1 previously (27). 

Phrase: "The second RING finger"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   913   C0230388:Second finger [Body Part, Organ, or Organ Component]
   901   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   901   C1521759:Ring Finger [Cell Component]
   827   C0016129:Finger [Body Location or Region]
   827   C0521164:Ring [Spatial Concept]
   827   C1260969:Ring [Medical Device]
   827   C1281584:Finger [Body Part, Organ, or Organ Component]
   827   C1705184:Ring [Medical Device]
   771 E C0442015:Digital [Intellectual Product]
   771 E C1883674:Digital [Qualitative Concept]
   743 E C0549188:fingers [Quantitative Concept]
   734 E C0582802:Digit [Body Part, Organ, or Organ Component]
   734 E C1283912:Digit [Body Part, Organ, or Organ Component]
   734 E C3241971:Digit [Quantitative Concept]

Phrase: "had"

Phrase: "been"

Phrase: "implicated in substrate binding of synphilin-1 previously"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
   770   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.381: One could argue that although these variants are capable of binding substrates, at least PDR-1(aa242247) will be unable to function in the ubiquitylation process due to the truncated UBL domain, resulting in the accumulation of both PDR-1 and misfolded -synuclein. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "could"

Phrase: "argue"

Phrase: "that"

Phrase: "although"

Phrase: "these variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "capable of binding substrates,"

Phrase: "at least PDR-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]
   793   C0439092:less [Intellectual Product]
   793   C0547044:Less [Qualitative Concept]

Phrase: "(aa242247"

Phrase: ")"

Phrase: "will"

Phrase: "be"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "function in the ubiquitylation process"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1519751:Ubiquitylation [Molecular Function]
   760   C1522240:Process [Phenomenon or Process]
   760   C1705273:Function [Intellectual Product]

Phrase: "due to the truncated UBL domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "resulting in the accumulation of both PDR-1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0332294:Resulting in [Functional Concept]
   744   C0154830:PDR [Disease or Syndrome]
   744   C0678226:resulting [Functional Concept]
   744   C1418444:PDR [Gene or Genome]
   744   C1845050:PDR [Disease or Syndrome]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "misfolded -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.382: In C. elegans neurons, this combination is cytotoxic and causes the death of the animals. 

Phrase: "In C. elegans neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C0162610:C ELEGANS [Eukaryote]

Phrase: "this combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "is"

Phrase: "cytotoxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
  1000   C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the death of the animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]
Processing 00000000.tx.383: Moreover, aggregation is dependent on the PDR-1 C-terminus, because in PDR-1(aa1199Stop) even -synuclein A53T is uniformly distributed throughout the cell. 

Phrase: "Moreover,"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "is"

Phrase: "dependent on the PDR-1 C-terminus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "because in PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa1199Stop"

Phrase: ")"

Phrase: "even -synuclein A53T"

Phrase: "is"

Phrase: "uniformly"

Phrase: "distributed throughout the cell."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1704711:Distributed [Functional Concept]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.384: Misfolding, not loss of expression, of Parkin may be the prime cause of neurotoxicity Similar to complete loss of fly (60,61) or mouse Parkin (47,48,62,63), we showed here that deletion mutants of the C. elegans parkin ortholog pdr-1 are viable and do not display obvious defects in dopaminergic neurons (Fig.7A). 

Phrase: "Misfolding,"

Phrase: "not loss of expression, of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "the prime cause of neurotoxicity Similar to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "loss of fly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "(60,"

Phrase: "61"

Phrase: ")"

Phrase: "or"

Phrase: "mouse Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(47,"

Phrase: "48,"

Phrase: "62,"

Phrase: "63"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that deletion mutants of the C. elegans parkin ortholog pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "obvious defects in dopaminergic neurons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.385: Furthermore, C. elegans parkin mutants are not sensitive to various stress conditions (Figs5A and B, 7BD and 9C and D). 

Phrase: "Furthermore,"

Phrase: "C. elegans parkin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "not sensitive to various stress conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332324:Sensitive to [Functional Concept]
           Sensitive
   753   C1550474:sensitive [Idea or Concept]

Phrase: "(Figs5A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "7BD"

Phrase: "and"

Phrase: "9C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.386: In contrast, homozygous pdr-1(lg103) in-frame deletion mutants are particularly hypersensitive to ER-derived and cytosolic protein folding stress (Figs5 and 7). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "homozygous pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019904:Homozygous [Organism Attribute]
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "in-frame deletion mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "particularly hypersensitive to ER-derived"

Phrase: "and"

Phrase: "cytosolic protein folding stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0038435:Stress [Finding]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "(Figs5"

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.387: Although the other in-frame deletion mutant pdr-1(tm598) did not show increased stress sensitivity that was detectable in our assay, it can serve as a sensitized background. pdr-1(lg103)/pdr-1 (tm598) compound heterozygotes showed an augmented susceptibility to tunicamycin treatment and -synuclein expression (Figs5B and 8A). 

Phrase: "Although"

Phrase: "the other in-frame deletion mutant pdr-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C0080089:Frame [Nucleotide Sequence]
   799   C0154830:PDR [Disease or Syndrome]
   799   C0180979:Frame [Medical Device]
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   799   C1418444:PDR [Gene or Genome]
   799   C1442161:Deletion [Cell or Molecular Dysfunction]
   799   C1511760:Deletion [Genetic Function]
   799   C1705858:Frame [Manufactured Object]
   799   C1845050:PDR [Disease or Syndrome]
   799   C1880274:Deletion [Activity]

Phrase: "(tm598"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "increased stress sensitivity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   913   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   913   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]
   734   C0231298:Increased stress [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "detectable in our assay,"

Phrase: "it"

Phrase: "can"

Phrase: "serve as a sensitized background. pdr-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0154830:PDR [Disease or Syndrome]
   748   C1418444:PDR [Gene or Genome]
   748   C1706907:Background [Conceptual Entity]
   748   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "/pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: "compound heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an augmented susceptibility to tunicamycin treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "and -"

Phrase: "synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Figs5B"

Phrase: "and"

Phrase: "8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.388: Moreover, in contrast to the pdr-1 loss-of-function allele tm395, both pdr-1 in-frame deletion alleles, lg103 and tm598, show a clear synergistic effect on the brood size of ire-1(v33) loss-of-function mutants (Fig.6A). 

Phrase: "Moreover,"

Phrase: "in contrast to the pdr-1 loss-of-function allele tm395,"

Phrase: "both pdr-1 in-frame deletion alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0002085:Alleles [Gene or Genome]

Phrase: "lg103"

Phrase: "and"

Phrase: "tm598,"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a clear synergistic effect on the brood size of ire-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0814843:effect size [Quantitative Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
   738   C2986495:Synergistic [Qualitative Concept]

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "loss-of-function mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.389: Taken together, mutations that eliminate or reduce pdr-1 expression obviously do not exert such effects. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "eliminate"

Phrase: "or"

Phrase: "reduce"

Phrase: "pdr-1 expression obviously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "such effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.390: The observation that the increased transcription of pdr-1(lg103) in the atf-6(ok551) hypermorphic background exacerbates the -synuclein A53T conferred cytotoxicity (Fig.8B) provides further support for the neomorphic nature of the lg103 mutation. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the increased transcription of pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040649:Transcription [Genetic Function]

Phrase: "(lg103"

Phrase: ")"

Phrase: "in the atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: "hypermorphic background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the -synuclein A53T"

Phrase: "conferred"

Phrase: "cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "(Fig.8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support for the neomorphic nature of the lg103 mutation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0026882:Mutation [Genetic Function]
   742   C0183683:Support [Medical Device]
   742   C0349590:Nature [Idea or Concept]
   742   C1262865:Nature [Functional Concept]
   742   C1521721:Support [Conceptual Entity]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.391: We therefore conclude that small domain-specific in-frame deletions of pdr-1 confer a different quality than a complete gene knockout. 

Phrase: "We therefore"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that small domain-specific in-frame deletions of pdr-1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C1880274:Deletions [Activity]
   706 E C1442161:Deletion [Cell or Molecular Dysfunction]
   706 E C1511760:Deletion [Genetic Function]

Phrase: "confer"

Phrase: "a different quality than a complete gene knockout."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332306:Quality [Qualitative Concept]
   720   C0443199:Differential quality [Qualitative Concept]
Processing 00000000.tx.392: Interestingly, allele lg103 confers a stronger phenotype than allele tm598. 

Phrase: "Interestingly,"

Phrase: "allele lg103"

Phrase: "confers"

Phrase: "a stronger phenotype than allele tm598."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.393: Both pdr-1 in-frame deletion variants lack the first RING domain, the difference being that in pdr-1(lg103) the UBL domain is also missing whereas it remains intact in pdr-1(tm598) (Fig.4A). 

Phrase: "Both pdr-1 in-frame deletion variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:variants [Qualitative Concept]

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the first RING domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "being"

Phrase: "that in pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0154830:PDR [Disease or Syndrome]
   770   C1418444:PDR [Gene or Genome]
   770   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "the UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "also"

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "whereas"

Phrase: "it"

Phrase: "remains"

Phrase: "intact in pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]

Phrase: "(tm598"

Phrase: ")"

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.394: It was recently shown that the UBL domain regulates the stability of the Parkin protein (14). 

Phrase: "It"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the UBL domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "regulates"

Phrase: "the stability of the Parkin protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2350440:Protein Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.395: In line with these data, we obtained higher amounts of the corresponding truncated PDR-1(aa24247) protein from recombinant expression in SF9 insect cells compared with full-length PDR-1 (data not shown). 

Phrase: "In line with these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "higher amounts of the corresponding truncated PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "protein from recombinant expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   819   C1171362:expression protein [Genetic Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in SF9 insect cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C3494245:Sf9 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "compared with full-length PDR-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0154830:PDR [Disease or Syndrome]
   753   C0443225:Full [Qualitative Concept]
   753   C1418444:PDR [Gene or Genome]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C1707455:Compared [Activity]
   753   C1845050:PDR [Disease or Syndrome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.396: Although both PDR-1 (aa24247) and also PDR-1(aa140263) still bind enzymes of the ubiquitylation machinery, interaction of PDR-1(aa24247) with the proteasome is abrogated (Fig.4C and D). 

Phrase: "Although"

Phrase: "both PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "and"

Phrase: "also PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0154830:PDR [Disease or Syndrome]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa140263"

Phrase: ")"

Phrase: "still"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "enzymes of the ubiquitylation machinery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]

Phrase: "interaction of PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "with the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "abrogated"

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.397: Moreover, only this allele expressed mutant Parkin that became insoluble within 48h after expression in human cell culture (Fig.4E). 

Phrase: "Moreover,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "this allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "expressed"

Phrase: "mutant Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "became"

Phrase: "insoluble within 48h"

Phrase: "after expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human cell culture"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0427861:human cell [Laboratory or Test Result]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.398: Thus, an increased intracellular concentration and/or a misregulation of PDR-1 (aa24247) combined with the residual binding activity may confer a more severe phenotype. 

Phrase: "Thus,"

Phrase: "an increased intracellular concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and/or"

Phrase: "a misregulation of PDR-1"

Phrase: "(aa24247"

Phrase: ")"

Phrase: "combined with the residual binding activity"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0205195:Combined [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1561536:*Activity [Idea or Concept]
   753   C1609982:Residual [Qualitative Concept]
   719 E C0336789:Combine [Manufactured Object]

Phrase: "may"

Phrase: "confer"

Phrase: "a more severe phenotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1836408:Severe phenotype [Finding]
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.399: As we showed that PDR-1(aa24247) still binds to essential components of the ubiquitylation system, including CHIP/CHN-1 (Fig.4C and D), it is possible that this mutant (and other PD-related parkin variants with similar capacities) sequesters and inactivates critical components of the protein degradation machinery. 

Phrase: "As"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "still"

Phrase: "binds to essential components of the ubiquitylation system,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0205224:Essential [Qualitative Concept]
   744   C0449432:Components [Manufactured Object]
   744   C0449913:System [Functional Concept]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1519751:Ubiquitylation [Molecular Function]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "CHIP/CHN-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600596:Chip [Research Device]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "and"

Phrase: "other PD-related parkin variants with similar capacities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: ")"

Phrase: "sequesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333312:sequester [Functional Concept]

Phrase: "and"

Phrase: "inactivates"

Phrase: "critical components of the protein degradation machinery."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.400: Recently, we have shown that CHN-1 is expressed in the cytosol and binds to chaperones (36), similar to its human ortholog CHIP, which is involved in the chaperone/Parkin-mediated quality control of the ER protein Pael-R (22). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CHN-1"

Phrase: "is"

Phrase: "expressed in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "binds to chaperones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   756   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "similar to its human ortholog CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "involved in the chaperone/Parkin-mediated quality control"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0034378:quality control [Functional Concept]
   770   C1561524:Quality Control [Intellectual Product]
   770   C1610034:Quality Control [Intellectual Product]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243148:control [Qualitative Concept]
   744   C0332306:Quality [Qualitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1418270:PARKIN [Gene or Genome]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C3274648:Control [Qualitative Concept]

Phrase: "of the ER protein Pael-R (22"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   839   C0168981:protein r [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014239:Endoplasmic Reticulum [Cell Component]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   799   C0205090:R- [Spatial Concept]
   799   C0684010:R. [Professional or Occupational Group]
   799   C2603358:R' [Clinical Attribute]
   727   C0598268:Endoplasm [Cell Component]

Phrase: ")."
Processing 00000000.tx.401: Thus, CHN-1 might assist in regulating the cellular balance between folding and degradation and its titration could lead to a dramatic change in the folding capacity of the cytosol. 

Phrase: "Thus,"

Phrase: "CHN-1"

Phrase: "might"

Phrase: "assist in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0018896:assist [Social Behavior]
   833   C0557034:assist [Health Care Activity]

Phrase: "regulating"

Phrase: "the cellular balance between folding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Balance [Organism Function]
   760   C0205415:Balance [Functional Concept]
   760   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "its titration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162621:Titration [Laboratory Procedure]
  1000   C2983683:TITRATION [Research Activity]

Phrase: "could"

Phrase: "lead to a dramatic change"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1705241:Change [Quantitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the folding capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "of the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.402: Thus, it is tempting to speculate that PDR-1 (aa24247) might sequester critical components of the cytosolic/ERAD ubiquitylation machinery and its associated chaperones, rendering these animals sensitive toward proteotoxic stress. pdr-1(lg103) can tolerate a certain threshold of aggregation-prone proteins, but high cellular levels, together with an impaired detoxification system, cause developmental defects. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "might"

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "critical components of the cytosolic/ERAD ubiquitylation machinery"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0449432:Components [Manufactured Object]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "its associated chaperones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "rendering"

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "sensitive toward proteotoxic stress. pdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332324:Sensitive [Functional Concept]
   753   C1550474:sensitive [Idea or Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "can"

Phrase: "tolerate"

Phrase: "a certain threshold of aggregation-prone proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449864:Threshold [Qualitative Concept]

Phrase: "but"

Phrase: "high cellular levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "together with an impaired detoxification system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "developmental defects."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0000768:Developmental defect [Congenital Abnormality]
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.403: The recent findings indicate that overexpression of torsin protects from -synuclein-induced toxicity is fully consistent with this model, as torsin has been suggested to manage protein folding (45). 

Phrase: "The recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that overexpression of torsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "protects from -synuclein-induced toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205263:Induced [Functional Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "fully consistent with this model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "as"

Phrase: "torsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0665823:torsin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "manage"

Phrase: "protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.404: In summary, these data suggest that studying parkin alleles, either neomorphic (gain-of-misfunction) alleles or partial loss-of-function alleles that have retained some properties of the enzyme (like substrate binding), may provide further insights into the biological role of Parkin. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that studying parkin alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "either neomorphic"

Phrase: "(gain-of-misfunction"

Phrase: ")"

Phrase: "alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "or"

Phrase: "partial loss-of-function alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Alleles [Gene or Genome]

Phrase: "that"

Phrase: "have"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "some properties of the enzyme"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "("

Phrase: "like substrate binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further insights into the biological role of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]
Processing 00000000.tx.405: It would be interesting in the future to adopt similar strategies in other model organisms to help elucidating the molecular and cellular mechanisms resulting in AR-JP. 

Phrase: "It"

Phrase: "would"

Phrase: "be"

Phrase: "interesting in the future to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016884:Future [Temporal Concept]
   760   C0543488:interesting [Mental Process]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "similar strategies in other model organisms to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679199:strategies [Mental Process]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "elucidating"

Phrase: "the molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "resulting in AR-JP."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   820   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   790   C0332294:Resulting in [Functional Concept]
   790   C0441748:Autosomal recessive [Intellectual Product]
   790   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0596142:autosomal [Cell Component]
   753   C0678226:resulting [Functional Concept]
   753   C3146221:Juvenile [Age Group]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]
Processing 00000000.tx.406: Moreover, the powerful genetics of C. elegans can now be exploited to identify modifiers of parkin/-synuclein-induced proteotoxicity as well as to study the effects of specific human disease-linked parkin mutations.  

Phrase: "Moreover,"

Phrase: "the powerful genetics of C. elegans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017398:Genetics [Biomedical Occupation or Discipline]
   753   C0017399:genetics [Biologic Function]

Phrase: "can"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "be"

Phrase: "exploited"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "modifiers of parkin/-synuclein-induced proteotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C0205349:Modifier [Qualitative Concept]
   719   C1514623:Modifier [Conceptual Entity]
   719   C1516451:Modifier [Chemical Viewed Functionally]
   719   C3542952:Modifier [Intellectual Product]

Phrase: "as well as"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of specific human disease-linked parkin mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.407: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Strains Worms were handled according to the standard procedures as previously described (64). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "Worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018889:WORM [Disease or Syndrome]
  1000   C0018893:Worm [Eukaryote]
  1000   C0040820:Worms NOS [Disease or Syndrome]
   900 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "handled according to the standard procedures"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0025664:procedures [Intellectual Product]
   753   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0680240:according [Social Behavior]
   753   C1442989:Standard [Qualitative Concept]
   753   C2700391:procedures [Activity]
   753   C2828392:Standard [Intellectual Product]
   719   C1708320:Handle [Conceptual Entity]
   719 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   719 E C3274430:PROCEDURE [Health Care Activity]
   719 E C3538935:Procedure [Idea or Concept]
   719 E C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.408: The mutations and integrated arrays used in this study are listed by chromosomes (LG) as follows. 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "integrated arrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "listed by chromosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008633:Chromosomes [Cell Component]
   756   C0745732:List [Conceptual Entity]
   756   C3272378:LIST [Intellectual Product]

Phrase: "(LG)"

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.409: LGII: ire-1(v33); 

Phrase: "LGII"

Phrase: ":"

Phrase: "ire-1"

Phrase: "(v33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0632858:V33 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.410: LGIII: pdr-1:lg101, lg103, tm395, tm598;mev-1(kn1); 

Phrase: "LGIII"

Phrase: ":"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: ":"

Phrase: "lg101,"

Phrase: "lg103,"

Phrase: "tm395,"

Phrase: "tm598"

Phrase: ";mev-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0556642:MeV [Quantitative Concept]
   861   C1881830:meV [Quantitative Concept]

Phrase: "(kn1"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.411: LGIV: WG8 Is[aex-3::-syn(A53T); 

Phrase: "LGIV"

Phrase: ":"

Phrase: "WG8 Is[aex-3"

Phrase: ":"

Phrase: ":-"

Phrase: "syn(A53T"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.412: Pdat-1::gfp]; 

Phrase: "Pdat-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.413: LGV: zcIs4[Phsp-4::gfp], Is[Pdat-1::gfp;rol-6]; 

Phrase: "LGV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024286:lgv [Disease or Syndrome]

Phrase: ":"

Phrase: "zcIs4"

Phrase: "[Phsp-4"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "],"

Phrase: "Is[Pdat-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";rol-6"

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.414: LGX: pek-1(ok275), atf-6(ok551); 

Phrase: "LGX"

Phrase: ":"

Phrase: "pek-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414326:PEK [Gene or Genome]
   861   C3539819:PEK [Gene or Genome]

Phrase: "(ok275"

Phrase: ")"

Phrase: ","

Phrase: "atf-6"

Phrase: "(ok551"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.415: Unmapped: WG3 Is[aex-3::-syn(WT);Pdat-1::gfp]. 

Phrase: "Unmapped"

Phrase: ":"

Phrase: "WG3 Is[aex-3"

Phrase: ":"

Phrase: ":-"

Phrase: "syn(WT);Pdat-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1309046:SYN-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C2362085:WT-1 [Gene or Genome]
   812   C2700323:WT [Fish]

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "]."
Processing 00000000.tx.416: N2 (Bristol) was used as the C. elegans wild-type strain, VT847 as the C. briggsae and EM464 as the C. remanei strain. 

Phrase: "N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: "(Bristol"

Phrase: ")"

Phrase: "was"

Phrase: "used as the C. elegans wild-type strain,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0445393:Wild C [Intellectual Product]
   744   C0080194:Strain [Injury or Poisoning]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0456178:strain [Intellectual Product]
   744   C1273517:used [Finding]
   744   C1518614:Strain [Organism]
   744   C1547052:*Type [Quantitative Concept]
   744   C2987481:Strain [Mental Process]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "VT847 as the C. briggsae"

Phrase: "and"

Phrase: "EM464 as the C. remanei strain."
Processing 00000000.tx.417: Isolation and characterization of pdr-1 deletion mutants Nested PCR was used to screen an UV/TMP mutagenized C. elegans library with pdr-1-specific primers and isolated two pdr-1 mutant deletion alleles, lg103 and lg101, and received two additional deletion alleles tm598 and tm395 provided by Dr Shohei Mitani. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "characterization of pdr-1 deletion mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "Nested"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "an UV/TMP mutagenized C. elegans library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0023621:Library [Manufactured Object,Organization]
   799   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with pdr-1-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "isolated two pdr-1 mutant deletion alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0002085:Alleles [Gene or Genome]

Phrase: "lg103"

Phrase: "and"

Phrase: "lg101,"

Phrase: "and"

Phrase: "received two additional deletion alleles tm598"

Phrase: "and"

Phrase: "tm395"

Phrase: "provided by Dr Shohei Mitani."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]
Processing 00000000.tx.418: Deletion breakpoints (cosmid K08E3 coordinates): lg103, 30885/3088632017/32018; 

Phrase: "Deletion breakpoints"

Phrase: "(cosmid K08E3 coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0427184:coordinates [Finding]
   827   C0700114:coordinates [Functional Concept]
   827   C1707511:Coordinates [Spatial Concept]

Phrase: ")"

Phrase: ":"

Phrase: "lg103,"

Phrase: "30885/3088632017/32018"

Phrase: ";"
Processing 00000000.tx.419: lg101, 31312/3131333059/33060; 

Phrase: "lg101,"

Phrase: "31312/3131333059/33060"

Phrase: ";"
Processing 00000000.tx.420: tm598, 31365/3136632062/32063; 

Phrase: "tm598,"

Phrase: "31365/3136632062/32063"

Phrase: ";"
Processing 00000000.tx.421: tm395, 31601/3160232081/32082. 

Phrase: "tm395,"

Phrase: "31601/3160232081/32082."
Processing 00000000.tx.422: The mutants were backcrossed several times with N2 wild-type animals. 

Phrase: "The mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "backcrossed"

Phrase: "several times with N2 wild-type animals."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.423: Twenty-five ng/l of the rescuing subclone was co-injected with 25ng/l marker sel-12::gfp into pdr-1(lg103) mutant animals. 

Phrase: "Twenty-five ng/l of the rescuing subclone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439297:ng/L [Quantitative Concept]

Phrase: "was"

Phrase: "co-injected with 25ng/l marker sel-12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0005516:Marker [Clinical Attribute]
   711   C1720154:Inject [Functional Concept]

Phrase: ":"

Phrase: ":"

Phrase: "gfp into pdr-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   783   C2263837:PDR protein [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332583:Green [Qualitative Concept]

Phrase: "(lg103"

Phrase: ")"

Phrase: "mutant animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.424: Six independent transgenic lines [pdr-1(lg103); 

Phrase: "Six independent transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0003069:Transgenic [Animal]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "[pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.425: byEx417-422[pdr-1(Rescue);sel-12::gfp]] were analyzed for rescue on plates containing 2.5g/ml tunicamycin. 

Phrase: "byEx417-422"

Phrase: "[pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(Rescue"

Phrase: ")"

Phrase: ";sel-12"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "]"

Phrase: "]"

Phrase: "were"

Phrase: "analyzed for rescue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "on plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.5g/ml tunicamycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.426: Plasmids To generate pdr-1 GFP reporter constructs, a 650-bp promoter region immediately 5' of the predicted initiation ATG codon of pdr-1 was amplified by PCR and ligated in-frame with GFP in the plasmid pPD117.01 (gift of Andy Fire). 

Phrase: "Plasmids To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "generate"

Phrase: "pdr-1 GFP reporter constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2827421:Construct [Classification]

Phrase: "a 650-bp promoter region immediately 5'"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0017446:Region [Geographic Area]
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0205147:Region [Spatial Concept]
   799   C0205548:Immediately [Temporal Concept]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "of the predicted initiation ATG codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0242610:Codon, Initiation [Nucleotide Sequence]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]

Phrase: "of pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "ligated"

Phrase: "in-frame with GFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080089:Frame [Nucleotide Sequence]
   770   C0180979:Frame [Medical Device]
   770   C1705858:Frame [Manufactured Object]

Phrase: "in the plasmid pPD117.01"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(gift of Andy Fire"

Phrase: ")."
Processing 00000000.tx.427: The translational fusion construct, Ppdr-1::gfp::pdr-1, was engineered by in-frame ligation of an 8.5-kb fragment, containing the complete genomic region of pdr-1, into the promoter construct Ppdr-1::gfp. 

Phrase: "The translational fusion construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "Ppdr-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "was"

Phrase: "engineered by in-frame ligation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023690:Ligation [Therapeutic or Preventive Procedure]
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C0878517:engineered [Professional or Occupational Group]
   760   C1705858:Frame [Manufactured Object]

Phrase: "of an 8.5-kb fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the complete genomic region of pdr-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017428:Genomic [Gene or Genome]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "into the promoter construct Ppdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C2827421:Construct [Classification]

Phrase: ":"

Phrase: ":"

Phrase: "gfp."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.428: To generate the rescuing subclone, a 13707-bp EcoRV fragment of cosmid K08E3 carrying the pdr-1/K08E3.8 operon was subcloned into vector pCRScript-AmpSK(+) (Stratagene) and a 4-bp insertion was introduced into exon 3 of the downstream gene K08E3.8, causing a frame shift at nucleotide 192 of the coding sequence. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the rescuing subclone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883178:Subclone [Cell]

Phrase: "a 13707-bp EcoRV fragment of cosmid K08E3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the pdr-1/K08E3.8 operon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0029073:Operon [Gene or Genome]

Phrase: "was"

Phrase: "subcloned into vector pCRScript-AmpSK"

Phrase: "(+"

Phrase: ")"

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "and"

Phrase: "a 4-bp insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0441587:Insertion [Health Care Activity]
   827   C1512796:Insertion [Genetic Function]
   827   C1883719:Insertion [Functional Concept]

Phrase: "was"

Phrase: "introduced into exon 3 of the downstream gene K08E3.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0017337:Gene [Gene or Genome]
   739   C0522506:Downstream [Spatial Concept]
   706   C1292748:introduce [Functional Concept]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a frame shift at nucleotide 192 of the coding sequence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0080089:Frame [Nucleotide Sequence]
   739   C0180979:Frame [Medical Device]
   739   C0333051:Shift [Functional Concept]
   739   C1705858:Frame [Manufactured Object]
   739   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.429: To verify the yeast two-hybrid results, full-length cDNAs of pdr-1, pdr-1(lg103), pdr-1(tm598), pdr-1(lg101), ubc-2, ubc-6, ubc-7, ubc-14, ubc-15, ubc-18, chn-1 and rpt-2 were cloned into vectors pGBKT7 and pGADT7 (Clontech). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the yeast two-hybrid results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "full-length cDNAs of pdr-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: ","

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm598"

Phrase: ")"

Phrase: ","

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg101"

Phrase: ")"

Phrase: ","

Phrase: "ubc-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubc-6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubc-7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubc-14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubc-15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubc-18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "chn-1"

Phrase: "and"

Phrase: "rpt-2"

Phrase: "were"

Phrase: "cloned into vectors pGBKT7"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1522642:Clone [Tissue]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "pGADT7"

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.430: pdr-1 and pdr-1(lg103) ORFs were cloned into vector pCite-4a(+) (Novagen) for in vitro translation. 

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg103"

Phrase: ")"

Phrase: "ORFs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0079941:ORFs [Gene or Genome]
   966 E C0013570:Orf [Disease or Syndrome]
   966 E C1412687:ORF [Gene or Genome]

Phrase: "were"

Phrase: "cloned into vector pCite-4a"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C0450373:4a [Intellectual Product]
   760   C1553636:4a [Medical Device]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "(+"

Phrase: ")"

Phrase: "(Novagen"

Phrase: ")"

Phrase: "for in vitro translation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.431: To generate GST-fusion proteins, ubc-2 and ubc-18 ORFs were cloned into vector pGSTparallel-3, pdr-1 ORF was cloned into a modified Baculovirus vector pAcUW51 (Pharmingen) and chn-1 ORF was cloned into vector pGEX4T1 (Pharmacia). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "GST-fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "ubc-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421267:UBC [Gene or Genome]
   861   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ubc-18 ORFs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0079941:ORFs [Gene or Genome]
   793 E C0013570:Orf [Disease or Syndrome]
   793 E C1412687:ORF [Gene or Genome]

Phrase: "were"

Phrase: "cloned into vector pGSTparallel-3,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "pdr-1 ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: "was"

Phrase: "cloned into a modified Baculovirus vector pAcUW51"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0009013:cloned [Cell]
   748   C0079005:Baculovirus [Virus]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0392747:Modified [Functional Concept]
   748   C0442335:Vector [Spatial Concept]
   748   C0935640:Baculovirus [Virus]
   748   C1705099:Vector [Idea or Concept]
   714 E C1522642:Clone [Tissue]

Phrase: "(Pharmingen"

Phrase: ")"

Phrase: "and"

Phrase: "chn-1 ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: "was"

Phrase: "cloned into vector pGEX4T1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0009013:cloned [Cell]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.432: For in vitro ubiquitylation assays, chn-1 ORF was cloned into vector pET21a(+) (Novagen). 

Phrase: "For in vitro ubiquitylation assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1515653:In Vitro Assay [Research Activity]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "chn-1 ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0079941:Open Reading Frame [Gene or Genome]
   840   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   804   C0034754:Reading [Daily or Recreational Activity]
   804   C0175566:Open [Spatial Concept]
   804   C0180979:Frame [Medical Device]
   804   C1705179:Reading [Finding]
   804   C1705858:Frame [Manufactured Object]
   733 E C0547049:Openness [Spatial Concept]

Phrase: "was"

Phrase: "cloned into vector pET21a"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0009013:cloned [Cell]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "(+"

Phrase: ")"

Phrase: "(Novagen"

Phrase: ")."
Processing 00000000.tx.433: pET21a-UbcH7 (gift of Martin Scheffner) was used to express human E2 enzyme UbcH7 in Escherichia coli. 

Phrase: "pET21a-UbcH7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421286:UBCH7 [Gene or Genome]

Phrase: "(gift of Martin Scheffner"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "human E2 enzyme UbcH7 in Escherichia coli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1421286:UBCH7 [Gene or Genome]
Processing 00000000.tx.434: To transfect human cells with pdr-1, full-length cDNAs of wild-type pdr-1 and truncated versions of the mutants lg103, tm598 and tm395 were cloned into a modified pcDNA3.1-FLAG (Invitrogen). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfect"

Phrase: "human cells with pdr-1,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0427861:Human cells [Laboratory or Test Result]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "full-length cDNAs of wild-type pdr-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "truncated versions of the mutants lg103,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0333052:versions [Functional Concept]
   719 E C2607870:Version [Spatial Concept]

Phrase: "tm598"

Phrase: "and"

Phrase: "tm395"

Phrase: "were"

Phrase: "cloned into a modified pcDNA3.1-FLAG"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0009013:cloned [Cell]
   748   C0392747:Modified [Functional Concept]
   748   C1708067:Flag [Functional Concept]
   714 E C1522642:Clone [Tissue]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.435: RNA isolation and northern blot analyses Total RNA was isolated from mixed or a specific staged worm plates and prepared with an RNAeasy kit according to the manufacturer's instructions (Qiagen). 

Phrase: "RNA isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "northern blot analyses Total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   701   C0005861:Northern blot analysis [Molecular Biology Research Technique]

Phrase: "was"

Phrase: "isolated from mixed"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205409:Isolated [Functional Concept]
   790   C0205430:Mixed [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C3160715:Mixed [Finding]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "a specific staged worm plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "prepared with an RNAeasy kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0812225:KIT [Medical Device]
   760   C1150635:KIT [Molecular Function]
   760   C1705212:Kit [Medical Device]
   760   C1705213:KIT [Medical Device]
   760   C3273202:Kit [Manufactured Object]
   726   C1521827:Prepare [Functional Concept]

Phrase: "according to the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.436: Five micrograms of total RNA was loaded per lane and blots were performed following standard procedures. 

Phrase: "Five micrograms of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439211:microgram [Quantitative Concept]

Phrase: "was"

Phrase: "loaded per lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "blots"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "standard procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.437: Probes were labeled with 32P dCTP using the Megaprime labeling kit according to the manufacturer's instructions (Amersham). 

Phrase: "Probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "labeled with 32P dCTP"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553631:32p [Medical Device]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Megaprime labeling kit according to the manufacturer's instructions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]

Phrase: "(Amersham"

Phrase: ")."
Processing 00000000.tx.438: ama-1- and act-1-specific probes were used as controls to adjust for equal loading. 

Phrase: "ama-1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002461:AMA [Professional Society]
   861   C0279755:AMA [Therapeutic or Preventive Procedure]
   861   C2825862:AMA [Laboratory Procedure]

Phrase: "and"

Phrase: "act-1-specific probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "used as controls"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "to"

Phrase: "adjust for equal loading."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205163:Equal [Qualitative Concept]
   770   C1549782:Equal [Idea or Concept]
   770   C1708715:Loading [Activity]
Processing 00000000.tx.439: RTPCR Single-strand cDNA synthesis was carried out using oligo-dT primer and reverse transcriptase with total RNA samples of the respective strains. 

Phrase: "RTPCR Single-strand cDNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligo-dT primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "reverse transcriptase with total RNA samples of the respective strains."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
           RNA Transcriptase
   739   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1555029:Reverse [Idea or Concept]
   739   C2257077:transcriptase [Genetic Function]
Processing 00000000.tx.440: All cDNAs were isolated by PCR on single-strand cDNA, using combinations of oligo-dT and gene-specific primers. 

Phrase: "All cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "isolated by PCR"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0205409:Isolated [Functional Concept]
   790   C0677874:pCR [Finding]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "on single-strand cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1979975:Single strand [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "combinations of oligo-dT"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0453882:Combinations [Manufactured Object]
   737 E C0205195:Combination [Qualitative Concept]
   737 E C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "gene-specific primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.441: Designed species-specific oligonucleotides were then used to amplify the respective pdr-1 ORFs from related species of the genus Caenorhabditis. 

Phrase: "Designed species-specific oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the respective pdr-1 ORFs from related species of the genus Caenorhabditis."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   736   C0079941:ORFs [Gene or Genome]
   703 E C0013570:Orf [Disease or Syndrome]
   703 E C1412687:ORF [Gene or Genome]
Processing 00000000.tx.442: GFP in vivo expression studies Both plasmids, the promoter construct Ppdr-1::gfp or the translational fusion Ppdr-1::gfp::pdr-1, were microinjected at a concentration of 25ng/l together with pRF4 at 75ng/l as an injection marker into N2 wild-type animals. 

Phrase: "GFP in vivo expression studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   872   C0681829:in vivo study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "Both plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the promoter construct Ppdr-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C2827421:Construct [Classification]

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "or"

Phrase: "the translational fusion Ppdr-1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]
   812   C1519614:Translational [Genetic Function]
   741 E C0040712:Translation [Intellectual Product]
   741 E C0597295:translation [Molecular Function]

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "were"

Phrase: "microinjected at a concentration of 25ng/l"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "together with pRF4"

Phrase: "at 75ng/l as"

Phrase: "an injection marker into N2 wild-type animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.443: Five to six independent lines transgenic for either the promoter construct (N2 byEx3187-3191[Ppdr-1::gfp;rol-6]) or the translational fusion (N2 byEx411-416[Ppdr-1::gfp::pdr-1;rol-6]), respectively, were used for expression pattern analysis. 

Phrase: "Five to six independent lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "transgenic for either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003069:Transgenic [Animal]

Phrase: "the promoter construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "(N2 byEx3187-3191"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441960:N2 [Finding]

Phrase: "[Ppdr-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";rol-6"

Phrase: "]"

Phrase: ")"

Phrase: "or"

Phrase: "the translational fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(N2 byEx411-416"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441960:N2 [Finding]

Phrase: "[Ppdr-1"

Phrase: ":"

Phrase: ":"

Phrase: "gfp"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ":"

Phrase: ":"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: ";rol-6"

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "respectively,"

Phrase: "were"

Phrase: "used for expression pattern analysis."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0449774:Pattern [Spatial Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1273517:used [Finding]
   760   C1524024:analysis [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.444: Yeast two-hybrid assays Protein interaction studies were performed using the MATCHMAKER GAL4 Two-Hybrid System 3 according to the manufacturer's instructions (Clontech). 

Phrase: "Yeast two-hybrid assays Protein interaction studies"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0872306:Yeast Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   829   C0598148:hybrid protein [Amino Acid, Peptide, or Protein]
   818   C0872079:protein interaction [Molecular Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0947630:studies [Laboratory Procedure]
   795   C1704675:Interaction [Functional Concept]
   762 E C0557651:Study [Manufactured Object]
   762 E C2603343:Study [Research Activity]
   710   C1961118:Yeast Two-Hybrid Assays [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MATCHMAKER GAL4 Two-Hybrid System 3 according to the manufacturer's instructions"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   753   C0599647:Two Hybrid [Molecular Biology Research Technique]
   736   C0020205:Hybrid [Organism]
   736   C0205448:Two [Quantitative Concept]
   736   C0302828:instructions [Intellectual Product]
   736   C0449913:System [Functional Concept]
   736   C0680240:according [Social Behavior]
   736   C0947322:Manufacturer [Intellectual Product]
   736   C1416832:GAL4 [Gene or Genome]
   736   C1442085:Instructions [Idea or Concept]
   736   C1553451:System [Manufactured Object]
   736   C1704459:System [Medical Device]
   736   C1705426:Manufacturer [Population Group]
   736   C3263700:Instructions [Clinical Attribute]
   703 E C0039401:Instruction [Educational Activity]

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.445: Full-length PDR-1 was fused to GAL4 DNA-binding domain (pGBKT7) and transformed into yeast AH109. 

Phrase: "Full-length PDR-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   812   C0154830:PDR [Disease or Syndrome]
   812   C0443225:Full [Qualitative Concept]
   812   C1418444:PDR [Gene or Genome]
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   812   C1845050:PDR [Disease or Syndrome]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "fused to GAL4 DNA-binding domain"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1511662:DNA Binding Domain [Amino Acid Sequence]
   790   C1148673:DNA Binding [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0699952:Fused [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "(pGBKT7"

Phrase: ")"

Phrase: "and"

Phrase: "transformed into yeast AH109."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1510411:Transformed [Pathologic Function]
Processing 00000000.tx.446: C. elegans GAL4 activation domain libraries (gift of Robert Barstead) were used as prey. 

Phrase: "C. elegans GAL4 activation domain libraries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0023621:Libraries [Manufactured Object,Organization]
   766 E C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   766 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(gift of Robert Barstead"

Phrase: ")"

Phrase: "were"

Phrase: "used as prey."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C3540252:PreY [Gene or Genome]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.447: Approximately 150000 transformants were screened and about 50 independent clones were identified as true positives, including several isolates of distinct ORFs. 

Phrase: "Approximately 150000 transformants"

Phrase: "were"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "and"

Phrase: "about 50 independent clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "identified as true positives,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   816   C0205559:True positive [Qualitative Concept]
   770   C0205238:True [Qualitative Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737   C0439178:% Positive [Quantitative Concept]
   737   C1446409:Positive [Qualitative Concept]
   737   C1514241:Positive [Finding]
   737   C2825490:Positive [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "several isolates of distinct ORFs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0370215:isolates [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.448: Protein interaction studies were carried out under high stringency conditions according to the manufacturer's instructions. 

Phrase: "Protein interaction studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0872079:protein interaction [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0947630:studies [Laboratory Procedure]
   827   C1704675:Interaction [Functional Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out under high stringency"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205250:High [Qualitative Concept]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "conditions according to the manufacturer's instructions."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0012634:condition [Disease or Syndrome]
   753   C0302828:instructions [Intellectual Product]
   753   C0348080:Condition [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705253:Condition [Conceptual Entity]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.449: Expression and purification of proteins Recombinant Baculovirus was generated using the Baculo Gold System as described by the manufacturer (Pharmingen). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "purification of proteins Recombinant Baculovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0597301:protein purification [Laboratory Procedure]
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Baculo Gold System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "as"

Phrase: "described by the manufacturer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]

Phrase: "(Pharmingen"

Phrase: ")."
Processing 00000000.tx.450: For protein production, 20ml of infected SF9 cells (3x106 cells/ml) were grown for 2 days. 

Phrase: "For protein production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "20ml of infected SF9 cells"

Phrase: "(3x106 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2699156:Cells/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "grown for 2 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.451: Cells were lysed in twice the volume of the cell pellet in buffer A [10mM Tris, pH 8; 10mM DTT or 10mM -mercaptoethanol+complete protease inhibitors (Boehringer)] using a dounce homogenizer. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in twice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0024348:lysed [Pathologic Function]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "the volume of the cell pellet"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0596292:Cell Volume [Organism Attribute,Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "in buffer A [10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]

Phrase: "pH 8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "; 10mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "10mM -mercaptoethanol+complete protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   804   C1947941:Protease [Enzyme]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Boehringer"

Phrase: ")"

Phrase: "]"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a dounce homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.452: BL21(pRIL) E. coli cells were used to produce recombinant E2 and E4 enzymes from the described clones and lysed in buffer A. 

Phrase: "BL21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450615:BL21 [Body Location or Region]

Phrase: "(pRIL"

Phrase: ")"

Phrase: "E. coli cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0014834:E coli [Bacterium]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "recombinant E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E4 enzymes from the described clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "lysed in buffer A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]
Processing 00000000.tx.453: For purification of GST-fusion proteins (GST::UBC-2/GST::UBC-18/GST::CHN-1/GST-mycPDR-1) cleared lysates were allowed to bind to 500g of glutathione-Sepharose beads (Pharmacia). 

Phrase: "For purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "of GST-fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(GST::UBC-2/GST::UBC-18/GST::CHN-1/GST-mycPDR-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C1421267:UBC [Gene or Genome]
   787   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "cleared lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to 500g of glutathione-Sepharose beads"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036681:Sepharose [Carbohydrate]
   748   C0991566:Beads [Biomedical or Dental Material]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   714 E C2346972:Bead [Spatial Concept]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.454: After extensive washing in buffer A with 0.1% Triton X-100 and 500mM NaCl, GST-fusion proteins were eluted with 10mM glutathione. 

Phrase: "After extensive washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "in buffer A"

Phrase: "with 0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "500mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "GST-fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "eluted with 10mM glutathione."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.455: GST-pull-down experiments PDR-1 and PDR-1(aa24247) mutant versions were radioactively labeled with 35S methionine/cysteine by in vitro translation using the respective plasmids according to the manufacturer's instructions (TNT Coupled Reticulocyte Lysate System, Promega). 

Phrase: "GST-pull-down experiments PDR-1"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   799   C0154830:PDR [Disease or Syndrome]
   799   C0580846:pull [Finding]
   799   C0681814:Experiments [Research Activity]
   799   C1418444:PDR [Gene or Genome]
   799   C1845050:PDR [Disease or Syndrome]
   766 E C1706386:Experiment [Conceptual Entity]
   743   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   743   C2626739:Lanugo [Eukaryote]
   716 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "PDR-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(aa24247"

Phrase: ")"

Phrase: "mutant versions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333052:versions [Functional Concept]
   827 E C2607870:Version [Spatial Concept]

Phrase: "were"

Phrase: "radioactively"

Phrase: "labeled with 35S methionine/cysteine"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "by in vitro translation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the respective plasmids according to the manufacturer's instructions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(TNT"

Phrase: "Coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "Reticulocyte Lysate System,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.456: Lysates were incubated overnight at 4C on the loaded glutathione-Sepharose beads and washed at least five times in buffer A with 0.1% Triton X-100 and 150mM NaCl. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "on the loaded glutathione-Sepharose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "washed at least five times"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205451:Five [Quantitative Concept]
   760   C1548982:Washed [Idea or Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C0441648:Wash [Activity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in buffer A"

Phrase: "with 0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "150mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.457: Reactions were separated by SDSPAGE and visualized by Coomassie blue staining and autoradiography. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "separated by SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "visualized by Coomassie blue staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.458: In vitro ubiquitylation assay Reactions were done as previously described (36). 

Phrase: "In vitro ubiquitylation assay Reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0443286:Reaction [Functional Concept]
   771   C1114821:Reaction [Clinical Attribute]
   722   C1515653:In Vitro Assay [Research Activity]

Phrase: "were"

Phrase: "done"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.459: Purified rabbit E1 (Affiniti), purified GST-UBC-2 as well as UbcH7 and CHN-1 crude E. coli cell extracts were used for self-ubiquitylation reactions of purified GST::myc::PDR-1. 

Phrase: "Purified rabbit E1"

Phrase: "(Affiniti"

Phrase: ")"

Phrase: ","

Phrase: "purified GST-UBC-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1421267:UBC [Gene or Genome]
   812   C1523983:UBC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "UbcH7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421286:UBCH7 [Gene or Genome]

Phrase: "and"

Phrase: "CHN-1 crude E. coli cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1258023:Crude Extracts [Chemical]
   818   C0007592:Cell Extracts [Cell Component]
   762   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "used for self-ubiquitylation reactions"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0036588:Self [Idea or Concept]
   760   C1273517:used [Finding]
   760   C1519751:Ubiquitylation [Molecular Function]
   760   C1551994:self [Intellectual Product]
   760   C3244295:Self [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726   C0443286:Reaction [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]
   726 E C1947944:Use [Intellectual Product]

Phrase: "of purified GST::myc::PDR-1."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0154830:PDR [Disease or Syndrome]
   804   C1418444:PDR [Gene or Genome]
   804   C1845050:PDR [Disease or Syndrome]
   804   C1998793:Purified [Functional Concept]
   711 E C1947930:Cleanse [Activity]
Processing 00000000.tx.460: Reactions were separated by SDS gel electrophoresis followed by western blotting using 9E10 anti-myc (Boehringer) antibody. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "separated by SDS gel electrophoresis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "followed by western blotting"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "9E10 anti-myc (Boehringer"

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.461: Expression of mutant PDR-1 in HEK293T cells HEK293T cells were cultured in Dulbecco's modified Eagle's medium with Glutmax (PAA Laboratories GmbH) supplemented with 10% fetal calf serum. 

Phrase: "Expression of mutant PDR-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HEK293T cells HEK293T cells"

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "with Glutmax"

Phrase: "(PAA Laboratories GmbH)"

Phrase: "supplemented with 10% fetal calf serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.462: Cells were transfected using Lipofectamine 2000 Reagent (Invitrogen) according to the supplier's instructions. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine 2000 Reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   734   C1312445:lipofectamine 2000 [Organic Chemical]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "according to the supplier's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.463: Cells were harvested 24 or 48h post-transfection and lysed in lysis buffer (10mM TrisHCl, pH 7.5, 150mM NaCl, 1mM EDTA, containing 1% Triton X-100) with proteinase inhibitors (Sigma) on ice for 15min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24"

Phrase: "or"

Phrase: "48h post-transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "lysed in lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
           lysed
   770   C1536403:lysis [Cell Function]

Phrase: "(10mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "with proteinase inhibitors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   966   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   966   C2673177:proteinase inhibitor [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 15min."
Processing 00000000.tx.464: Cell lysates were centrifuged at 50000g for 1h at 4C. 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "centrifuged at 50000g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.465: Supernatants were saved as the Triton X-100 soluble fractions (S) and pellets were washed once with lysis buffer containing Triton X-100 before re-extraction with SDS buffer (lysis buffer containing 1% SDS in place of Triton X-100). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "saved as the Triton X-100 soluble fractions"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0242759:Triton [Geographic Area]
   744   C1264633:Fractions [Quantitative Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   711 E C1554103:Fraction [Idea or Concept]
   711   C2347840:Save [Machine Activity]

Phrase: "("

Phrase: "S)"

Phrase: "and"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with lysis buffer containing Triton X-100"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
   744   C0242759:Triton [Geographic Area]
   744   C0332256:Containing [Functional Concept]
   744   C1536403:lysis [Cell Function]
   744   C1720092:Once [Intellectual Product]
   744   C1948045:Once [Temporal Concept]
   744   C2700400:Containing [Activity]

Phrase: "before re-extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]
   861   C2986904:RE [Idea or Concept]

Phrase: "with SDS buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% SDS in place of Triton X-100"

Phrase: ")."
Processing 00000000.tx.466: After centrifugation at 50000g for 1h at 4C supernatants were saved as the SDS fractions (P). 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 50000g"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "saved as the SDS fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726   C2347840:Save [Machine Activity]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.467: Equivalent amounts of proteins among different S and P fractions were resolved by SDSPAGE and analyzed by western blotting procedures using anti-FLAG and anti--actin antibodies (Sigma). 

Phrase: "Equivalent amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "among different S"

Phrase: "and"

Phrase: "P fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "resolved by SDSPAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514893:Resolved [Idea or Concept]
   790   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "analyzed by western blotting procedures"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1705493:Western [Spatial Concept]
   760   C2700391:procedures [Activity]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti--actin antibodies"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   988   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.468: Immunocytochemistry with FLAG-tagged PDR-1 HEK293T were cultivated on 4-well chamber slides (Nunc) and transfected using Lipofectamine 2000 according to the manufacturer's instruction (Invitrogen). 

Phrase: "Immunocytochemistry with FLAG-tagged PDR-1 HEK293T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "were"

Phrase: "cultivated on 4-well chamber slides"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C0444330:slides [Research Device]
   753   C0935616:Chamber [Body Part, Organ, or Organ Component]
   753   C3146287:Well [Manufactured Object]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "(Nunc"

Phrase: ")"

Phrase: "and"

Phrase: "transfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine 2000 according to the manufacturer's instruction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1312445:lipofectamine 2000 [Organic Chemical]
   748   C0039401:Instruction [Educational Activity]
   748   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
   748   C0302828:Instruction [Intellectual Product]
   748   C0680240:according [Social Behavior]
   748   C0947322:Manufacturer [Intellectual Product]
   748   C1442085:instruction [Idea or Concept]
   748   C1705426:Manufacturer [Population Group]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.469: After 48h, transfected cells were washed once with PBS and fixed with cold methanol for 10min and acetone for 5min at 20C. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "fixed with cold methanol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0231441:Fixed [Finding]
   770   C0234192:Cold [Physiologic Function]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 10min"

Phrase: "and"

Phrase: "acetone for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "at 20C."
Processing 00000000.tx.470: Fixed cells were washed twice with PBS and blocked with 1% BSA for 30min. 

Phrase: "Fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "blocked with 1% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "for 30min."
Processing 00000000.tx.471: Cells were then incubated with the primary rabbit anti-FLAG antibody (1:200, Sigma) and the monoclonal anti-Synuclein antibody (1:500, Biosource). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with the primary rabbit anti-FLAG antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0034493:Rabbit [Mammal]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1708067:Flag [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200,"

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the monoclonal anti-Synuclein antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500,"

Phrase: "Biosource"

Phrase: ")."
Processing 00000000.tx.472: The secondary antibody against mouse was labeled with Cy3 (1:800, Jackson Immunoresearch) and the anti-rabbit antibody was labeled with Alexa 488 (1:800, Invitrogen). 

Phrase: "The secondary antibody against mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "labeled with Cy3"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "800,"

Phrase: "Jackson Immunoresearch"

Phrase: ")"

Phrase: "and"

Phrase: "the anti-rabbit antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "labeled with Alexa 488"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1071616:Alexa [Plant]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "800,"

Phrase: "Invitrogen"

Phrase: ")."
Processing 00000000.tx.473: Single-optic sections were recorded using Zeiss Axiovision microscope. 

Phrase: "Single-optic sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Zeiss Axiovision microscope."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]
Processing 00000000.tx.474: Drug treatments Adult worms were allowed to lay eggs for 3h at 20C on NGM agar plates containing varying concentrations of DTT, -mercaptoethanol or tunicamycin (Calbiochem). 

Phrase: "Drug treatments Adult worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0018889:WORM [Disease or Syndrome]
   812   C0018893:Worm [Eukaryote]
   812   C0040820:Worms NOS [Disease or Syndrome]
   712 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lay"

Phrase: "eggs for 3h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "at 20C"

Phrase: "on NGM agar plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "varying concentrations of DTT, -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "or"

Phrase: "tunicamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041385:Tunicamycin [Antibiotic,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.475: Eggs were counted and progenies were studied 3 days later (42). 

Phrase: "Eggs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0013710:Eggs [Food]
   966 E C0029974:Egg [Cell]
   966 E C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "progenies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Progeny [Family Group]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.476: Synchronized L1 worms were treated with 2mM paraquat (Sigma) solution and survival at 20C was studied 3 days later. 

Phrase: "Synchronized L1 worms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0018889:WORM [Disease or Syndrome]
   827   C0018893:Worm [Eukaryote]
   827   C0040820:Worms NOS [Disease or Syndrome]
   727 E C1563952:Vermin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "treated with 2mM paraquat"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "survival at 20C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038952:Survival [Activity]
   790   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "3 days later."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1442459:3 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.477: Mean values were calculated from different experimental groups of 310 independent assays, each. 

Phrase: "Mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated from different experimental groups of 310 independent assays,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   762   C0332291:Independent of [Functional Concept]
   742   C0085862:Independent [Idea or Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0444686:Calculated [Functional Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1299583:Independent [Finding]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1517586:Experimental [Qualitative Concept]
   742   C1552516:Group [Health Care Related Organization]
   742   C1552839:groups [Idea or Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   708   C0005507:Assay [Laboratory Procedure]
   708   C0243073:assay [Qualitative Concept]
   708   C1510438:Assay [Laboratory Procedure]

Phrase: "each."
Processing 00000000.tx.478: Heat-shock experiments Synchronized L2 larvae grown at 20C were heat stressed for 2h at 35C and afterwards further maintained at 20C. 

Phrase: "Heat-shock experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0282498:Heat Shock [Physiologic Function]

Phrase: "Synchronized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439580:Synchronized [Temporal Concept]

Phrase: "L2 larvae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023047:Larvae [Eukaryote]

Phrase: "grown at 20C"

Phrase: "were"

Phrase: "heat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "stressed for 2h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038435:stressed [Finding]
   790   C1292425:2H [Temporal Concept]

Phrase: "at 35C"

Phrase: "and"

Phrase: "afterwards further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "maintained at 20C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
Processing 00000000.tx.479: Development and survival was scored 2 days later. 

Phrase: "Development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: "was"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "2 days later."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1442455:2 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.480: Mean values were calculated from different experimental groups of six independent assays. 

Phrase: "Mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated from different experimental groups of six independent assays."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   762   C0332291:Independent of [Functional Concept]
   742   C0085862:Independent [Idea or Concept]
   742   C0205452:Six [Quantitative Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0444686:Calculated [Functional Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1299583:Independent [Finding]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1517586:Experimental [Qualitative Concept]
   742   C1552516:Group [Health Care Related Organization]
   742   C1552839:groups [Idea or Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   708   C0005507:Assay [Laboratory Procedure]
   708   C0243073:assay [Qualitative Concept]
   708   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.481: Software and microscopy Quantitative evaluation of northern blots was performed using ImageQuant 5.0 software (Molecular Dynamics). 

Phrase: "Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "microscopy Quantitative evaluation of northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034384:Quantitative Evaluation [Quantitative Concept]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ImageQuant 5.0 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")."
Processing 00000000.tx.482: The amino acid alignment was generated using Vector NTI version 6.0 (InforMax). 

Phrase: "The amino acid alignment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1706765:Alignment [Quantitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Vector NTI version 6.0"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0333052:Version [Functional Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705048:NTI [Gene or Genome]
   804   C1705099:Vector [Idea or Concept]
   804   C2607870:Version [Spatial Concept]

Phrase: "(InforMax"

Phrase: ")."
Processing 00000000.tx.483: Pictures of GFP expression were taken with an AxioPlan 2 Microscope (Zeiss) using the AxioVision 3.0 software.  

Phrase: "Pictures of GFP expression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441469:pictures [Manufactured Object]
   737 E C0441468:picture [Manufactured Object]

Phrase: "were"

Phrase: "taken with an AxioPlan 2 Microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0181839:Microscope [Medical Device]
   753   C1706379:Microscope [Medical Device]
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]

Phrase: "(Zeiss"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AxioVision 3.0 software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.484: ACKNOWLEDGEMENTS  We thank Bianca Sperl for excellent technical assistance, Philipp Kahle, Stefan Eimer and the members of the Baumeister lab for helpful discussions and critical reading of the manuscript, Christian Haass for support, Claudia Rudolph (EleGene) for isolating pdr-1(lg103) and pdr-1(lg101), Julia Smann for help with the yeast experiments, Shohei Mitani for providing pdr-1(tm598) and pdr-1(tm395), Garry Wong for integrated -synuclein strains, Randal Kaufmann, David Ron, Randy Blakely, Andy Fire, Martin Scheffner and Robert Barstead for strains, plasmids and cDNA libraries. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Bianca Sperl for excellent technical assistance,"

Phrase: "Philipp Kahle,"

Phrase: "Stefan Eimer"

Phrase: "and"

Phrase: "the members of the Baumeister lab"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "for helpful discussions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "critical reading of the manuscript,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034754:Reading [Daily or Recreational Activity]
   760   C1705179:Reading [Finding]

Phrase: "Christian Haass for support,"

Phrase: "Claudia Rudolph"

Phrase: "(EleGene"

Phrase: ")"

Phrase: "for isolating pdr-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0154830:PDR [Disease or Syndrome]
   827   C0370215:isolating [Substance]
   827   C1418444:PDR [Gene or Genome]
   827   C1845050:PDR [Disease or Syndrome]
   793 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(lg103"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(lg101"

Phrase: ")"

Phrase: ","

Phrase: "Julia Smann for"

Phrase: "help with the yeast experiments,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0018896:Help [Social Behavior]
   760   C0036025:yeast [Fungus]
   760   C0043392:Yeast [Food]
   760   C0043393:Yeast [Fungus]
   760   C0681814:Experiments [Research Activity]
   760   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   760   C1552861:help [Idea or Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "Shohei Mitani for providing pdr-1"

Phrase: "(tm598"

Phrase: ")"

Phrase: "and"

Phrase: "pdr-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0154830:PDR [Disease or Syndrome]
   861   C1418444:PDR [Gene or Genome]
   861   C1845050:PDR [Disease or Syndrome]

Phrase: "(tm395"

Phrase: ")"

Phrase: ","

Phrase: "Garry Wong for integrated -synuclein strains,"

Phrase: "Randal Kaufmann,"

Phrase: "David Ron,"

Phrase: "Randy Blakely,"

Phrase: "Andy Fire,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016141:Fire [Phenomenon or Process]
   861   C0700614:Fire [Natural Phenomenon or Process]
   861   C0702194:Fire [Human-caused Phenomenon or Process]
   861   C1880775:FIRE [Event]

Phrase: "Martin Scheffner"

Phrase: "and"

Phrase: "Robert Barstead for strains,"

Phrase: "plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cDNA libraries."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0751608:cDNA Libraries [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
       E   Library
   861   C0023621:Libraries [Manufactured Object,Organization]
   827 E C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.485: Some strains used in this study were obtained from the C. elegans Genetics Center, St Louis, which is funded by the NIH. 

Phrase: "Some strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0080194:Strains [Injury or Poisoning]
  1000   C0456178:strains [Intellectual Product]
   966 E C1518614:Strain [Organism]
   966 E C2987481:Strain [Mental Process]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "obtained from the C. elegans Genetics"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0017398:Genetics [Biomedical Occupation or Discipline]
   753   C0017399:genetics [Biologic Function]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ","

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "funded by the NIH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016820:funded [Quantitative Concept]
   770   C0027468:NIH [Health Care Related Organization]
Processing 00000000.tx.486: This work was supported by grants from the European Community (through the Integrated Project APOPIS), the Friedrich-Baur Stiftung, the Fonds der Chemischen Industrie to R.B., and the Deutsche Forschungsgemeinschaft to R.B. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the European Community"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015179:European Community [Organization]
   861   C0009462:Community [Geographic Area]

Phrase: "("

Phrase: "through the Integrated Project APOPIS"

Phrase: ")"

Phrase: ","

Phrase: "the Friedrich-Baur Stiftung,"

Phrase: "the Fonds der Chemischen Industrie to R.B.,"

Phrase: "and"

Phrase: "the Deutsche Forschungsgemeinschaft to R.B."
Processing 00000000.tx.487: (SFB596) and to T.H. 

Phrase: "(SFB596"

Phrase: ")"

Phrase: "and to T.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.488: (SFB 444). 

Phrase: "(SFB 444"

Phrase: ")."
Processing 00000000.tx.489: Conflict of Interest statement. 

Phrase: "Conflict of Interest statement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710187:Statement [Idea or Concept]
   756   C0079152:Conflict of Interest [Idea or Concept]
Processing 00000000.tx.490: All authors have no conflict of interest to declare.  

Phrase: "All authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "have"

Phrase: "no conflict of interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0079152:Conflict of Interest [Idea or Concept]
   812   C0009671:Conflict [Individual Behavior]
   812   C0543488:Interest [Mental Process]
   812   C1705242:Conflict [Qualitative Concept]

Phrase: "declare."
Processing 00000000.tx.491: FOOTNOTES  Present address: Centre for Molecular Neurobiology (ZMNH), University of Hamburg, Germany.  

Phrase: "FOOTNOTES  Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Centre for Molecular Neurobiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "(ZMNH"

Phrase: ")"

Phrase: ","

Phrase: "University of Hamburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.492: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Riess, O., Berg, D., Kruger, R. and Schulz, J.B. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Riess,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Berg,"

Phrase: "D."

Phrase: ","

Phrase: "Kruger,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schulz,"

Phrase: "J.B."
Processing 00000000.tx.493: (2003) Therapeutic strategies for Parkinson's disease based on data derived from genetic research. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Therapeutic strategies for Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679199:strategies [Mental Process]

Phrase: "based on data"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   841   C0242356:data base [Intellectual Product]
   841   C0993637:Data Base [Intellectual Product]
   790   C1511726:Data [Idea or Concept]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C3245479:data [Medical Device]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "derived from genetic research."
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   833   C0243064:Genetic Research [Research Activity]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0314603:Genetic [Functional Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: Neurol., 250 (Suppl. 1), I3I10.[Medline] Lykkebo, S. and Jensen, P.H. 

Phrase: "Neurol.,"

Phrase: "250"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ","

Phrase: "I3I10."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lykkebo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Jensen,"

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.496: (2002) Alpha-synuclein and presynaptic function: implications for Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "presynaptic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.497: Neuromol. 

Phrase: "Neuromol."
Processing 00000000.tx.498: Med., 2, 115129.[CrossRef][ISI] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. etal. 

Phrase: "Med.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "115129."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. etal."
Processing 00000000.tx.499: (1997) Mutation in the -synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the -synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.500: Science, 276, 20452047.[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T.,"

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.501: (1998) Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.502: Nat. 

Phrase: "Nat."
Processing 00000000.tx.503: Genet., 18, 106108.[CrossRef][ISI][Medline] Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106108."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarranz,"

Phrase: "J.J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gomez-Esteban,"

Phrase: "J.C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atares,"

Phrase: "B. etal."
Processing 00000000.tx.504: (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The new mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2985439:new mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "E46K,"

Phrase: "of alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Lewy body dementia."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.505: Ann. 

Phrase: "Ann."
Processing 00000000.tx.506: Neurol., 55, 164173.[CrossRef][ISI][Medline] Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M. etal. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164173."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Roumier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mouroux,"

Phrase: "V.,"

Phrase: "Douay,"

Phrase: "X.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Levecque,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Larvor,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andrieux,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M. etal."
Processing 00000000.tx.507: (2004) -Synuclein locus duplication as a cause of familial Parkinson's disease. 

Phrase: "(2004"

Phrase: ") -"

Phrase: "Synuclein locus duplication as a cause of familial Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332597:Duplication [Functional Concept]
   739   C1705960:Duplication [Cell or Molecular Dysfunction]
Processing 00000000.tx.508: Lancet, 364, 11671169.[CrossRef][ISI][Medline] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. etal. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "364,"

Phrase: "11671169."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. etal."
Processing 00000000.tx.509: (2003) -Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ") -"

Phrase: "Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.510: Science, 302, 841.[Free FullText] Ibanez, P., Bonnet, A.M., Debarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Durr, A. and Brice, A. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bonnet,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Debarges,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Tison,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pollak,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Durr,"

Phrase: "A."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.511: (2004) Causal relation between -synuclein gene duplication and familial Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Causal relation between -synuclein gene duplication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "familial Parkinson's disease."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.512: Lancet, 364, 11691171.[CrossRef][ISI][Medline] Maries, E., Dass, B., Collier, T.J., Kordower, J.H. and Steece-Collier, K. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "364,"

Phrase: "11691171."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maries,"

Phrase: "E.,"

Phrase: "Dass,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   966   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Collier,"

Phrase: "T.J.,"

Phrase: "Kordower,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Steece-Collier,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.513: (2003) The role of -synuclein in Parkinson's disease: insights from animal models. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The role of -synuclein in Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "insights from animal models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:insights [Mental Process]
Processing 00000000.tx.514: Nat. 

Phrase: "Nat."
Processing 00000000.tx.515: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.516: Neurosci., 4, 727738.[CrossRef][ISI][Medline] Lakso, M., Vartiainen, S., Moilanen, A.M., Sirvio, J., Thomas, J.H., Nass, R., Blakely, R.D. and Wong, G. 

Phrase: "Neurosci.,"

Phrase: "4,"

Phrase: "727738."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lakso,"

Phrase: "M."

Phrase: ","

Phrase: "Vartiainen,"

Phrase: "S."

Phrase: ","

Phrase: "Moilanen,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sirvio,"

Phrase: "J.,"

Phrase: "Thomas,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027609:NAS [Disease or Syndrome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blakely,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.517: (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Dopaminergic neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1850496:Neuronal loss [Finding]
   865 E C0598940:neuron loss [Finding]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0746626:deficits motor [Pathologic Function]
   742   C2987487:deficits [Qualitative Concept]
   708 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.518: J. 

Phrase: "J."
Processing 00000000.tx.519: Neurochem., 86, 165172.[CrossRef][ISI][Medline] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Neurochem.,"

Phrase: "86,"

Phrase: "165172."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.520: (1998) Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the Parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile Parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.521: Nature, 392, 605608.[CrossRef][ISI][Medline] Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., Yokosawa, H., Hattori, N., Mizuno, Y. etal. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sakata,"

Phrase: "E.,"

Phrase: "Yamaguchi,"

Phrase: "Y.,"

Phrase: "Kurimoto,"

Phrase: "E.,"

Phrase: "Kikuchi,"

Phrase: "J.,"

Phrase: "Yokoyama,"

Phrase: "S."

Phrase: ","

Phrase: "Yamada,"

Phrase: "S."

Phrase: ","

Phrase: "Kawahara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yokosawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y. etal."
Processing 00000000.tx.522: (2003) Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the Rpn10 subunit of 26S proteasomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1711351:Subunit [Quantitative Concept]

Phrase: "through its ubiquitin-like domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.523: EMBO Rep., 4, 301306.[Abstract/Free FullText] Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "EMBO Rep., 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1744664:REP [Molecular Function]

Phrase: "301306."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.524: (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitination of a new form of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.525: Science, 293, 263269.[Abstract/Free FullText] Finney, N., Walther, F., Mantel, P.Y., Stauffer, D., Rovelli, G. and Dev, K.K. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Finney,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Walther,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mantel,"

Phrase: "P.Y.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Stauffer,"

Phrase: "D."

Phrase: ","

Phrase: "Rovelli,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Dev,"

Phrase: "K.K."
Processing 00000000.tx.526: (2003) The cellular protein level of parkin is regulated by its ubiquitin-like domain. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The cellular protein level of parkin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0428479:Protein level [Laboratory or Test Result]
   783   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "regulated by its ubiquitin-like domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.527: J. 

Phrase: "J."
Processing 00000000.tx.528: Biol. 

Phrase: "Biol."
Processing 00000000.tx.529: Chem., 278, 1605416058.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. etal. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "1605416058."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. etal."
Processing 00000000.tx.530: (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial Parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin-protein ligase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1442769:ubiquitin-protein ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.531: Nat. 

Phrase: "Nat."
Processing 00000000.tx.532: Genet., 25, 302305.[CrossRef][ISI][Medline] Pickart, C.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pickart,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: (2001) Mechanisms underlying ubiquitination. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "ubiquitination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.534: Annu. 

Phrase: "Annu."
Processing 00000000.tx.535: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.536: Biochem., 70, 503533.[CrossRef][ISI][Medline] Imai, Y., Soda, M. and Takahashi, R. 

Phrase: "Biochem.,"

Phrase: "70,"

Phrase: "503533."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.537: (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "unfolded protein stress-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "through its E3 ubiquitin-protein ligase activity."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   937   C1150685:ubiquitin-protein ligase activity [Molecular Function]
           ubiquitin-ligase activity
   875   C1325411:ubiquitin activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150651:ligase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   722   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ligase
   722   C1418270:E3 ubiquitin ligase [Gene or Genome]
   717   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1442769:ubiquitin-protein ligase [Gene or Genome]
Processing 00000000.tx.538: J. 

Phrase: "J."
Processing 00000000.tx.539: Biol. 

Phrase: "Biol."
Processing 00000000.tx.540: Chem., 275, 3566135664.[Abstract/Free FullText] Rutkowski, D.T. and Kaufman, R.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3566135664."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rutkowski,"

Phrase: "D.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Kaufman,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: (2004) A trip to the ER: coping with stress. 

Phrase: "(2004"

Phrase: ")"

Phrase: "A trip to the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0221188:trip [Phenomenon or Process]

Phrase: ":"

Phrase: "coping with stress."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009967:Coping [Individual Behavior]
   790   C0038435:Stress [Finding]
   718 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.542: Trends Cell Biol., 14, 2028.[CrossRef][ISI][Medline] Kostova, Z. and Wolf, D.H. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol.,"

Phrase: "14,"

Phrase: "2028."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kostova,"

Phrase: "Z."

Phrase: "and"

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.543: (2003) For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. 

Phrase: "(2003"

Phrase: ")"

Phrase: "For whom"

Phrase: "the bell tolls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1321919:TOLL [Amino Acid, Peptide, or Protein,Receptor]
   827   C1336636:TOLL [Gene or Genome]
   827   C1705581:TOLL [Gene or Genome]

Phrase: ":"

Phrase: "protein quality control of the endoplasmic reticulum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0034378:quality control [Functional Concept]
   778   C1561524:Quality Control [Intellectual Product]
   778   C1610034:Quality Control [Intellectual Product]
   748   C0243148:control [Qualitative Concept]
   748   C0332306:Quality [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the ubiquitin-proteasome connection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449379:Connection [Intellectual Product]
Processing 00000000.tx.544: EMBO J., 22, 23092317.[Abstract/Free FullText] Friedlander, R., Jarosch, E., Urban, J., Volkwein, C. and Sommer, T. 

Phrase: "EMBO J.,"

Phrase: "22,"

Phrase: "23092317."

Phrase: "[Abstract/Free FullText"

Phrase: "] Friedlander,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jarosch,"

Phrase: "E.,"

Phrase: "Urban,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442529:Urban [Geographic Area]
  1000   C2700386:Urban [Qualitative Concept]

Phrase: "J.,"

Phrase: "Volkwein,"

Phrase: "C."

Phrase: "and"

Phrase: "Sommer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.545: (2000) A regulatory link between ER-associated protein degradation and the unfolded-protein response. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A regulatory link between ER-associated protein degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1517892:Link [Intellectual Product]
   742   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the unfolded-protein response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.546: Nat. 

Phrase: "Nat."
Processing 00000000.tx.547: Cell Biol., 2, 379384.[CrossRef][ISI][Medline] Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S. and Walter, P. 

Phrase: "Cell Biol.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "379384."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Travers,"

Phrase: "K.J.,"

Phrase: "Patil,"

Phrase: "C.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wodicka,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Weissman,"

Phrase: "J.S."

Phrase: "and"

Phrase: "Walter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.548: (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "genomic analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an essential coordination between the unfolded protein response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0242414:Coordination [Physiologic Function]
   744   C0700114:Coordination [Functional Concept]

Phrase: "and"

Phrase: "ER-associated degradation."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C3178997:Endoplasmic Reticulum-Associated Degradation [Molecular Function]
   861   C0014239:Endoplasmic Reticulum [Cell Component]
   812   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   812   C0243125:degradation [Functional Concept]
   812   C0332281:Associated [Qualitative Concept]
   812   C0699900:Degradation [Organism Function]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
   741   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.549: Cell, 101, 249258.[CrossRef][ISI][Medline] Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "101,"

Phrase: "249258."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Hatakeyama,"

Phrase: "S."

Phrase: ","

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakayama,"

Phrase: "K.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.550: (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. 

Phrase: "(2002"

Phrase: ")"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "is"

Phrase: "associated with Parkin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "responsible for familial Parkinson's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its ubiquitin ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150685:ubiquitin-ligase activity [Molecular Function]
   913   C1325411:ubiquitin activity [Molecular Function]
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.551: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.552: Cell, 10, 5567.[CrossRef][ISI][Medline] Kahle, P.J. and Haass, C. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "10,"

Phrase: "5567."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kahle,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.553: (2004) How does parkin ligate ubiquitin to Parkinson's disease? 

Phrase: "(2004"

Phrase: ")"

Phrase: "How"

Phrase: "does"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ligate"

Phrase: "ubiquitin to Parkinson's disease?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.554: EMBO Rep., 5, 681685.[Abstract/Free FullText] Petrucelli, L., O'Farrell, C., Lockhart, P.J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. etal. 

Phrase: "EMBO Rep., 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1744664:REP [Molecular Function]

Phrase: "681685."

Phrase: "[Abstract/Free FullText"

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P.J.,"

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vink,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J. etal."
Processing 00000000.tx.555: (2002) Parkin protects against the toxicity associated with mutant -synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protects against the toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "associated with mutant -synuclein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "proteasome dysfunction selectively"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "catecholaminergic neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.556: Neuron, 36, 10071019.[CrossRef][ISI][Medline] Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. and Lu, B. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "36,"

Phrase: "10071019."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "Nishimura,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Imai,"

Phrase: "Y.,"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.557: (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "dopaminergic neuron-selective neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "induced by Pael-R in Drosophila."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0013138:Drosophila [Eukaryote]
   753   C0205090:R- [Spatial Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0684010:R. [Professional or Occupational Group]
   753   C1028876:Drosophila [Fungus]
   753   C1504613:Drosophila [Eukaryote]
   753   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.558: Neuron, 37, 911924.[CrossRef][ISI][Medline] Mata, I.F., Lockhart, P.J. and Farrer, M.J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "911924."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "I.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.559: (2004) Parkin genetics: one model for Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Parkin genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "one model for Parkinson's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0683033:disease model [Intellectual Product]
   797   C0684309:Disease model [Experimental Model of Disease]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.560: Hum. 

Phrase: "Hum."
Processing 00000000.tx.561: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.562: Genet., 13, R127R133.[Abstract/Free FullText] Sriram, S.R., Li, X., Ko, H.S., Chung, K.K., Wong, E., Lim, K.L., Dawson, V.L. and Dawson, T.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "13,"

Phrase: "R127R133."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sriram,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "H.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Wong,"

Phrase: "E.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.563: (2005) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of Parkin. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Familial-associated mutations differentially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the solubility,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037628:Solubility [Qualitative Concept]
   928 E C1749467:soluble [Cell Component]
   928 E C1948047:Soluble [Qualitative Concept]

Phrase: "localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ubiquitination properties of Parkin."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]
Processing 00000000.tx.564: Hum. 

Phrase: "Hum."
Processing 00000000.tx.565: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.566: Genet., in press. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in press."
Processing 00000000.tx.567: Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.568: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.569: Cell, 105, 891902.[CrossRef][ISI][Medline] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.570: (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the alpha-synuclein-interacting protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3541909:Alpha-Synuclein-Interacting Protein [Amino Acid, Peptide, or Protein]
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.571: Nat. 

Phrase: "Nat."
Processing 00000000.tx.572: Med., 7, 11441150.[CrossRef][ISI][Medline] Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. etal. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hampe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koutnikova,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Darios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jacquier,"

Phrase: "S."

Phrase: ","

Phrase: "Prigent,"

Phrase: "A.,"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Mirande,"

Phrase: "M. etal."
Processing 00000000.tx.573: (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The p38 subunit of the aminoacyl-tRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "protein biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597295:Protein Biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.574: Hum. 

Phrase: "Hum."
Processing 00000000.tx.575: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.576: Genet., 12, 14271437.[Abstract/Free FullText] Hyun, D.H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B. and Jenner, P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "14271437."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hyun,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Halliwell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.577: (2002) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Effect of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "mutant Parkin on oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "antioxidant defenses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003402:Antioxidant [Pharmacologic Substance]
   861   C1880266:Defense [Conceptual Entity]

Phrase: "and"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.578: J. 

Phrase: "J."
Processing 00000000.tx.579: Biol. 

Phrase: "Biol."
Processing 00000000.tx.580: Chem., 277, 2857228577.[Abstract/Free FullText] Gu, W.J., Corti, O., Araujo, F., Hampe, C., Jacquier, S., Lucking, C.B., Abbas, N., Duyckaerts, C., Rooney, T., Pradier, L. etal. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "2857228577."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gu,"

Phrase: "W.J.,"

Phrase: "Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Araujo,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hampe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jacquier,"

Phrase: "S."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Duyckaerts,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rooney,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pradier,"

Phrase: "L. etal."
Processing 00000000.tx.581: (2003) The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The C289G"

Phrase: "and"

Phrase: "C418R missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "rapid sequestration of human Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]

Phrase: "into insoluble aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.582: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.583: Dis., 14, 357364.[CrossRef][ISI][Medline] Winklhofer, K.F., Henn, I.H., Kay-Jackson, P.C., Heller, U. and Tatzelt, J. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "14,"

Phrase: "357364."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Winklhofer,"

Phrase: "K.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Henn,"

Phrase: "I.H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021966:I- [Inorganic Chemical]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kay-Jackson,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Heller,"

Phrase: "U."

Phrase: "and"

Phrase: "Tatzelt,"

Phrase: "J."
Processing 00000000.tx.584: (2003) Inactivation of Parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Inactivation of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "by oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "C-terminal truncations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706395:Truncation [Cell or Molecular Dysfunction]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: ":"

Phrase: "a protective role of molecular chaperones."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.585: J. 

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem., 278, 4719947208.[Abstract/Free FullText] Henn, I.H., Gostner, J.M., Lackner, P., Tatzelt, J. and Winklhofer, K.F. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "4719947208."

Phrase: "[Abstract/Free FullText"

Phrase: "] Henn,"

Phrase: "I.H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021966:I- [Inorganic Chemical]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gostner,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Lackner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tatzelt,"

Phrase: "J."

Phrase: "and"

Phrase: "Winklhofer,"

Phrase: "K.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.588: (2005) Pathogenic mutations inactivate Parkin by distinct mechanisms. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "inactivate"

Phrase: "Parkin by distinct mechanisms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.589: J. 

Phrase: "J."
Processing 00000000.tx.590: Neurochem., 92, 114122.[CrossRef][ISI][Medline] Jones, D., Crowe, E., Stevens, T.A. and Candido, E.P. 

Phrase: "Neurochem.,"

Phrase: "92,"

Phrase: "114122."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "D."

Phrase: ","

Phrase: "Crowe,"

Phrase: "E.,"

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "T.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Candido,"

Phrase: "E.P."
Processing 00000000.tx.591: (2002) Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "phylogenetic analysis of the ubiquitylation system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1519068:Phylogenetic Analysis [Research Activity]
   783   C0039152:analysis system [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in Caenorhabditis elegans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162610:Caenorhabditis elegans [Eukaryote]
   861   C0006638:Caenorhabditis [Eukaryote]

Phrase: ":"

Phrase: "ubiquitin-conjugating enzymes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0084913:Ubiquitin-Conjugating Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0301869:Conjugate [Immunologic Factor]

Phrase: "ubiquitin-activating enzymes,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0163974:Ubiquitin-Activating Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "ubiquitin-like proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.592: Genome Biol., 3, RESEARCH0002.1-0002.15 Hoppe, T., Cassata, G., Barral, J.M., Springer, W., Hutagalung, A.H., Epstein, H.F. and Baumeister, R. 

Phrase: "Genome Biol.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "RESEARCH0002.1-0002.15 Hoppe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cassata,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barral,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Springer,"

Phrase: "W.,"

Phrase: "Hutagalung,"

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Epstein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1396851:Epstein [Disease or Syndrome]

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Baumeister,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.593: (2004) Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Regulation of the myosin-directed chaperone UNC-45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by a novel E3/E4-multiubiquitylation complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in C. elegans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162610:C ELEGANS [Eukaryote]
Processing 00000000.tx.594: Cell, 118, 337349.[CrossRef][ISI][Medline] Hoppe, T. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "118,"

Phrase: "337349."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoppe,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.595: (2005) Multiubiquitylation by E4 enzymes: one size doesn't fit all. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Multiubiquitylation by E4 enzymes"

Phrase: ":"

Phrase: "one size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "doesn't"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "all."
Processing 00000000.tx.596: Trends Biochem. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.597: Sci., 30, 183187.[CrossRef][ISI][Medline] Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S. and Weissman, A.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "30,"

Phrase: "183187."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lorick,"

Phrase: "K.L., Jensen,"

Phrase: "J.P.,"

Phrase: "Fang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227136:Fang [Body Part, Organ, or Organ Component]

Phrase: "S."

Phrase: ","

Phrase: "Ong,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hatakeyama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Weissman,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.598: (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. 

Phrase: "(1999"

Phrase: ")"

Phrase: "RING fingers"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   966   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   966   C1521759:Ring Finger [Cell Component]
   861   C0016129:Fingers [Body Location or Region]
   861   C0521164:Ring [Spatial Concept]
   861   C0549188:fingers [Quantitative Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]
   827 E C1281584:Finger [Body Part, Organ, or Organ Component]
   789 E C0442015:Digital [Intellectual Product]
   789 E C1883674:Digital [Qualitative Concept]
   761 E C0582802:Digit [Body Part, Organ, or Organ Component]
   761 E C1283912:Digit [Body Part, Organ, or Organ Component]
   761 E C3241971:Digit [Quantitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "ubiquitin-conjugating enzyme"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0084913:Ubiquitin-conjugating enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0301869:Conjugate [Immunologic Factor]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ")-"

Phrase: "dependent ubiquitination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.599: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.600: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.601: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.602: USA, 96, 1136411369.[Abstract/Free FullText] Cookson, M.R., Lockhart, P.J., McLendon, C., O'Farrell, C., Schlossmacher, M. and Farrer, M.J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "1136411369."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cookson,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lockhart,"

Phrase: "P.J.,"

Phrase: "McLendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.603: (2003) RING finger 1 mutations in Parkin produce altered localization of the protein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "RING finger 1 mutations in Parkin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produce"

Phrase: "altered localization of the protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.604: Hum. 

Phrase: "Hum."
Processing 00000000.tx.605: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.606: Genet., 12, 29572965.[Abstract/Free FullText] Wang, C., Tan, J.M., Ho, M.W., Zaiden, N., Wong, S.H., Chew, C.L., Eng, P.W., Lim, T.M., Dawson, T.M. and Lim, K.L. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "29572965."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "M."

Phrase: "W., Zaiden,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wong,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chew,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024888:chew [Organ or Tissue Function]
  1000   C0699816:chew [Finding]
  1000   C1549534:Chew [Functional Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Eng,"

Phrase: "P.W., Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449205:LIM [Body Location or Region]
   827   C1538613:LIM [Gene or Genome]

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L."
Processing 00000000.tx.607: (2005) Alterations in the solubility and intracellular localization of Parkin by several familial Parkinson's disease-linked point mutations. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Alterations in the solubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "intracellular localization of Parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1660749:intracellular localization [Cell Function]
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "by several familial Parkinson's disease-linked point mutations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   818   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   795   C0026882:Mutations [Genetic Function]
   795   C1552961:Point [Quantitative Concept]
   795   C2347617:point [Quantitative Concept]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.608: J. 

Phrase: "J."
Processing 00000000.tx.609: Neurochem., 93, 422431.[CrossRef][ISI][Medline] Nass, R., Hall, D.H., Miller, D.M., III and Blakely, R.D. 

Phrase: "Neurochem.,"

Phrase: "93,"

Phrase: "422431."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027609:NAS [Disease or Syndrome]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hall,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "Blakely,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.610: (2002) Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurotoxin-induced degeneration of dopamine neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "in Caenorhabditis elegans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162610:Caenorhabditis elegans [Eukaryote]
   861   C0006638:Caenorhabditis [Eukaryote]
Processing 00000000.tx.611: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.612: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.613: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.614: USA, 99, 32643269.[Abstract/Free FullText] Shen, X., Ellis, R.E., Lee, K., Liu, C.Y., Yang, K., Solomon, A., Yoshida, H., Morimoto, R., Kurnit, D.M., Mori, K. etal. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "99,"

Phrase: "32643269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shen,"

Phrase: "X.,"

Phrase: "Ellis,"

Phrase: "R.E.,"

Phrase: "Lee,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liu,"

Phrase: "C.Y.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "A.,"

Phrase: "Yoshida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morimoto,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kurnit,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "K. etal."
Processing 00000000.tx.615: (2001) Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Complementary signaling pathways"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0037080:Signal Pathways [Molecular Function]
   884   C0037083:signaling pathway [Cell Function]
   884   C0086982:Signaling Pathway [Molecular Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "regulate"

Phrase: "the unfolded protein response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155342:Unfolded Protein Response [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "are"

Phrase: "required for C. elegans development."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1514873:Required [Functional Concept]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.616: Cell, 107, 893903.[CrossRef][ISI][Medline] Calfon, M., Zeng, H., Urano, F., Till, J.H., Hubbard, S.R., Harding, H.P., Clark, S.G. and Ron, D. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "107,"

Phrase: "893903."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Calfon,"

Phrase: "M."

Phrase: ","

Phrase: "Zeng,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Urano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Till,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hubbard,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Harding,"

Phrase: "H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Clark,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.617: (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. 

Phrase: "(2002"

Phrase: ")"

Phrase: "IRE1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414444:IRE1 [Gene or Genome]

Phrase: "couples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:Couples [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "endoplasmic reticulum load to secretory capacity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550025:Load [Idea or Concept]
   753   C1704782:Load [Manufactured Object]
   753   C1708715:Load [Activity]

Phrase: "by processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "the XBP-1 mRNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C2825104:XBP-1 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.618: Nature, 415, 9296.[CrossRef][ISI][Medline] Urano, F., Calfon, M., Yoneda, T., Yun, C., Kiraly, M., Clark, S.G. and Ron, D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "415,"

Phrase: "9296."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Urano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Calfon,"

Phrase: "M."

Phrase: ","

Phrase: "Yoneda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yun,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kiraly,"

Phrase: "M."

Phrase: ","

Phrase: "Clark,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ron,"

Phrase: "D."
Processing 00000000.tx.619: (2002) A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. 

Phrase: "(2002"

Phrase: ")"

Phrase: "A survival pathway for Caenorhabditis elegans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "with a blocked unfolded protein response."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1155342:Unfolded Protein Response [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
Processing 00000000.tx.620: J. 

Phrase: "J."
Processing 00000000.tx.621: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.622: Biol., 158, 639646.[Abstract/Free FullText] Cao, S., Gelwix, C.C., Caldwell, K.A. and Caldwell, G.A. 

Phrase: "Biol.,"

Phrase: "158,"

Phrase: "639646."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cao,"

Phrase: "S."

Phrase: ","

Phrase: "Gelwix,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Caldwell,"

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Caldwell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.623: (2005) Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Torsin-mediated protection from cellular stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "in the dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of Caenorhabditis elegans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162610:Caenorhabditis elegans [Eukaryote]
   861   C0006638:Caenorhabditis [Eukaryote]
Processing 00000000.tx.624: J. 

Phrase: "J."
Processing 00000000.tx.625: Neurosci., 25, 38013812.[Abstract/Free FullText] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Neurosci.,"

Phrase: "25,"

Phrase: "38013812."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.626: (2000) Parkin functions as an E2-dependent ubiquitinprotein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitinprotein ligase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1705273:Function [Intellectual Product]
   748   C3244310:dependent [Functional Concept]
   748   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.627: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.628: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.629: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.630: USA, 97, 1335413359.[Abstract/Free FullText] Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Palacino,"

Phrase: "J.J.,"

Phrase: "Sagi,"

Phrase: "D."

Phrase: ","

Phrase: "Goldberg,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krauss,"

Phrase: "S."

Phrase: ","

Phrase: "Motz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wacker,"

Phrase: "M."

Phrase: ","

Phrase: "Klose,"

Phrase: "J."

Phrase: "and"

Phrase: "Shen,"

Phrase: "J."
Processing 00000000.tx.631: (2004) Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidative damage in Parkin-deficient mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]
Processing 00000000.tx.632: J. 

Phrase: "J."
Processing 00000000.tx.633: Biol. 

Phrase: "Biol."
Processing 00000000.tx.634: Chem., 279, 1861418622.[Abstract/Free FullText] Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J. etal. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "279,"

Phrase: "1861418622."

Phrase: "[Abstract/Free FullText"

Phrase: "] Goldberg,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fleming,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331812:Fleming [Health Care Related Organization]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Palacino,"

Phrase: "J.J.,"

Phrase: "Cepeda,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lam,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Bhatnagar,"

Phrase: "A.,"

Phrase: "Meloni,"

Phrase: "E.G."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ackerson,"

Phrase: "L.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Klapstein,"

Phrase: "G.J. etal."
Processing 00000000.tx.635: (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "nigrostriatal deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "but"

Phrase: "not loss of dopaminergic neurons."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C3550005:Loss of dopaminergic neurons [Finding]
   844   C0598940:Loss of neurons [Finding]
           neuron loss
   760   C1517945:Loss [Quantitative Concept]
   756 E C1850496:Neuronal loss [Finding]
Processing 00000000.tx.636: J. 

Phrase: "J."
Processing 00000000.tx.637: Biol. 

Phrase: "Biol."
Processing 00000000.tx.638: Chem., 278, 4362843635.[Abstract/Free FullText] Lorenzetti, D., Antalffy, B., Vogel, H., Noveroske, J., Armstrong, D. and Justice, M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "4362843635."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lorenzetti,"

Phrase: "D."

Phrase: ","

Phrase: "Antalffy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vogel,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Noveroske,"

Phrase: "J.,"

Phrase: "Armstrong,"

Phrase: "D."

Phrase: "and"

Phrase: "Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022437:Justice [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.639: (2004) The neurological mutant quaking (viable) is Parkin deficient. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The neurological mutant quaking"

Phrase: "(viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "deficient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011155:Deficient [Functional Concept]
  1000   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.640: Mamm. 

Phrase: "Mamm."
Processing 00000000.tx.641: Genome, 15, 210217.[CrossRef][ISI][Medline] Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A. etal. 

Phrase: "Genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "15,"

Phrase: "210217."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Chew,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024888:chew [Organ or Tissue Function]
   827   C0699816:chew [Finding]
   827   C1549534:Chew [Functional Concept]

Phrase: "K.C., Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302595:tan [Individual Behavior]
   827   C1537110:Tan [Clinical Attribute]
   827   C3275241:Tan [Qualitative Concept]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "W.,"

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A. etal."
Processing 00000000.tx.642: (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "nonclassical, proteasomal-independent ubiquitination of synphilin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1519751:Ubiquitination [Molecular Function]

Phrase: ":"

Phrase: "implications for Lewy body formation."
Processing 00000000.tx.643: J. 

Phrase: "J."
Processing 00000000.tx.644: Neurosci., 25, 20022009.[Abstract/Free FullText] Liani, E., Eyal, A., Avraham, E., Shemer, R., Szargel, R., Berg, D., Bornemann, A., Riess, O., Ross, C.A., Rott, R. etal. 

Phrase: "Neurosci.,"

Phrase: "25,"

Phrase: "20022009."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liani,"

Phrase: "E.,"

Phrase: "Eyal,"

Phrase: "A.,"

Phrase: "Avraham,"

Phrase: "E.,"

Phrase: "Shemer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Szargel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berg,"

Phrase: "D."

Phrase: ","

Phrase: "Bornemann,"

Phrase: "A.,"

Phrase: "Riess,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Rott,"

Phrase: "R. etal."
Processing 00000000.tx.645: (2004) Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ubiquitylation of synphilin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitylation [Molecular Function]

Phrase: "and"

Phrase: "alpha-synuclein by SIAH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439095:Alpha [Intellectual Product]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "its presence in cellular inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "imply"

Phrase: "a role in Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.646: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.647: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.648: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.649: USA, 101, 55005505.[Abstract/Free FullText] Nagano, Y., Yamashita, H., Takahashi, T., Kishida, S., Nakamura, T., Iseki, E., Hattori, N., Mizuno, Y., Kikuchi, A. and Matsumoto, M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "101,"

Phrase: "55005505."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nagano,"

Phrase: "Y.,"

Phrase: "Yamashita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iseki,"

Phrase: "E.,"

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kikuchi,"

Phrase: "A."

Phrase: "and"

Phrase: "Matsumoto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.650: (2003) Siah-1 facilitates ubiquitination and degradation of synphilin-1. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Siah-1"

Phrase: "facilitates"

Phrase: "ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation of synphilin-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.651: J. 

Phrase: "J."
Processing 00000000.tx.652: Biol. 

Phrase: "Biol."
Processing 00000000.tx.653: Chem., 278, 5150451514.[Abstract/Free FullText] Ito, T., Niwa, J., Hishikawa, N., Ishigaki, S., Doyu, M. and Sobue, G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "5150451514."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Niwa,"

Phrase: "J.,"

Phrase: "Hishikawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ishigaki,"

Phrase: "S."

Phrase: ","

Phrase: "Doyu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sobue,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.654: (2003) Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Dorfin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421990:DORFIN [Gene or Genome]

Phrase: "localizes to Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C0392752:localize [Spatial Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "ubiquitylates synphilin-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
   901   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.655: J. 

Phrase: "J."
Processing 00000000.tx.656: Biol. 

Phrase: "Biol."
Processing 00000000.tx.657: Chem., 278, 2910629114.[Abstract/Free FullText] Sherman, M.Y. and Goldberg, A.L. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "2910629114."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sherman,"

Phrase: "M."

Phrase: "Y."

Phrase: "and"

Phrase: "Goldberg,"

Phrase: "A.L."
Processing 00000000.tx.658: (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Cellular defenses against unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880266:Defense [Conceptual Entity]

Phrase: ":"

Phrase: "a cell biologist thinks about neurodegenerative diseases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0039869:think [Mental Process]
Processing 00000000.tx.659: Neuron, 29, 1532.[CrossRef][ISI][Medline] Forman, M.S., Lee, V.M. and Trojanowski, J.Q. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "29,"

Phrase: "1532."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Forman,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J.Q."
Processing 00000000.tx.660: (2003) Unfolding pathways in neurodegenerative disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Unfolding pathways in neurodegenerative disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1511986:Disease Pathway [Conceptual Entity]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.661: Trends Neurosci., 26, 407410.[CrossRef][ISI][Medline] Ryu, E.J., Harding, H.P., Angelastro, J.M., Vitolo, O.V., Ron, D. and Greene, L.A. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "26,"

Phrase: "407410."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ryu,"

Phrase: "E.J.,"

Phrase: "Harding,"

Phrase: "H.P.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Angelastro,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Vitolo,"

Phrase: "O.V., Ron,"

Phrase: "D."

Phrase: "and"

Phrase: "Greene,"

Phrase: "L.A."
Processing 00000000.tx.662: (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "the unfolded protein response in cellular models of Parkinson's disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   782   C1155342:Unfolded Protein Response [Molecular Function]
   757   C1704632:Disease Response [Finding]
           Response
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0871261:Response [Organism Attribute]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]
Processing 00000000.tx.663: J. 

Phrase: "J."
Processing 00000000.tx.664: Neurosci., 22, 1069010698.[Abstract/Free FullText] Braungart, E., Gerlach, M., Riederer, P., Baumeister, R. and Hner, M. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "1069010698."

Phrase: "[Abstract/Free FullText"

Phrase: "] Braungart,"

Phrase: "E.,"

Phrase: "Gerlach,"

Phrase: "M."

Phrase: ","

Phrase: "Riederer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baumeister,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.665: (2004) Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Caenorhabditis elegans MPP+ model of Parkinson's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0683033:disease model [Intellectual Product]
   774   C0684309:Disease model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]

Phrase: "for high-throughput drug screenings."
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   912   C0872187:High Throughput Screening [Diagnostic Procedure]
   861   C0013206:Screenings, Drug [Research Activity]
   827 E C0373483:drug screening [Laboratory Procedure]
   812   C0013227:Drug [Pharmacologic Substance]
   812   C0220908:Screenings [Health Care Activity]
   812   C1254351:Drug [Pharmacologic Substance]
   779 E C0220909:screening [Functional Concept]
   779 E C1698960:screening [Intellectual Product]
   779 E C1710031:Screening [Diagnostic Procedure]
   779 E C1710477:SCREENING [Research Activity]
   756 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   756 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   719 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.666: Neurodegenerative Dis., 1, 175183.[CrossRef] Eriksen, J.L., Dawson, T.M., Dickson, D.W. and Petrucelli, L. 

Phrase: "Neurodegenerative Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "175183."

Phrase: "[CrossRef"

Phrase: "] Eriksen,"

Phrase: "J.L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551910:Dawson [Language]

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Petrucelli,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.667: (2003) Caught in the act: -synuclein is the culprit in Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Caught in the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0231617:Catch [Sign or Symptom]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: ": -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the culprit in Parkinson's disease."
Processing 00000000.tx.668: Neuron, 40, 453456.[CrossRef][ISI][Medline] Giasson, B.I., Duda, J.E., Quinn, S.M., Zhang, B., Trojanowski, J.Q. and Lee, V.M. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "453456."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giasson,"

Phrase: "B.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Duda,"

Phrase: "J.E.,"

Phrase: "Quinn,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.669: (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuronal alpha-synucleinopathy with severe movement disorder"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "A53T human alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439095:Alpha [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.670: Neuron, 34, 521533.[CrossRef][ISI][Medline] Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B. and Pallanck, L.J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "34,"

Phrase: "521533."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greene,"

Phrase: "J.C., Whitworth,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Kuo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Andrews,"

Phrase: "L.A.,"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Pallanck,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.671: (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mitochondrial pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "apoptotic muscle degeneration in Drosophila parkin mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0234958:MUSCLE DEGENERATION [Disease or Syndrome]
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.672: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.673: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.674: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.675: USA, 100, 40784083.[Abstract/Free FullText] Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M., Bellen, H. and Mardon, G. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "40784083."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pesah,"

Phrase: "Y.,"

Phrase: "Pham,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Burgess,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Middlebrooks,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Verstreken,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhou,"

Phrase: "Y.,"

Phrase: "Harding,"

Phrase: "M."

Phrase: ","

Phrase: "Bellen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mardon,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.676: (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Drosophila parkin mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "decreased mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "cell size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162658:Cell Size [Organism Attribute,Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "increased sensitivity to oxygen radical stress."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   790   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.677: Development, 131, 21832194.[Abstract/Free FullText] Itier, J.M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L. etal. 

Phrase: "Development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "131,"

Phrase: "21832194."

Phrase: "[Abstract/Free FullText"

Phrase: "] Itier,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cohen-Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036110:Salmon [Fish]
   861   C0327949:salmon [Fish]
   861   C0459210:Salmon [Food]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bohme,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Laville,"

Phrase: "M."

Phrase: ","

Phrase: "Pratt,"

Phrase: "J.,"

Phrase: "Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Pradier,"

Phrase: "L. etal."
Processing 00000000.tx.678: (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin gene inactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0598496:Gene Inactivation [Genetic Function]
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "behaviour"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "dopamine neurotransmission in the mouse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027793:Neurotransmission [Cell Function]
Processing 00000000.tx.679: Hum. 

Phrase: "Hum."
Processing 00000000.tx.680: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.681: Genet., 12, 22772291.[Abstract/Free FullText] Von Coelln, R., Thomas, B., Savitt, J.M., Lim, K.L., Sasaki, M., Hess, E.J., Dawson, V.L. and Dawson, T.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "22772291."

Phrase: "[Abstract/Free FullText"

Phrase: "] Von Coelln,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thomas,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Savitt,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Sasaki,"

Phrase: "M."

Phrase: ","

Phrase: "Hess,"

Phrase: "E.J.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.682: (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Loss of locus coeruleus neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C0598940:Loss of neurons [Finding]
           neuron loss
   760   C1517945:Loss [Quantitative Concept]
   756 E C1850496:Neuronal loss [Finding]

Phrase: "and"

Phrase: "reduced startle in parkin null mice."
Processing 00000000.tx.683: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.684: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.685: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.686: USA, 101, 1074410749.[Abstract/Free FullText] Brenner, S. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "101,"

Phrase: "1074410749."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brenner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.687: (1974) The genetics of Caenorhabditis elegans. 

Phrase: "(1974"

Phrase: ")"

Phrase: "The genetics of Caenorhabditis elegans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
Processing 00000000.tx.688: Genetics, 77, 7194.[Abstract/Free FullText]

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "77,"

Phrase: "7194."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

